
<html lang="en"     class="pb-page"  data-request-id="8294730c-c71b-4904-afae-033d25fc386a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.8b01723;issue:issue:10.1021/jmcmar.2019.62.issue-2;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Molecular Mechanism of Inhibition of Acid Ceramidase by Carmofur" /></meta><meta name="dc.Creator" content="Alexey  Dementiev" /></meta><meta name="dc.Creator" content="Andrzej  Joachimiak" /></meta><meta name="dc.Creator" content="Ha  Nguyen" /></meta><meta name="dc.Creator" content="Alexei  Gorelik" /></meta><meta name="dc.Creator" content="Katalin  Illes" /></meta><meta name="dc.Creator" content="Saman  Shabani" /></meta><meta name="dc.Creator" content="Michael  Gelsomino" /></meta><meta name="dc.Creator" content="Eun-Young Erin  Ahn" /></meta><meta name="dc.Creator" content="Bhushan  Nagar" /></meta><meta name="dc.Creator" content="Ninh  Doan" /></meta><meta name="dc.Description" content="Human acid ceramidase (AC) is a lysosomal cysteine amidase, which has received a great deal of interest in recent years as a potential target for the development of new therapeutics against melanom..." /></meta><meta name="Description" content="Human acid ceramidase (AC) is a lysosomal cysteine amidase, which has received a great deal of interest in recent years as a potential target for the development of new therapeutics against melanom..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 7, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01723" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01723" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01723" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01723" /></link>
        
    
    

<title>Molecular Mechanism of Inhibition of Acid Ceramidase by Carmofur | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01723" /></meta><meta property="og:title" content="Molecular Mechanism of Inhibition of Acid Ceramidase by Carmofur" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01723/20190116/images/large/jm-2018-017236_0004.jpeg" /></meta><meta property="og:description" content="Human acid ceramidase (AC) is a lysosomal cysteine amidase, which has received a great deal of interest in recent years as a potential target for the development of new therapeutics against melanoma and glioblastoma tumors. Despite the strong interest in obtaining structural information, only the structures of the apo-AC enzyme in its zymogen and activated conformations are available. In this work, the crystal structure of AC in complex with the covalent carmofur inhibitor is presented. Carmofur is an antineoplastic drug containing an electrophilic carbonyl reactive group that targets the catalytic cysteine. This novel structural data explains the basis of the AC inhibition, provides insights into the enzymatic properties of the protein, and is a great aid toward the structure-based drug design of potent inhibitors for AC, providing the detailed mechanism, which has eluded the scientific community for more than 30 years, of carmofur’s mysterious 5-fluorouracil-independent antitumor activity." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01723"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01723">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01723&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01723&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01723&amp;href=/doi/10.1021/acs.jmedchem.8b01723" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 2</span><span class="cit-fg-pageRange">, 987-992</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/2" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b01655" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b01755" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Molecular Mechanism of Inhibition of Acid Ceramidase by Carmofur</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Alexey Dementiev</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alexey Dementiev</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Structural Biology Center, Biosciences Division, Argonne National Laboratory, Lemont, Illinois 60439, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alexey++Dementiev">Alexey Dementiev</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Andrzej Joachimiak</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Andrzej Joachimiak</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Structural Biology Center, Biosciences Division, Argonne National Laboratory, Lemont, Illinois 60439, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Andrzej++Joachimiak">Andrzej Joachimiak</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ha Nguyen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ha Nguyen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">California Institute of Neuroscience, Thousand Oaks, California 91360, United States</div><div class="loa-info-affiliations-info">National Skull Base Center, Thousand Oaks, California 91360, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ha++Nguyen">Ha Nguyen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alexei Gorelik</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alexei Gorelik</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry and Groupe de Recherche Axé sur la Structure des Protéines, McGill University, Montreal, Quebec H3G 0B1, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alexei++Gorelik">Alexei Gorelik</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Katalin Illes</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Katalin Illes</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry and Groupe de Recherche Axé sur la Structure des Protéines, McGill University, Montreal, Quebec H3G 0B1, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Katalin++Illes">Katalin Illes</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Saman Shabani</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Saman Shabani</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Neurosurgery, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Saman++Shabani">Saman Shabani</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael Gelsomino</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael Gelsomino</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Neurosurgery, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Gelsomino">Michael Gelsomino</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eun-Young Erin Ahn</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eun-Young Erin Ahn</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Neurosurgery, Mitchell Cancer Institute, University of South Alabama, Mobile, Alabama 36617 United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eun-Young+Erin++Ahn">Eun-Young Erin Ahn</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bhushan Nagar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bhushan Nagar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry and Groupe de Recherche Axé sur la Structure des Protéines, McGill University, Montreal, Quebec H3G 0B1, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bhushan++Nagar">Bhushan Nagar</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Ninh Doan</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ninh Doan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Neurosurgery, Mitchell Cancer Institute, University of South Alabama, Mobile, Alabama 36617 United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#a6c8c2c9c7c8e6cec3c7cad2ce88d5c9d3d2cec7cac7c4c7cbc788c3c2d3"><span class="__cf_email__" data-cfemail="563832393738163e33373a223e78253923223e373a3734373b3778333223">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ninh++Doan">Ninh Doan</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9211-2162" title="Orcid link">http://orcid.org/0000-0001-9211-2162</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01723&amp;href=/doi/10.1021%2Facs.jmedchem.8b01723" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 2</span><span class="cit-pageRange">, 987–992</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 7, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>4 November 2018</li><li><span class="item_label"><b>Published</b> online</span>7 December 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 January 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01723" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01723</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D987%26pageCount%3D6%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAlexey%2BDementiev%252C%2BAndrzej%2BJoachimiak%252C%2BHa%2BNguyen%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D2%26contentID%3Dacs.jmedchem.8b01723%26title%3DMolecular%2BMechanism%2Bof%2BInhibition%2Bof%2BAcid%2BCeramidase%2Bby%2BCarmofur%26numPages%3D6%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D992%26publicationDate%3DJanuary%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01723"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1145</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">16</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01723" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Molecular Mechanism of Inhibition of Acid Ceramidase by Carmofur&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Alexey&quot;,&quot;last_name&quot;:&quot;Dementiev&quot;},{&quot;first_name&quot;:&quot;Andrzej&quot;,&quot;last_name&quot;:&quot;Joachimiak&quot;},{&quot;first_name&quot;:&quot;Ha&quot;,&quot;last_name&quot;:&quot;Nguyen&quot;},{&quot;first_name&quot;:&quot;Alexei&quot;,&quot;last_name&quot;:&quot;Gorelik&quot;},{&quot;first_name&quot;:&quot;Katalin&quot;,&quot;last_name&quot;:&quot;Illes&quot;},{&quot;first_name&quot;:&quot;Saman&quot;,&quot;last_name&quot;:&quot;Shabani&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Gelsomino&quot;},{&quot;first_name&quot;:&quot;Eun-Young&quot;,&quot;last_name&quot;:&quot;Erin Ahn&quot;},{&quot;first_name&quot;:&quot;Bhushan&quot;,&quot;last_name&quot;:&quot;Nagar&quot;},{&quot;first_name&quot;:&quot;Ninh&quot;,&quot;last_name&quot;:&quot;Doan&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;07&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;987-992&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01723&quot;},&quot;abstract&quot;:&quot;Human acid ceramidase (AC) is a lysosomal cysteine amidase, which has received a great deal of interest in recent years as a potential target for the development of new therapeutics against melanoma and glioblastoma tumors. Despite the strong interest in obtaining structural information, only the structures of the apo-AC enzyme in its zymogen and activated conformations are available. In this work, the crystal structure of AC in complex with the covalent carmofur inhibitor is presented. Carmofur is an antineoplastic drug containing an electrophilic carbonyl reactive group that targets the catalytic cysteine. This novel structural data explains the basis of the AC inhibition, provides insights into the enzymatic properties of the protein, and is a great aid toward the structure-based drug design of potent inhibitors for AC, providing the detailed mechanism, which has eluded the scientific community for more than 30 years, of carmofur’s mysterious 5-fluorouracil-independent antitumor activity.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01723&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01723" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01723&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01723" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01723&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01723" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01723&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01723&amp;href=/doi/10.1021/acs.jmedchem.8b01723" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01723" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01723" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01723%26sid%3Dliteratum%253Aachs%26genre%3Darticle%26aulast%3DDementiev%26date%3D2019%26atitle%3DMolecular%2BMechanism%2Bof%2BInhibition%2Bof%2BAcid%2BCeramidase%2Bby%2BCarmofur%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D2%26spage%3D987%26epage%3D992%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291120" title="Hydrophobicity">Hydrophobicity</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291137" title="Lipids">Lipids</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/2" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/jmcmar.2019.62.issue-2/20190124/jmcmar.2019.62.issue-2.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01723/20190116/images/medium/jm-2018-017236_0004.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01723/20190116/images/large/jm-2018-017236_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01723&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Human acid ceramidase (AC) is a lysosomal cysteine amidase, which has received a great deal of interest in recent years as a potential target for the development of new therapeutics against melanoma and glioblastoma tumors. Despite the strong interest in obtaining structural information, only the structures of the apo-AC enzyme in its zymogen and activated conformations are available. In this work, the crystal structure of AC in complex with the covalent carmofur inhibitor is presented. Carmofur is an antineoplastic drug containing an electrophilic carbonyl reactive group that targets the catalytic cysteine. This novel structural data explains the basis of the AC inhibition, provides insights into the enzymatic properties of the protein, and is a great aid toward the structure-based drug design of potent inhibitors for AC, providing the detailed mechanism, which has eluded the scientific community for more than 30 years, of carmofur’s mysterious 5-fluorouracil-independent antitumor activity.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36157" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36157" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The pyrimidine analogue 5-fluorouracil (5-FU) inhibits thymidylate synthase, an enzyme responsible for the synthesis of thymidine that contributes to DNA replication.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The compound has been effective in the treatment of several solid tumors, particularly head, neck, and gastrointestinal tumors.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> In fact, the compound is the third most common agent employed against solid cancers globally.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Efforts to discover derivatives of 5-FU that were less toxic to the host and more effective against malignancies led to the discovery of carmofur (1-hexylcarbamoyl-5-fluorouracil), which has been used to treat patients with colorectal cancers for more than 30 years.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> Early studies suggested that the hexylcarbamoyl structure (more lipophilic) eases the transport of carmofur through the cell membrane, providing a higher therapeutic ratio.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> For more than 30 years, carmofur has been considered a masked compound of 5-FU and believed to function similarly to 5-FU.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> However, some researchers have questioned this mechanism, as carmofur was also as effective in targeting 5-FU resistant cells compared to control.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The exact mechanism of the 5-FU independent antitumor activity of carmofur has remained a mystery. Studies have implicated carmofur’s involvement in multiple pathways.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> Carmofur, which has seen clinical use since 1981, significantly augments overall survival and disease-free survival in colon cancers.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> In addition, carmofur appears effective against breast, gastric, bladder, and colorectal cancers.<a onclick="showRef(event, 'ref7 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref7 ref10 ref11">(7,10,11)</a></div><div class="NLM_p">Human acid ceramidase (AC) (EC 3.5.1.23), an intracellular two-subunit cysteine amidase, catalyzes hydrolysis of ceramides into sphingosine and free fatty acids.<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12−14)</a> Ceramides favor cell-cycle arrest and apoptosis; on the other hand, sphingososine-1-phospate (S1P), a direct derivative of sphingosine, encourages angiogenesis, cell survival, and cell proliferation.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> AC levels are raised in several malignancies, including breast,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> prostate,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> colorectal,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> melanoma,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and brain.<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20,21)</a> Moreover, downregulation or inhibition of AC has been associated with anticancer activity. The deletion of AC gene in melanoma cells has been shown to hinder the formation of cancer-initiating cells.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> We have shown that inhibition of AC effectively combats several brain cancer cell lines, including glioblastoma, medulloblastoma, and atypical teratoid/rhaboid tumors.<a onclick="showRef(event, 'ref13 ref20 ref21 ref23 ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref13 ref20 ref21 ref23 ref24 ref25 ref26">(13,20,21,23−26)</a> Thus, recent data has made AC an attractive target for designing selective and potent inhibitors, which can modulate the balance between cell proliferation and death with the influence on both growth and survival of normal and neoplastic cells. Currently, there is no AC inhibitor clinically available to treat patients.</div><div class="NLM_p">Recently, colleagues discovered that carmofur inhibits the activity of AC, and using liquid chromatography mass spectrometry, they revealed a derivative of carmofur inhibited AC through the covalent modification of the catalytic cysteine residue.<a onclick="showRef(event, 'ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29">(27−29)</a> However, the exact mechanism of inhibition between actual carmofur and AC has not been elaborated. These results prompted us to study the interaction between the carmofur inhibitor and human AC at the structural level.</div><div class="NLM_p">The inactive zymogen form of AC is secreted as a single-chain polypeptide of 374 residues with molecular weight of 50–55 kDa, depending on the extent of glycosylation.<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12−14)</a> Upon autoactivation, the AC proenzyme is cleaved at the Thr142-Cys143 peptide bond, generating an α-subunit consisting of a 13 kDa chain and a 37–42 kDa β-subunit chain held together by the Cys31–Cys340 disulfide bond.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a> In recent work, a catalytic mechanism for AC autoactivation was described based on structural data obtained for the apo-form of the enzyme in its zymogen and activated states.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><div class="NLM_p">In this work, we crystallized and solved the structure of human active AC in complex with carmofur at 2.7 Å resolution. The mature form of AC in the complex adopts the same fold as the apo protein. The fatty acid moiety of the carmofur molecule after catalytic cleavage of the inhibitor at its carbonyl group covalently modifies the active site Cys143 and occupies one of the hydrophobic cavities close to the enzyme active site. Simple modeling data reveals the plausible mechanism of substrate degradation. Also, the structure of the AC–inhibitor complex provides important information about the geometry of the binding site, which is a critical asset for understanding the determinants for selectivity and specificity in AC–ligand interactions.</div><div class="NLM_p last">Via crystal structural analysis, this study is the first to definitively demonstrate that carmofur directly binds to AC and prompts its inhibition, providing the detailed mechanism which has eluded the scientific community for more than 30 years of its mysterious 5-FU-independent antitumor activity. This provides the impetus to now engage in clinical trial with carmofur for treatment of various types of cancers targeting AC as a new class of anticancer drugs.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48583" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48583" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Overall Structure of the AC–Carmofur Complex</h3><div class="NLM_p">The structure of human AC in covalent complex with the free fatty acid tail of the small carmofur inhibitor (5-fluoro-<i>N</i>-hexyl-2,4-dioxo-pyrimidine-1-carboxamide, Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01723/suppl_file/jm8b01723_si_001.pdf" class="ext-link">Figure S1</a>) was solved at a resolution of 2.7 Å (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). For the final model, 114 residues (residues 27–140 excluding the signal peptide) of the α-subunit and all 253 residues (residues 143–395) of the β-subunit, with the exception of a few side chains, were traceable in the electron density map (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). The heterodimeric structure of AC displays strong structural similarity with that of other members of the Ntn-hydrolase family, consisting of two β sheets forming the substrate-binding site and the catalytic residues, Cys143, Asp162, Glu225, and Asn320, located at the cleft between these two sheets, which are flanked by six α-helices (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A). The main body of the α-subunit is positioned on the molecular surface of the β-subunit far away from the active site entrance, with its N-terminal segment wrapping around the β-subunit to reach a distance of 12.5 Å between Cα atoms of the α-chain N-terminal Trp27 and the α-chain C-terminal Trp396 and is covalently linked to the β-domain through a disulfide bridge between Cys31–Cys340. The α-chain also makes contacts from both the backbone and side chains of its C-terminus to the residues in the β-domain located close to the active site cleft (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A). These include a weak hydrogen bond from the backbone carbonyl of Glu138 to the backbone amino group of Gly232, a hydrogen bond from the side chain of Glu138 to the backbone amino group of Ile249, and a hydrogen bond from the side chain of Asn134 to the backbone amino group of Val208. Finally, the side chains of Phe140, Leu139, Tyr137, and Ile135 of α-subunit form extensive hydrophobic interactions with residues located on the helix (230–241) and the loop (244–249) of the β-subunit.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Data Collection and Refinement Statistics</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="2" align="center">Data Collection</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">wavelength (Å)</td><td class="colsep0 rowsep0" align="left">0.9793</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">resolution range (Å)</td><td class="colsep0 rowsep0" align="left">50.00–2.74 (2.79–2.74)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">space group</td><td class="colsep0 rowsep0" align="left"><i>C</i>2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">unit cell</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>a</i>, <i>b</i>, <i>c</i> (Å)</td><td class="colsep0 rowsep0" align="left">153.718, 68.650, 98.386</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">α, β, γ (deg)</td><td class="colsep0 rowsep0" align="left">90.000, 120.727, 90.000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">total reflections</td><td class="colsep0 rowsep0" align="left">114299</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">unique reflections</td><td class="colsep0 rowsep0" align="left">23259 (1,186)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">multiplicity</td><td class="colsep0 rowsep0" align="left">4.9 (4.0)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">completeness (%)</td><td class="colsep0 rowsep0" align="left">100.00 (99.9)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">17.86 (1.89)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i><sub>merge</sub><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a> (%)</td><td class="colsep0 rowsep0" align="left">11.1 (68.0)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Wilson <i>B</i>-factor (Å<sup>2</sup>)</td><td class="colsep0 rowsep0" align="left">53.95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">Refinement</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">resolution range (Å)</td><td class="colsep0 rowsep0" align="left">48.65–2.74 (2.84–2.74)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i><sub>work</sub>/<i>R</i><sub>free</sub><a class="ref internalNav" href="#t1fn4" aria-label="d">d</a> (%)</td><td class="colsep0 rowsep0" align="left">21.41 (29.57)/226.16 (36.72)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">no. of non-hydrogen atoms<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">6208</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">protein</td><td class="colsep0 rowsep0" align="left">5864</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ligands</td><td class="colsep0 rowsep0" align="left">265</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">waters</td><td class="colsep0 rowsep0" align="left">79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RMS<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> (bonds, Å)</td><td class="colsep0 rowsep0" align="left">0.006</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RMS (angles, deg)</td><td class="colsep0 rowsep0" align="left">1.006</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ramachandran favored (%)</td><td class="colsep0 rowsep0" align="left">97.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ramachadran allowed (%)</td><td class="colsep0 rowsep0" align="left">2.75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ramachandran outliers (%)</td><td class="colsep0 rowsep0" align="left">0.00</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">average <i>B</i>-factor (Å<sup>2</sup>)</td><td class="colsep0 rowsep0" align="left">51.13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">macromolecules</td><td class="colsep0 rowsep0" align="left">50.36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ligands</td><td class="colsep0 rowsep0" align="left">69.90</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">waters</td><td class="colsep0 rowsep0" align="left">45.25</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">RMS, root-mean-square deviation from ideal values (crystallography).</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Statistics for the highest-resolution shell are shown in parentheses.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last"><i>R</i><sub>merge</sub> = 100∑(<i>h</i>) ∑(<i>i</i>)|<i>I</i>(<i>i</i>) – ⟨<i>I</i>⟩|/∑(<i>h</i>) Σ(<i>i</i>)<i>I</i>(<i>i</i>), where <i>I</i>(<i>i</i>) is the <i>i</i>th intensity measurement of reflection <i>h</i>, and ⟨<i>I</i> is the average intensity from multiple observations.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last"><i>R</i><sub>factor</sub> = ∑||<i>F</i><sub>obs</sub>| – |<i>F</i><sub>calc</sub>||/∑|<i>F</i><sub>obs</sub>|, where <i>F</i><sub>obs</sub> and <i>F</i><sub>calc</sub> are the structure factor amplitudes from the data and the model, respectively; 8.6% reflections were used to calculate <i>R</i><sub>free</sub> values.</p></div><div class="footnote" id="t1fn5"><sup><sup>e</sup></sup><p class="last">Per asymmetric unit.</p></div></div></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01723/20190116/images/medium/jm-2018-017236_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01723/20190116/images/large/jm-2018-017236_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Crystal structure of human AC in covalent complex with the carmofur fatty acid moiety. (A) Ribbon diagram (α-subunit in magenta, β-subunit in cyan) of the covalent complex. The inhibitor fatty acid moiety is shown in yellow sticks. The side chains of <i>N</i>-glycosylated Asn173, Asn259, Asn286, and Asn342 are shown in cyan sticks, and modeled sugar units are shown in orange sticks. One disulfide bond, Cys31–Cys340, is shown in yellow. The N- and C-termini are labeled. (B) Superposition of the covalent complex (cyan) and apo-form of AC (magenta) crystal structures. The two structures are superimposed by aligning all Cα atoms of β-subunits and are presented as cartoon diagrams.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01723/20190116/images/large/jm-2018-017236_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01723&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The AC protein has six cysteine residues. Four of them form two disulfide bridges, Cys31–Cys340 and Cys388–Cys392, whereas two others are not oxidized: Cys143 is the active site cysteine, and Cys292 is buried in the body of the protein molecule. There are six potential <i>N</i>-glycosylation sites in the molecule of human AC, and only four of them, Asn173, Asn259, Asn286, and Asn342, could be modeled in the final electron density map. The sugar residues of <i>N</i>-glycosylation sites at Asn173 and Asn259 located on the surface loops of the β-subunit make extensive hydrogen bonds with both subunits.</div><div class="NLM_p last">The structure of the complex is very similar to that of the apo-form in its active conformation with an overall root-mean-square deviation (RMSD) of 0.41 Å for all Cα pairs (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B). The main conformational differences between the two structures are observed in the areas of the N-terminal part of helix (230–241) and the surface loop (319–322) of the β-subunit, with the maximum distances between the corresponding Cα atoms of 3.1 Å. These results suggest that the covalent modification of the active site cysteine during the inhibition of the enzyme by the potent carmofur inhibitor does not induce major conformation changes in the body of both the α- and β-subunits.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Inhibitor Binding</h3><div class="NLM_p">In a recent work, the small compound 2-oxo-<i>N</i>-(4-phenylbutyl)-1,3-benzoxazole-3-carboxamide (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01723/suppl_file/jm8b01723_si_001.pdf" class="ext-link">Figure S1</a>), a close structural homologue of carmofur, was shown to be an effective noncompetitive inhibitor of the enzyme with an inhibition constant of 64 nM for the human AC.<a onclick="showRef(event, 'ref27 ref29'); return false;" href="javascript:void(0);" class="ref ref27 ref29">(27,29)</a> The authors proposed that the catalytic Cys143 attacks the electrophilic carbonyl group of the inhibitor, which results in the covalent modification of the cysteine residue by the C<sub>11</sub>H<sub>14</sub>NO moiety of the compound.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> We revealed a similar mechanism of inhibition of human AC by carmofur, which is a close structural homologue of the above-mentioned 2,4-dioxopyrimidine-1-carboxamide and a potent inhibitor of acid ceramidases with an IC<sub>50</sub> value of 29 nM for the rat orthologue.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The fatty acid moiety of the carmofur inhibitor (C<sub>7</sub>H<sub>14</sub>NO, Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01723/suppl_file/jm8b01723_si_001.pdf" class="ext-link">Figure S1</a>) in the crystal structure is clearly defined by electron density in the enzyme substrate-binding site, with Cys143 positioned at the bottom of the pocket (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A). Continuous electron density links the inhibitor C7 atom to the Sγ of Cys143, indicating the presence of a covalent linkage between the inhibitor moiety and the enzyme. In addition, other electrostatic interactions include hydrogen bonds between the backbone carbonyl oxygen of Asp162, the backbone amide of Glu225, and the Nδ of Asn320, with the carbonyl and amide groups of the free fatty acid tail. An extended conformation of the fatty acid moiety of the inhibitor molecule in this complex is sandwiched between the side chains of Phe136, Phe163, Met161, Leu211, and Leu223 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A). This binding mode is similar to the covalent inhibition of the related enzyme <i>N</i>-acylethanolamine acid amidase (NAAA) by the β-lactam inhibitor ARN726.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01723/20190116/images/medium/jm-2018-017236_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01723/20190116/images/large/jm-2018-017236_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Binding interactions of the inhibitor fatty acid to AC active site. (A) Close-up view of the binding area in the complex (magenta and cyan ribbons for α- and β-subunits, respectively). The inhibitor moiety (yellow sticks) and the residues defining the interaction with the inhibitor (cyan sticks) are shown. The electron density map (gray) around the bound inhibitor is contoured at 1σ. Hydrogen bonds are indicated by gray dotted lines. (B) The part of the protein surface (in the same colors as in A) showing the deep channel into the active site with Cys143 covalently modified by the fatty acid (in yellow sticks) is presented.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01723/20190116/images/large/jm-2018-017236_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01723&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">There are several hydrophobic patches on the surface of the AC enzyme around its active site (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). On the basis of biochemical and mutagenesis experiments, these hydrophobic surfaces were shown to be very important for substrate hydrolysis and for binding to membrane lipids in order to assess its substrates.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> For instance, the mutagenesis experiments showed substantial reduction of ceramide hydrolysis for the AC variants where hydrophobic patches containing Leu80/Val165/Leu167 and Phe328/Phe329/Leu330 residues were mutated (>80% reduction). Our structural data also confirm these mutagenesis results: the loop (161–165) is involved in the inhibitor’s fatty acid moiety binding and simple modeling of a ceramide substrate also suggests that Val165, Phe166, Trp176, Phe227, Leu367, and Trp396 reside on the hydrophobic surface underneath the modeled d17 substrate moiety (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A). It should be noted that plausible interchain hydrophobic interactions could result in dimer formation as was observed by Al et al.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> This dimer was disrupted with addition of Triton-100. In our work, we observed some interchain hydrophobic contacts between symmetry related molecules in the crystal packing, however, there is no biological or biochemical evidence that dimer or multimer formation have potential relevance for AC functions.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01723/20190116/images/medium/jm-2018-017236_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01723/20190116/images/large/jm-2018-017236_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Hydrophobic surface of AC with a modeled ceramide substrate. (A) The surface representation of the hydrophobic areas of the AC in ribbon diagram are colored yellow, and the remaining residues are colored in magenta (α-subunit) and in cyan (β-subunit). The locations of the residues mutated in our previous work (black) and that of the residues forming plausible hydrophobic contacts with the substrate d17 moiety (red) are labeled.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> (B) Close-up view of the modeled C8 ceramide substrate (d17:1/8:0, ball and stick in orange) interacting with enzyme residues in the substrate-binding area. The positions of several AC catalytic residues, which can form hypothetical interactions with the substrate in the tetrahedral complex, are indicated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01723/20190116/images/large/jm-2018-017236_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01723&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Optimal superposition of the fatty acid tail of ceramide substrate onto that of the carmofur molecule sitting in the enzyme active site can provide a reliable structural model for the acyl-enzyme intermediate. Our simple modeling based on this superposition followed by introduction of a covalent bond between the Cys143 Cγ and C8 ceramide substrate shows that the N-terminal amino group of Cys143, the backbone amide of Glu225, and the Nδ atom of Asn320 are at hydrogen-bonding distance (3.3, 2.8, and 3.0 Å, respectively) from the carbonyl oxygen of the substrate scissile bond (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B). This suggests that these groups form the oxyanion hole that stabilizes the tetrahedral transition state. These three residues constituting the oxyanion hole are highly conserved among all acid ceramidase orthologues.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> There are also other close contacts stabilizing the transition state around the catalytic Cys143 residue between the backbone amide of Asp162 and the amide of the scissile substrate bond (2.9 Å), meanwhile the N-terminal amino group of Cys143 and the guanidine group of Arg333 make hydrogen bonds with the O19 atom of the substrate (2.7 and 3.4 Å, respectively, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B). In our previous work, we proposed a plausible mechanism of substrate hydrolysis by AC, where all of the above-mentioned residues were shown to be involved.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30071" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30071" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In conclusion, a high quality structure of human acid ceramidase in complex with a potent covalent inhibitor, an enzyme which likely contributes to different pathological diseases via its biological functions, is presented. The new structural features of the inhibitor binding, the hydrophobic surfaces around the substrate binding site could be a foundation for an efficient structure-based drug design platform targeting the AC activities. Currently, there is no AC inhibitor clinically available to treat patients. This study is the first to crystallographically demonstrate that carmofur directly binds to AC and prompts its inhibition, providing the detailed mechanism, which has eluded the scientific community for more than 30 years, of its mysterious 5-FU independent antitumor activity. There is a strong clinical interest in developing AC inhibitors to treat GBM, prostate cancer, and melanoma.<a onclick="showRef(event, 'ref13 ref20 ref21 ref22 ref34 ref35 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref13 ref20 ref21 ref22 ref34 ref35 ref36 ref37">(13,20−22,34−37)</a> This provides the impetus to now engage in clinical trials with carmofur for treatment of various types of cancers, targeting AC as a new class of anticancer drugs.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83006" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83006" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Protein Expression and Purification</h3><div class="NLM_p last">Recombinant full-length AC (molecular weight ∼ 50 kDa) was expressed as a secreted protein in Sf9 insect cells (Invitrogen) infected with baculovirus as previously described.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> AC protein sample was isolated from culture media using nickel-nitrilotriacetic acid (Ni-NTA) resin (Thermo Fisher Scientific) and further purified by size exclusion chromatography on a Superdex 200 column (GE Healthcare) in 15 mM Tris-HCl buffer, pH 7.5, supplemented with 100 mM NaCl.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Protein for crystallization first underwent proteolytic autocleavage at 37 °C for 60 h. Then 100 mM sodium acetate solution, pH 5.0, was added for autocleavage, and the solution was subsequently exchanged back into the neutral buffer followed by protein concentration up to 9.7 mg/mL.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Protein purity >95% was confirmed by gel electrophoresis.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Complex Formation, Crystallization, and Structure Determination</h3><div class="NLM_p">A small aliquot of 1 M sodium-phosphate citrate buffer, pH 4.3, was added to the protein sample to adjust the pH value to 4.5. The complex between the protein and the inhibitor was formed by adding 30 mM carmofur (Sigma-Aldrich) in 100% DMSO and 5% Triton X-100 in water to the protein solution at a final concentrations of 1 mM each. Initial crystals of the AC–carmofur complex were obtained at 16 °C from drops containing 1.5 μL of the protein sample and 1.5 μL of reservoir solution (0.2 M sodium-phosphate-citrate, pH 4.3, 0.275 M lithium sulfate, and 18% polyethylene glycol 1000). Protein crystals of the complex suitable for X-ray analysis were obtained after several cycles of microseeding under similar crystallization conditions.</div><div class="NLM_p">For data collection, crystals were harvested with 20% (v/v) glycerol in the reservoir solution. Diffraction data were collected from a single flash-frozen crystal on the SBC-CAT BM beamline (APS, Argonne National Laboratory) at 100 K. Data were indexed and processed with HKL-3000.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> The crystals belonged to the monoclinic space group <i>C</i>2 and contained two molecules of the complex per asymmetric unit. Cell parameters are listed in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.</div><div class="NLM_p">The structure of the complex was solved by molecular replacement using the PHASER program from the CCP4 software suite, with the structure of the activated apo-AC (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5U7Z">5U7Z</a>) as a search model.<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39,40)</a> The final model of the complex was obtained by carrying out several cycles consisting of manual model building using COOT, followed by structure isotropic refinement with Phenix.Refine from the PHENIX software suite.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Coordinates have been deposited in the Protein Data Bank (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MHM">6MHM</a>). Final refinement statistics are listed in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.</div><div class="NLM_p last">The tetrahedral enzyme–substrate intermediate was modeled by superposition of the C8 fatty chain of ceramide substrate (d17:1/8:0) and free fatty acid tail of carmofur (5-fluoro-<i>N</i>-hexyl-2,4-dioxo-pyrimidine-1-carboxamide, C<sub>11</sub>H<sub>16</sub>FN<sub>3</sub>O<sub>3</sub>; molecular weight, 257.265 g/mol) from the covalent complex, followed by introducing a covalent bond between Cys143 Sγ atom and the carbonyl carbon of the C8 ceramide scissile bond. The d17 moiety of the substrate was manually placed in the second hydrophobic cavity of the protein to avoid any steric clashes.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11"><a href="/doi/suppl/10.1021/acs.jmedchem.8b01723" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31517" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31517" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b01723" class="ext-link">10.1021/acs.jmedchem.8b01723</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Chemical structures of carmofur and its mechanism of inhibition (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01723/suppl_file/jm8b01723_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01723/suppl_file/jm8b01723_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01723/suppl_file/jm8b01723_si_001.pdf">jm8b01723_si_001.pdf (132.32 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01723/suppl_file/jm8b01723_si_002.csv">jm8b01723_si_002.csv (0.11 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Structures and reflection data of AC-carmofur complexes reported here have been deposited to the Protein Data Bank under the accession code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MHM">6MHM</a>. Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.8b01723" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58108" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58108" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ninh Doan</span> - <span class="hlFld-Affiliation affiliation">Department
of Neurosurgery, Mitchell Cancer Institute, University of South Alabama, Mobile, Alabama 36617 United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9211-2162" title="Orcid link">http://orcid.org/0000-0001-9211-2162</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e08e848f818ea08885818c9488ce938f959488818c8182818d81ce858495"><span class="__cf_email__" data-cfemail="ff919b909e91bf979a9e938b97d18c908a8b979e939e9d9e929ed19a9b8a">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexey Dementiev</span> - <span class="hlFld-Affiliation affiliation">Structural Biology
Center, Biosciences Division, Argonne National
Laboratory, Lemont, Illinois 60439, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrzej Joachimiak</span> - <span class="hlFld-Affiliation affiliation">Structural Biology
Center, Biosciences Division, Argonne National
Laboratory, Lemont, Illinois 60439, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ha Nguyen</span> - <span class="hlFld-Affiliation affiliation">California Institute of Neuroscience, Thousand Oaks, California 91360, United States</span>; 
    <span class="hlFld-Affiliation affiliation">National Skull Base Center, Thousand
Oaks, California 91360, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexei Gorelik</span> - <span class="hlFld-Affiliation affiliation">Department of Biochemistry and Groupe de
Recherche Axé sur la Structure des Protéines, McGill University, Montreal, Quebec H3G 0B1, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katalin Illes</span> - <span class="hlFld-Affiliation affiliation">Department of Biochemistry and Groupe de
Recherche Axé sur la Structure des Protéines, McGill University, Montreal, Quebec H3G 0B1, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Saman Shabani</span> - <span class="hlFld-Affiliation affiliation">Department of Neurosurgery, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Gelsomino</span> - <span class="hlFld-Affiliation affiliation">Department of Neurosurgery, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eun-Young Erin Ahn</span> - <span class="hlFld-Affiliation affiliation">Department
of Neurosurgery, Mitchell Cancer Institute, University of South Alabama, Mobile, Alabama 36617 United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bhushan Nagar</span> - <span class="hlFld-Affiliation affiliation">Department of Biochemistry and Groupe de
Recherche Axé sur la Structure des Protéines, McGill University, Montreal, Quebec H3G 0B1, Canada</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>A.D. designed the crystallization experiments, analyzed data, solved the crystal structure, and wrote the manuscript. A.J. was responsible for oversight of the project. N.D. and HN. analyzed experimental data and wrote the manuscript. K.I. carried out insect cell culture. A.G. purified recombinant acid ceramidase. All authors read and approved the final manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28787" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28787" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are grateful to the staff at the SBC-CAT BM beamline of the Advanced Proton Source, Argonne National Laboratory, IL, where data were collected. The Musella Foundation Grant from the Department of Neurosurgery, Mitchell Cancer Institute, University of South Alabama, funded this work.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AC</td><td class="NLM_def"><p class="first last">acid ceramidase</p></td></tr><tr><td class="NLM_term">SIP</td><td class="NLM_def"><p class="first last">sphingosine-1-phosphate</p></td></tr><tr><td class="NLM_term">5-FU</td><td class="NLM_def"><p class="first last">5-fluorouracil</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24130" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24130" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 41 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, H.</span></span> <span> </span><span class="NLM_article-title">Recent studies of 5-fluorouracil resistance in pancreatic cancer</span>. <i>World J. Gastroenterol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">15682</span>– <span class="NLM_lpage">15690</span>, <span class="refDoi"> DOI: 10.3748/wjg.v20.i42.15682</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.3748%2Fwjg.v20.i42.15682" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=25400452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvF2qu7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=15682-15690&author=W.+B.+Wangauthor=Y.+Yangauthor=Y.+P.+Zhaoauthor=T.+P.+Zhangauthor=Q.+Liaoauthor=H.+Shu&title=Recent+studies+of+5-fluorouracil+resistance+in+pancreatic+cancer&doi=10.3748%2Fwjg.v20.i42.15682"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Recent studies of 5-fluorouracil resistance in pancreatic cancer</span></div><div class="casAuthors">Wang, Wei-Bin; Yang, Yu; Zhao, Yu-Pei; Zhang, Tai-Ping; Liao, Quan; Shu, Hong</div><div class="citationInfo"><span class="NLM_cas:title">World Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">15682-15690</span>CODEN:
                <span class="NLM_cas:coden">WJGAF2</span>;
        ISSN:<span class="NLM_cas:issn">1007-9327</span>.
    
            (<span class="NLM_cas:orgname">Baishideng Publishing Group Inc.</span>)
        </div><div class="casAbstract">A review.  Resistance to 5-fluorouracil (5-FU), an important anticancer drug, is a serious challenge in the treatment of pancreatic cancer.  Equilibrative nucleoside transporter 1 and multidrug-resistance protein (MRP) 5 and MRP8, rather than P-glycoprotein, play important roles in 5-FU transport.  Thymidylate synthase, dihydropyrimidine dehydrogenase, methylenetetrahydrofolate reductase and thymidine phosphorylase are four key enzymes involved in 5-FU metab.  Other metabolic enzymes, including uridine monophosphate synthetase, also contribute to chemoresistance.  Intracellular signaling pathways are an integrated network, and nuclear factor kappa-light-chain-enhancer of activated B cells, AKT and extracellular signal-regulated kinases are signaling pathways that are particularly relevant to 5-FU resistance.  In addn., recent reports indicate that STAT-3 is a crucial survival protein.  Proteomic assays provide a powerful tool for identifying target proteins and understanding the role of microRNAs and stromal factors to facilitate the development of strategies to combat 5-FU resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2tpmAau6fWrVg90H21EOLACvtfcHk0lia9CoL3G4tYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvF2qu7bM&md5=6272404fe2a49682df2b67dc9e9ca5cb</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3748%2Fwjg.v20.i42.15682&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3748%252Fwjg.v20.i42.15682%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%2BB.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DY.%2BP.%26aulast%3DZhang%26aufirst%3DT.%2BP.%26aulast%3DLiao%26aufirst%3DQ.%26aulast%3DShu%26aufirst%3DH.%26atitle%3DRecent%2520studies%2520of%25205-fluorouracil%2520resistance%2520in%2520pancreatic%2520cancer%26jtitle%3DWorld%2520J.%2520Gastroenterol.%26date%3D2014%26volume%3D20%26spage%3D15682%26epage%3D15690%26doi%3D10.3748%2Fwjg.v20.i42.15682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sara, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khodadadi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakrabarti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lerman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grothey, A.</span></span> <span> </span><span class="NLM_article-title">5-fluorouracil and cardiotoxicity: a review</span>. <i>Ther. Adv. Med. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1</span>, <span class="refDoi"> DOI: 10.1177/1758835918780140</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1177%2F1758835918780140" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=1&author=J.+D.+Saraauthor=J.+Kaurauthor=R.+Khodadadiauthor=M.+Rehmanauthor=R.+Loboauthor=S.+Chakrabartiauthor=J.+Herrmannauthor=A.+Lermanauthor=A.+Grothey&title=5-fluorouracil+and+cardiotoxicity%3A+a+review&doi=10.1177%2F1758835918780140"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1177%2F1758835918780140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1758835918780140%26sid%3Dliteratum%253Aachs%26aulast%3DSara%26aufirst%3DJ.%2BD.%26aulast%3DKaur%26aufirst%3DJ.%26aulast%3DKhodadadi%26aufirst%3DR.%26aulast%3DRehman%26aufirst%3DM.%26aulast%3DLobo%26aufirst%3DR.%26aulast%3DChakrabarti%26aufirst%3DS.%26aulast%3DHerrmann%26aufirst%3DJ.%26aulast%3DLerman%26aufirst%3DA.%26aulast%3DGrothey%26aufirst%3DA.%26atitle%3D5-fluorouracil%2520and%2520cardiotoxicity%253A%2520a%2520review%26jtitle%3DTher.%2520Adv.%2520Med.%2520Oncol.%26date%3D2018%26volume%3D10%26spage%3D1%26doi%3D10.1177%2F1758835918780140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamada, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buyse, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burzykowski, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piedbois, P.</span></span> <span> </span><span class="NLM_article-title">Efficacy of oral adjuvant therapy after resection of colorectal cancer: 5-year results from three randomized trials</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">484</span>– <span class="NLM_lpage">492</span>, <span class="refDoi"> DOI: 10.1200/JCO.2004.04.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1200%2FJCO.2004.04.065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=14752071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A280%3ADC%252BD2c%252Fms1Omug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2004&pages=484-492&author=J.+Sakamotoauthor=Y.+Ohashiauthor=C.+Hamadaauthor=M.+Buyseauthor=T.+Burzykowskiauthor=P.+Piedbois&title=Efficacy+of+oral+adjuvant+therapy+after+resection+of+colorectal+cancer%3A+5-year+results+from+three+randomized+trials&doi=10.1200%2FJCO.2004.04.065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy of oral adjuvant therapy after resection of colorectal cancer: 5-year results from three randomized trials</span></div><div class="casAuthors">Sakamoto Junichi; Ohashi Yasuo; Hamada Chikuma; Buyse Marc; Burzykowski Tomasz; Piedbois Pascal</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">484-92</span>
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    </div><div class="casAbstract">PURPOSE:  Adjuvant therapy of colorectal cancer with oral fluorinated pyrimidines is attractive because of its ease of administration and good tolerability.  The purpose of this meta-analysis is to assess the survival and disease-free survival benefits of treating patients after surgical resection of a primary colorectal tumor with oral fluoropyrimidines for 1 year.  PATIENTS AND METHODS:  This meta-analysis was performed on individual data from three randomized trials conducted by the Japanese Foundation for Multidisciplinary Treatment for Cancer involving a total of 5,233 patients with stages I to III colorectal cancer.  RESULTS:  The overall hazard ratio in favor of oral therapy was 0.89 for survival (95% CI, 0.80 to 0.99; P =.04), and 0.85 for disease-free survival (95% CI, 0.77 to 0.93; P <.001).  Thus oral therapy reduced the risk of death by 11% and the risk of recurrence or death by 15%.  There was no significant heterogeneity between trials, nor did the benefit of oral therapy depend on tumor stage (I, II, or III), tumor site (rectum or colon), patient age, or patient sex.  CONCLUSION:  Oral fluoropyrimidines improve disease-free survival and survival of patients after resection of early-stage colorectal cancer.  These observations support the use of these agents alone after resection of early-stage disease, as well as further testing of oral agents in combination with new drugs that have recently shown antitumor activity in advanced colorectal cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ0OoBH9nuTIyjiVMCqkKxVfW6udTcc2eb1PvFzAlc85rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c%252Fms1Omug%253D%253D&md5=4c2b2e65f0bb9083c4d4278e3e41246d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1200%2FJCO.2004.04.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2004.04.065%26sid%3Dliteratum%253Aachs%26aulast%3DSakamoto%26aufirst%3DJ.%26aulast%3DOhashi%26aufirst%3DY.%26aulast%3DHamada%26aufirst%3DC.%26aulast%3DBuyse%26aufirst%3DM.%26aulast%3DBurzykowski%26aufirst%3DT.%26aulast%3DPiedbois%26aufirst%3DP.%26atitle%3DEfficacy%2520of%2520oral%2520adjuvant%2520therapy%2520after%2520resection%2520of%2520colorectal%2520cancer%253A%25205-year%2520results%2520from%2520three%2520randomized%2520trials%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2004%26volume%3D22%26spage%3D484%26epage%3D492%26doi%3D10.1200%2FJCO.2004.04.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kusumoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maehara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugimachi, K.</span></span> <span> </span><span class="NLM_article-title">Hyperthermia enhances the in vitro activity of 1-hexylcarbamoyl-5-fluorouracil compared to that of 5-fluorouracil</span>. <i>Eur. J. Cancer Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">477</span>– <span class="NLM_lpage">481</span>, <span class="refDoi"> DOI: 10.1016/0277-5379(89)90260-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1016%2F0277-5379%2889%2990260-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=2703002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A528%3ADyaL1MXhvVGnu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1989&pages=477-481&author=T.+Kusumotoauthor=Y.+Maeharaauthor=Y.+Sakaguchiauthor=K.+Sugimachi&title=Hyperthermia+enhances+the+in+vitro+activity+of+1-hexylcarbamoyl-5-fluorouracil+compared+to+that+of+5-fluorouracil&doi=10.1016%2F0277-5379%2889%2990260-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Hyperthermia enhances the in vitro activity of 1-hexylcarbamoyl-5-fluorouracil compared to that of 5-fluorouracil</span></div><div class="casAuthors">Kusumoto, Tetsuya; Maehara, Yoshihiko; Sakaguchi, Yoshihisa; Sugimachi, Keizo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Cancer & Clinical Oncology</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">477-81</span>CODEN:
                <span class="NLM_cas:coden">EJCODS</span>;
        ISSN:<span class="NLM_cas:issn">0277-5379</span>.
    </div><div class="casAbstract">The synergic effects of 1-hexylcarbomoyl-5-fluorouracil (HCFU), a lipophilic masked compd. of 5-fluorouracil (5-FU), and hyperthermia on HeLa cells were investigated, with the following results: (1) after the cells had been exposed to the drug at 77 μM for 1 to 3 days, with or without heat (43°) for 2 h, treatment with HCFU and heat inhibited cell growth by 9.2% on day 3, compared to control cells, HCFU alone, heat alone or 5-FU plus heat.  (2) The cells were exposed to the drugs at 77 μM or heat (43°) for 15-45 min, and the colonies counted on day 14.  Combined treatment with HCFU plus heat inhibited the clonogenicity of HeLa cells to 22.4% of control cells.  The combination of 5-FU, n-hexylamine and heat had much the same effect as the combined effect of the treatment of HCFU plus heat.  (3) Intracellular levels of the drugs did not increase with hyperthermic treatment.  These findings suggest that the synergic effect between HCFU and hyperthermia is related to the hexylcarbamoyl structure of HCFU.  This combination may have pos. effects for treating patients with malignancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtzYZTLIcs5bVg90H21EOLACvtfcHk0ljaKbUvSkHTBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhvVGnu70%253D&md5=9b653b825c4bcc73fbffa618ffb84989</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2F0277-5379%2889%2990260-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0277-5379%252889%252990260-5%26sid%3Dliteratum%253Aachs%26aulast%3DKusumoto%26aufirst%3DT.%26aulast%3DMaehara%26aufirst%3DY.%26aulast%3DSakaguchi%26aufirst%3DY.%26aulast%3DSugimachi%26aufirst%3DK.%26atitle%3DHyperthermia%2520enhances%2520the%2520in%2520vitro%2520activity%2520of%25201-hexylcarbamoyl-5-fluorouracil%2520compared%2520to%2520that%2520of%25205-fluorouracil%26jtitle%3DEur.%2520J.%2520Cancer%2520Clin.%2520Oncol.%26date%3D1989%26volume%3D25%26spage%3D477%26epage%3D481%26doi%3D10.1016%2F0277-5379%2889%2990260-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ooi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohkubo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashigawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawasaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakito, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, M.</span></span> <span> </span><span class="NLM_article-title">Plasma, intestine and tumor levels of 5-fluorouracil in mice bearing L1210 ascites tumor following oral administration of 5-fluorouracil, UFT (mixed compound of tegafur and uracil), carmofur and 5′-deoxy-5-fluorouridine</span>. <i>Biol. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1329</span>– <span class="NLM_lpage">1331</span>, <span class="refDoi"> DOI: 10.1248/bpb.24.1329</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1248%2Fbpb.24.1329" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=11725974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotFans70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2001&pages=1329-1331&author=A.+Ooiauthor=T.+Ohkuboauthor=M.+Higashigawaauthor=H.+Kawasakiauthor=H.+Kakitoauthor=Y.+Kagawaauthor=M.+Kojimaauthor=M.+Sakurai&title=Plasma%2C+intestine+and+tumor+levels+of+5-fluorouracil+in+mice+bearing+L1210+ascites+tumor+following+oral+administration+of+5-fluorouracil%2C+UFT+%28mixed+compound+of+tegafur+and+uracil%29%2C+carmofur+and+5%E2%80%B2-deoxy-5-fluorouridine&doi=10.1248%2Fbpb.24.1329"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma, intestine and tumor levels of 5-fluorouracil in mice bearing L1210 ascites tumor following oral administration of 5-fluorouracil, UFT (mixed compound of Tegafur and uracil), Carmofur and 5'-deoxy-5-fluorouridine</span></div><div class="casAuthors">Ooi, Kazuya; Ohkubo, Toshiki; Higashigawa, Masamune; Kawasaki, Hajime; Kakito, Hideshi; Kagawa, Yoshiyuki; Kojima, Michio; Sakurai, Minoru</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1329-1331</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">Several 5-fluorouracil (5-FU) derivs., 1-hexylcarbamoyl-5-fluorouracil (HCFU), 5'-deoxy-5-fluorouridine (5'-DFUR) and UFT (mixed compd. of Tegafur and uracil), have been developed and clin. widely used.  However, comparative pharmacokinetic studies of the parent compd. and other fluorinated derivs. have not been precisely reported.  The dosage of the oral clin. use for human cancer of 5-FU, HCFU, 5'-DFUR and UFT as Tegafur (FT) is 200-300 mg/d, 600 mg/d, 800-1200 mg/d and 300-600 mg/d resp.  These amts. of the drugs are almost equimolar.  Previously, we reported the effect of oral equimolar administration of each four drugs on thymidylate synthase activity, deoxyribonucleotide metab. and cell cycle progression in L1210 ascites tumor.  In this study, we examd. the antitumor effect and 5-FU concn. in the plasma, intestine and tumor after oral equimolar administrations of each drug using BDF1 mice bearing L1210 ascites tumor.  In our study, UFT showed the best life prolongation among these four drugs.  The intestine 5-FU level was highest by treatment with 5-FU during the initial 4 h.  The plasma 5-FU level was highest by treatment with HCFU for 4 h.  But the tumor 5-FU level was highest by treatment with UFT over the 24 h.  In spite of the high plasma 5-FU concn. after the treatment with HCFU, the 5-FU concn. in the tumor was below the detectable level until 24 h.  These findings suggested that the highest specific accumulation of 5-FU in tumor cells may explain the best therapeutic results of UFT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrO5GC3dR1XBLVg90H21EOLACvtfcHk0ljaKbUvSkHTBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotFans70%253D&md5=4e1e56c9513722e49b6ec72f7f22afb0</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1248%2Fbpb.24.1329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.24.1329%26sid%3Dliteratum%253Aachs%26aulast%3DOoi%26aufirst%3DA.%26aulast%3DOhkubo%26aufirst%3DT.%26aulast%3DHigashigawa%26aufirst%3DM.%26aulast%3DKawasaki%26aufirst%3DH.%26aulast%3DKakito%26aufirst%3DH.%26aulast%3DKagawa%26aufirst%3DY.%26aulast%3DKojima%26aufirst%3DM.%26aulast%3DSakurai%26aufirst%3DM.%26atitle%3DPlasma%252C%2520intestine%2520and%2520tumor%2520levels%2520of%25205-fluorouracil%2520in%2520mice%2520bearing%2520L1210%2520ascites%2520tumor%2520following%2520oral%2520administration%2520of%25205-fluorouracil%252C%2520UFT%2520%2528mixed%2520compound%2520of%2520tegafur%2520and%2520uracil%2529%252C%2520carmofur%2520and%25205%25E2%2580%25B2-deoxy-5-fluorouridine%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2001%26volume%3D24%26spage%3D1329%26epage%3D1331%26doi%3D10.1248%2Fbpb.24.1329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuwano, M.</span></span> <span> </span><span class="NLM_article-title">Anti-tumor effects of carmofur on human 5-FU resistant cells</span>. <i>Cancer Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1613</span>– <span class="NLM_lpage">1616</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A280%3ADC%252BD3c%252FitV2qsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1999&pages=1613-1616&author=S.+Satoauthor=T.+Ueyamaauthor=H.+Fukuiauthor=K.+Miyazakiauthor=M.+Kuwano&title=Anti-tumor+effects+of+carmofur+on+human+5-FU+resistant+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-tumor effects of carmofur on human 5-FU resistant cells</span></div><div class="casAuthors">Sato S; Ueyama T; Fukui H; Miyazaki K; Kuwano M</div><div class="citationInfo"><span class="NLM_cas:title">Gan to kagaku ryoho. Cancer & chemotherapy</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1613-6</span>
        ISSN:<span class="NLM_cas:issn">0385-0684</span>.
    </div><div class="casAbstract">As a part of studies to clarify the efficacy mechanism of carmofur (HCFU), a 5-FU analog, the degree of cross-resistance to HCFU of cell lines of cultured human colon cancer DLD-1 and a stomach cancer NUGC-3, both of which had acquired resistance to 5-FU, was studied in vitro and in vivo.  In vitro, both resistant cell lines showed no or little cross-resistance to HCFU under a short-term drug exposure, and very low cross-resistance to HCFU, as compared to resistance to 5-FU, under a long-term drug exposure.  In therapeutic experiments using nude mice bearing parent or subcutaneously transplanted 5-FU-resistant DLD-1 cells, HCFU exerted almost the same growth-inhibitory effects on both tumors.  These results suggest that HCFU itself may have its own anti-tumor mechanism, different from that of 5-FU.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR3MnUxYytFDoIRAdBLKY41fW6udTcc2eZfqTkj8Z8A0rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c%252FitV2qsQ%253D%253D&md5=3275eda2e6b1896911317dc2deedc195</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DS.%26aulast%3DUeyama%26aufirst%3DT.%26aulast%3DFukui%26aufirst%3DH.%26aulast%3DMiyazaki%26aufirst%3DK.%26aulast%3DKuwano%26aufirst%3DM.%26atitle%3DAnti-tumor%2520effects%2520of%2520carmofur%2520on%2520human%25205-FU%2520resistant%2520cells%26jtitle%3DCancer%2520Chemother.%26date%3D1999%26volume%3D26%26spage%3D1613%26epage%3D1616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span>; <span class="NLM_string-name">Ma, S.</span>; <span class="NLM_string-name">Liu, H.</span>; <span class="NLM_string-name">Han, H.</span>; <span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">HCFU inhibits cervical cancer cells growth and metastasis by inactivating wnt/beta-catenin pathway</span>.  <i>J. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>, DOI: <span class="refDoi"> DOI: 10.1002/jcb.26570</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1002%2Fjcb.26570" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=P.+Liu&author=S.+Ma&author=H.+Liu&author=H.+Han&author=S.+Wang&title=HCFU+inhibits+cervical+cancer+cells+growth+and+metastasis+by+inactivating+wnt%2Fbeta-catenin+pathway&doi=10.1002%2Fjcb.26570"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fjcb.26570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.26570%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DP.%26atitle%3DHCFU%2520inhibits%2520cervical%2520cancer%2520cells%2520growth%2520and%2520metastasis%2520by%2520inactivating%2520wnt%252Fbeta-catenin%2520pathway%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2017%26doi%3D10.1002%2Fjcb.26570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sueyoshi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ema, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takaishi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hisatomi, H.</span></span> <span> </span><span class="NLM_article-title">Induction of oxidative stress by anticancer drugs in the presence and absence of cells</span>. <i>Oncol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">6066</span>– <span class="NLM_lpage">6070</span>, <span class="refDoi"> DOI: 10.3892/ol.2017.6931</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.3892%2Fol.2017.6931" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=29113247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A280%3ADC%252BC1M7oslOhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2017&pages=6066-6070&author=C.+Yokoyamaauthor=Y.+Sueyoshiauthor=M.+Emaauthor=Y.+Moriauthor=K.+Takaishiauthor=H.+Hisatomi&title=Induction+of+oxidative+stress+by+anticancer+drugs+in+the+presence+and+absence+of+cells&doi=10.3892%2Fol.2017.6931"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of oxidative stress by anticancer drugs in the presence and absence of cells</span></div><div class="casAuthors">Yokoyama Chikako; Yokoyama Chikako; Sueyoshi Yuto; Ema Mika; Mori Yumi; Hisatomi Hisashi; Takaishi Kazuto</div><div class="citationInfo"><span class="NLM_cas:title">Oncology letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">6066-6070</span>
        ISSN:<span class="NLM_cas:issn">1792-1074</span>.
    </div><div class="casAbstract">Reactive oxygen species (ROS) are generated in the cell through multiple mechanisms.  Intracellular ROS are rapidly detoxified by various enzymatic and non-enzymatic mechanisms; however, disruption of the oxidant-antioxidant balance causes oxidative stress and elicits cell damage.  The oxidative stress induced by chemotherapy is known to cause side effects in patients with cancer.  However, few studies have examined whether anticancer drugs induce oxidative stress in cancer cells.  Furthermore, the precise mechanism by which anticancer drugs induce the generation of ROS remains unclear.  In the present study, to investigate whether anticancer drugs induce oxidative stress, DLD-1 human colorectal cancer cells were treated with 20 different anticancer drugs and then stained with CellROX(®) ROS detection reagent.  Furthermore, an oxygen radical absorbance capacity assay in the presence of copper was performed to estimate the oxidative activities of the anticancer drugs in the absence of cells.  The data of the present study using assay methods in the presence and absence of cells suggest that nimustine, actinomycin D, doxorubicin, mitomycin C, mitoxantrone, carmofur, gemcitabine, mercaptopurine, camptothecin, paclitaxel, vinblastine, and vinorelbine are able to induce oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTWi2bvABUN7J6KlWarZTAzfW6udTcc2eY-xsW-nn6ArLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M7oslOhuw%253D%253D&md5=8950812e07435f9d17d134c7e42b9365</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3892%2Fol.2017.6931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fol.2017.6931%26sid%3Dliteratum%253Aachs%26aulast%3DYokoyama%26aufirst%3DC.%26aulast%3DSueyoshi%26aufirst%3DY.%26aulast%3DEma%26aufirst%3DM.%26aulast%3DMori%26aufirst%3DY.%26aulast%3DTakaishi%26aufirst%3DK.%26aulast%3DHisatomi%26aufirst%3DH.%26atitle%3DInduction%2520of%2520oxidative%2520stress%2520by%2520anticancer%2520drugs%2520in%2520the%2520presence%2520and%2520absence%2520of%2520cells%26jtitle%3DOncol.%2520Lett.%26date%3D2017%26volume%3D14%26spage%3D6066%26epage%3D6070%26doi%3D10.3892%2Fol.2017.6931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamada, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodaira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakazato, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasutomi, M.</span></span> <span> </span><span class="NLM_article-title">An individual patient data meta-analysis of adjuvant therapy with carmofur in patients with curatively resected colon cancer</span>. <i>Jpn. J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">536</span>– <span class="NLM_lpage">544</span>, <span class="refDoi"> DOI: 10.1093/jjco/hyi147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1093%2Fjjco%2Fhyi147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=16155120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A280%3ADC%252BD2MrisFSktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2005&pages=536-544&author=J.+Sakamotoauthor=C.+Hamadaauthor=M.+Rahmanauthor=S.+Kodairaauthor=K.+Itoauthor=H.+Nakazatoauthor=Y.+Ohashiauthor=M.+Yasutomi&title=An+individual+patient+data+meta-analysis+of+adjuvant+therapy+with+carmofur+in+patients+with+curatively+resected+colon+cancer&doi=10.1093%2Fjjco%2Fhyi147"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">An individual patient data meta-analysis of adjuvant therapy with carmofur in patients with curatively resected colon cancer</span></div><div class="casAuthors">Sakamoto Junichi; Hamada Chikuma; Rahman Mahbubur; Kodaira Susumu; Ito Katsuki; Nakazato Hiroaki; Ohashi Yasuo; Yasutomi Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Japanese journal of clinical oncology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">536-44</span>
        ISSN:<span class="NLM_cas:issn">0368-2811</span>.
    </div><div class="casAbstract">BACKGROUND:  Oral carmofur, either as a single or in combination with other chemotherapeutic agents, has been used as adjuvant chemotherapy for curatively resected colon cancer patients.  Past trials and meta-analyses indicate that it is somewhat effective in extending survival of patients with this cancer.  The objective of this study was to perform a reappraisal of randomized clinical trials conducted in this regard.  METHODS:  We designed an individual patient-based meta-analysis of relevant clinical trials to examine the benefit of oral carmofur for curatively resected colon cancer in terms of overall survival (OS) and disease-free survival (DFS).  RESULTS:  We analyzed individual patient data of three randomized clinical trials, which met the predetermined inclusion criteria.  These three trials had a combined total of 2152 patients, carmofur as adjuvant chemotherapy compared with surgery-alone, 5 years follow-up, intention-to-treat-based analytic strategy and similar end points (OS and DFS).  In a pooled analysis, 5 year OS rates were 80.4 and 76.4%, and 5 year DFS rates 76.9 and 71.0%, respectively, in carmofur and surgery-alone group.  Oral carmofur had significant advantage over surgery-alone in terms of both OS [pooled hazard ratio, 0.82; 95% confidence interval (CI) = 0.68-0.99; P = 0.043] and DFS (pooled hazard ratio, 0.77; 95% CI = 0.65-0.91; P = 0.003).  CONCLUSIONS:  This individual patient-based meta-analysis demonstrated that oral carmofur significantly improves both OS and DFS in patients with curatively resected colon cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQfLp2ktEb9SjDnmmyUf5qOfW6udTcc2eY-xsW-nn6ArLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MrisFSktw%253D%253D&md5=fce3e26f1b534beb0ea58df08031c294</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1093%2Fjjco%2Fhyi147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjjco%252Fhyi147%26sid%3Dliteratum%253Aachs%26aulast%3DSakamoto%26aufirst%3DJ.%26aulast%3DHamada%26aufirst%3DC.%26aulast%3DRahman%26aufirst%3DM.%26aulast%3DKodaira%26aufirst%3DS.%26aulast%3DIto%26aufirst%3DK.%26aulast%3DNakazato%26aufirst%3DH.%26aulast%3DOhashi%26aufirst%3DY.%26aulast%3DYasutomi%26aufirst%3DM.%26atitle%3DAn%2520individual%2520patient%2520data%2520meta-analysis%2520of%2520adjuvant%2520therapy%2520with%2520carmofur%2520in%2520patients%2520with%2520curatively%2520resected%2520colon%2520cancer%26jtitle%3DJpn.%2520J.%2520Clin.%2520Oncol.%26date%3D2005%26volume%3D35%26spage%3D536%26epage%3D544%26doi%3D10.1093%2Fjjco%2Fhyi147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grohn, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinonen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumpulainen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lansimies, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lantto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyrhonen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Numminen, S.</span></span> <span> </span><span class="NLM_article-title">Oral carmofur in advanced gastrointestinal cancer</span>. <i>Am. J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">477</span>– <span class="NLM_lpage">479</span>, <span class="refDoi"> DOI: 10.1097/00000421-199012000-00005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1097%2F00000421-199012000-00005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=2239802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A280%3ADyaK3M%252FltFemug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1990&pages=477-479&author=P.+Grohnauthor=E.+Heinonenauthor=E.+Kumpulainenauthor=H.+Lansimiesauthor=A.+Lanttoauthor=R.+Salmiauthor=S.+Pyrhonenauthor=S.+Numminen&title=Oral+carmofur+in+advanced+gastrointestinal+cancer&doi=10.1097%2F00000421-199012000-00005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Oral carmofur in advanced gastrointestinal cancer</span></div><div class="casAuthors">Grohn P; Heinonen E; Kumpulainen E; Lansimies H; Lantto A; Salmi R; Pyrhonen S; Numminen S</div><div class="citationInfo"><span class="NLM_cas:title">American journal of clinical oncology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">477-9</span>
        ISSN:<span class="NLM_cas:issn">0277-3732</span>.
    </div><div class="casAbstract">One hundred and twenty-four patients with a diagnosis of metastatic gastrointestinal cancer and no prior therapy were included in this clinical study of carmofur monotherapy, 300-500 mg/m2 daily for 6 weeks.  For the 115 evaluable patients, the response rates were 19.4% in gastric cancer, 27.2% in cancer of mobile colon, and 12.5% in rectal cancer.  No objective responses were seen in 38 patients with pancreatic cancer, although the disease of 13 of these patients has remained stable over a considerably long period of follow-up.  The toxicity profile was interesting; the main adverse effects were urinary bladder symptoms and flush.  Hematologic toxicity was minimal.  The treatment proved to be safe and could be used for outpatients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRksPOiCQ3-LUkUaC_kzhvyfW6udTcc2eY-xsW-nn6ArLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M%252FltFemug%253D%253D&md5=303aa178260fdb0ca91ca009befc825c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1097%2F00000421-199012000-00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00000421-199012000-00005%26sid%3Dliteratum%253Aachs%26aulast%3DGrohn%26aufirst%3DP.%26aulast%3DHeinonen%26aufirst%3DE.%26aulast%3DKumpulainen%26aufirst%3DE.%26aulast%3DLansimies%26aufirst%3DH.%26aulast%3DLantto%26aufirst%3DA.%26aulast%3DSalmi%26aufirst%3DR.%26aulast%3DPyrhonen%26aufirst%3DS.%26aulast%3DNumminen%26aufirst%3DS.%26atitle%3DOral%2520carmofur%2520in%2520advanced%2520gastrointestinal%2520cancer%26jtitle%3DAm.%2520J.%2520Clin.%2520Oncol.%26date%3D1990%26volume%3D13%26spage%3D477%26epage%3D479%26doi%3D10.1097%2F00000421-199012000-00005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maehara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusumoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusumoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugimachi, K.</span></span> <span> </span><span class="NLM_article-title">Colorectal carcinoma in vitro is more sensitive to 1-hexylcarbamoyl-5-fluorouracil compared with six other antitumor drugs: carboquone, adriamycin, mitomycin C, aclacinomycin A, cisplatin, 5-fluorouracil</span>. <i>Dis. Colon Rectum</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">62</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1007/BF02552573</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1007%2FBF02552573" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=3130239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A280%3ADyaL1c3htFeltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1988&pages=62-67&author=Y.+Maeharaauthor=H.+Anaiauthor=H.+Kusumotoauthor=T.+Kusumotoauthor=K.+Sugimachi&title=Colorectal+carcinoma+in+vitro+is+more+sensitive+to+1-hexylcarbamoyl-5-fluorouracil+compared+with+six+other+antitumor+drugs%3A+carboquone%2C+adriamycin%2C+mitomycin+C%2C+aclacinomycin+A%2C+cisplatin%2C+5-fluorouracil&doi=10.1007%2FBF02552573"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Colorectal carcinoma in vitro is more sensitive to 1-hexylcarbamoyl-5-fluorouracil compared with six other antitumor drugs: carboquone, Adriamycin, mitomycin C, aclacinomycin A, cisplatin, 5-fluorouracil</span></div><div class="casAuthors">Maehara Y; Anai H; Kusumoto H; Kusumoto T; Sugimachi K</div><div class="citationInfo"><span class="NLM_cas:title">Diseases of the colon and rectum</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">62-7</span>
        ISSN:<span class="NLM_cas:issn">0012-3706</span>.
    </div><div class="casAbstract">The sensitivity to 1-hexylcarbamoyl-5-fluorouracil (HCFU) of 25 colorectal cancer tissues was compared with that of six antitumor drugs: carboquone (CQ), Adriamycin (ADM), mitomycin C (MMC), aclacinomycin A (ACR), cisplatin (DDP), and 5-fluorouracil (5-FU), using the in vitro succinate dehydrogenase inhibition (SDI) test.  Chemosensitivity was determined to be positive when the succinate dehydrogenase (SD) activity of the drug-exposed cells, at ten times the peak plasma concentration, was decreased to below 50 percent of that of control cells on day 3 of exposure.  Decrease in SD activity was remarkable in cases of exposure to HCFU, compared with six other drugs.  The sensitivity rates were 32 percent for CQ, 40 percent for ADM, 24 percent for MMC, 28 percent for ACR, 32 percent for DDP, 16 percent for 5-FU, and 68 percent for HCFU.  The sensitivity rate for at least one of the six drugs (CQ, ADM, MMC, ACR, DDP, and 5-FU) was 52 percent, but was 80 percent when HCFU was taken into account.  Since colorectal cancer tissues are resistant to various antitumor drugs, the chemosensitivity test of HCFU should aid in determining the effects of a particular drug for an individual patient.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTj8qWwivgaw7qxQ2mb9Pu8fW6udTcc2ebDPeX2cAjjmLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1c3htFeltQ%253D%253D&md5=ef2f5bd767f47712b77fa0782997b6b0</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2FBF02552573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02552573%26sid%3Dliteratum%253Aachs%26aulast%3DMaehara%26aufirst%3DY.%26aulast%3DAnai%26aufirst%3DH.%26aulast%3DKusumoto%26aufirst%3DH.%26aulast%3DKusumoto%26aufirst%3DT.%26aulast%3DSugimachi%26aufirst%3DK.%26atitle%3DColorectal%2520carcinoma%2520in%2520vitro%2520is%2520more%2520sensitive%2520to%25201-hexylcarbamoyl-5-fluorouracil%2520compared%2520with%2520six%2520other%2520antitumor%2520drugs%253A%2520carboquone%252C%2520adriamycin%252C%2520mitomycin%2520C%252C%2520aclacinomycin%2520A%252C%2520cisplatin%252C%25205-fluorouracil%26jtitle%3DDis.%2520Colon%2520Rectum%26date%3D1988%26volume%3D31%26spage%3D62%26epage%3D67%26doi%3D10.1007%2FBF02552573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okino, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhami, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dagan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulze, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandhoff, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuchman, E. H.</span></span> <span> </span><span class="NLM_article-title">Purification and characterization of recombinant, human acid ceramidase: catalytic reactions and interactions with acid sphingomyelinase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">32978</span>– <span class="NLM_lpage">32986</span>, <span class="refDoi"> DOI: 10.1074/jbc.M301936200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1074%2Fjbc.M301936200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=32978-32986&author=X.+Heauthor=N.+Okinoauthor=R.+Dhamiauthor=A.+Daganauthor=S.+Gattauthor=H.+Schulzeauthor=K.+Sandhoffauthor=E.+H.+Schuchman&title=Purification+and+characterization+of+recombinant%2C+human+acid+ceramidase%3A+catalytic+reactions+and+interactions+with+acid+sphingomyelinase&doi=10.1074%2Fjbc.M301936200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M301936200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M301936200%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DX.%26aulast%3DOkino%26aufirst%3DN.%26aulast%3DDhami%26aufirst%3DR.%26aulast%3DDagan%26aufirst%3DA.%26aulast%3DGatt%26aufirst%3DS.%26aulast%3DSchulze%26aufirst%3DH.%26aulast%3DSandhoff%26aufirst%3DK.%26aulast%3DSchuchman%26aufirst%3DE.%2BH.%26atitle%3DPurification%2520and%2520characterization%2520of%2520recombinant%252C%2520human%2520acid%2520ceramidase%253A%2520catalytic%2520reactions%2520and%2520interactions%2520with%2520acid%2520sphingomyelinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D32978%26epage%3D32986%26doi%3D10.1074%2Fjbc.M301936200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awad, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shabani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doan, N.</span></span> <span> </span><span class="NLM_article-title">Molecular targeting of acid ceramidase in glioblastoma: a review of its role, potential treatment, and challenges</span>. <i>Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.3390/pharmaceutics10020045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.3390%2Fpharmaceutics10020045" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=45-45&author=H.+S.+Nguyenauthor=A.+J.+Awadauthor=S.+Shabaniauthor=N.+Doan&title=Molecular+targeting+of+acid+ceramidase+in+glioblastoma%3A+a+review+of+its+role%2C+potential+treatment%2C+and+challenges&doi=10.3390%2Fpharmaceutics10020045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3390%2Fpharmaceutics10020045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fpharmaceutics10020045%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DH.%2BS.%26aulast%3DAwad%26aufirst%3DA.%2BJ.%26aulast%3DShabani%26aufirst%3DS.%26aulast%3DDoan%26aufirst%3DN.%26atitle%3DMolecular%2520targeting%2520of%2520acid%2520ceramidase%2520in%2520glioblastoma%253A%2520a%2520review%2520of%2520its%2520role%252C%2520potential%2520treatment%252C%2520and%2520challenges%26jtitle%3DPharmaceutics%26date%3D2018%26volume%3D10%26spage%3D45%26epage%3D45%26doi%3D10.3390%2Fpharmaceutics10020045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuchman, E. H.</span></span> <span> </span><span class="NLM_article-title">Acid ceramidase and human disease</span>. <i>Biochim. Biophys. Acta, Biomembr.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1758</i></span>,  <span class="NLM_fpage">2133</span>– <span class="NLM_lpage">2138</span>, <span class="refDoi"> DOI: 10.1016/j.bbamem.2006.08.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1016%2Fj.bbamem.2006.08.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=17064658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12kt73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1758&publication_year=2006&pages=2133-2138&author=J.+H.+Parkauthor=E.+H.+Schuchman&title=Acid+ceramidase+and+human+disease&doi=10.1016%2Fj.bbamem.2006.08.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Acid ceramidase and human disease</span></div><div class="casAuthors">Park, Jae-Ho; Schuchman, Edward H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1758</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2133-2138</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Acid ceramidase (N-acylsphingosine deacylase, EC 3.5.1.23; AC) is the lipid hydrolase responsible for the degrdn. of ceramide into sphingosine and free fatty acids within lysosomes.  The enzymic activity was first identified over four decades ago, and is deficient in the inherited lipid storage disorder, Farber Lipogranulomatosis (Farber disease).  Importantly, AC not only hydrolyzes ceramide into sphingosine, but also can synthesize ceramide from sphingosine and free fatty acids in vitro and in situ.  This "reverse" enzymic activity occurs at a distinct pH from the hydrolysis ("forward") reaction (6.0 vs. 4.5, resp.), suggesting that the enzyme may have diverse functions within cells dependent on its subcellular location and the local pH.  Most information concerning the role of AC in human disease stems from work on Farber disease.  This lipid storage disease is caused by mutations in the gene encoding AC, leading to a profound redn. in enzymic activity.  Recent studies have also shown that AC activity is aberrantly expressed in several human cancers, and that the enzyme may be a useful cancer drug target.  For example, AC inhibitors have been used to slow the growth of cancer cells, alone or in combination with other established, anti-oncogenic treatments.  Aberrant AC activity also has been described in Alzheimer's disease, and overexpression of AC may prevent insulin resistant (Type II) diabetes induced by free fatty acids.  Current information concerning the biol. of this enzyme and its role in human disease is reviewed within.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrexBzUOOWihrVg90H21EOLACvtfcHk0lhIuE6t1hrb8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12kt73I&md5=d6ba8e8a62727eab934b939c2e49fe0e</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2006.08.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2006.08.019%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DJ.%2BH.%26aulast%3DSchuchman%26aufirst%3DE.%2BH.%26atitle%3DAcid%2520ceramidase%2520and%2520human%2520disease%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2006%26volume%3D1758%26spage%3D2133%26epage%3D2138%26doi%3D10.1016%2Fj.bbamem.2006.08.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obeid, L. M.</span></span> <span> </span><span class="NLM_article-title">Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate</span>. <i>Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>1781</i></span>,  <span class="NLM_fpage">424</span>– <span class="NLM_lpage">434</span>, <span class="refDoi"> DOI: 10.1016/j.bbalip.2008.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1016%2Fj.bbalip.2008.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=18619555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVKjtbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1781&publication_year=2008&pages=424-434&author=C.+Maoauthor=L.+M.+Obeid&title=Ceramidases%3A+regulators+of+cellular+responses+mediated+by+ceramide%2C+sphingosine%2C+and+sphingosine-1-phosphate&doi=10.1016%2Fj.bbalip.2008.06.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate</span></div><div class="casAuthors">Mao, Cungui; Obeid, Lina M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1781</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">424-434</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Ceramidases catalyze hydrolysis of ceramides to generate sphingosine (SPH), which is phosphorylated to form sphingosine-1-phosphate (S1P).  Ceramide, SPH, and S1P are bioactive lipids that mediate cell proliferation, differentiation, apoptosis, adhesion, and migration.  Presently, 5 human ceramidases encoded by 5 distinct genes have been cloned: acid ceramidase (AC), neutral ceramidase (NC), alk. ceramidase 1 (ACER1), alk. ceramidase 2 (ACER2), and alk. ceramidase 3 (ACER3).  Each human ceramidase has a mouse counterpart.  AC, NC, and ACER1-3 have maximal activities in acidic, neutral, and alk. environments, resp.  ACER1-3 have similar protein sequences but no homol. to AC and NC.  AC and NC also have distinct protein sequences.  The human AC (hAC) was implicated in Farber disease, and hAC may be important for cell survival.  The mouse AC (mAC) is needed for early embryo survival.  NC is protective against inflammatory cytokines, and the mouse NC (mNC) is required for the catabolism of ceramides in the digestive tract.  ACER1 is crit. in mediating cell differentiation by controlling the generation of SPH and S1P and that ACER2's role in cell proliferation and survival depends on its expression or the cell type in which it is found.  Here, we discuss the role of each ceramidase in regulating cellular responses mediated by ceramides, SPH, and S1P.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEgvBkM7CJsLVg90H21EOLACvtfcHk0lgWuhMDqstQNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVKjtbrM&md5=0ff10423032645e5c8a9baa1c442b85d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2008.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2008.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DC.%26aulast%3DObeid%26aufirst%3DL.%2BM.%26atitle%3DCeramidases%253A%2520regulators%2520of%2520cellular%2520responses%2520mediated%2520by%2520ceramide%252C%2520sphingosine%252C%2520and%2520sphingosine-1-phosphate%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2008%26volume%3D1781%26spage%3D424%26epage%3D434%26doi%3D10.1016%2Fj.bbalip.2008.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanger, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruckhaberle, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gyorffy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engels, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrich, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fehm, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holtrich, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karn, T.</span></span> <span> </span><span class="NLM_article-title">Acid ceramidase is associated with an improved prognosis in both DCIS and invasive breast cancer</span>. <i>Mol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">58</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1016/j.molonc.2014.07.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1016%2Fj.molonc.2014.07.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=25131496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A280%3ADC%252BC2M%252FisFamsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=58-67&author=N.+Sangerauthor=E.+Ruckhaberleauthor=B.+Gyorffyauthor=K.+Engelsauthor=T.+Heinrichauthor=T.+Fehmauthor=A.+Grafauthor=U.+Holtrichauthor=S.+Beckerauthor=T.+Karn&title=Acid+ceramidase+is+associated+with+an+improved+prognosis+in+both+DCIS+and+invasive+breast+cancer&doi=10.1016%2Fj.molonc.2014.07.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Acid ceramidase is associated with an improved prognosis in both DCIS and invasive breast cancer</span></div><div class="casAuthors">Sanger Nicole; Heinrich Tomas; Graf Anna; Holtrich Uwe; Becker Sven; Ruckhaberle Eugen; Fehm Tanja; Gyorffy Balazs; Engels Knut; Karn Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Molecular oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">58-67</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Acid ceramidase (ASAH1) a key enzyme of sphingolipid metabolism converting pro-apoptotic ceramide to sphingosine has been shown to be overexpressed in various cancers.  We previously demonstrated higher expression of ASAH1 in ER positive compared to ER negative breast cancer.  In the current study we performed subtype specific analyses of ASAH1 gene expression in invasive and non invasive breast cancer.  We show that expression of ASAH1 is mainly associated with luminal A - like cancers which are known to have the best prognosis of all breast cancer subtypes.  Moreover tumors with high ASAH1 expression among the other subtypes are also characterized by an improved prognosis.  The good prognosis of tumors with high ASAH1 is independent of the type of adjuvant treatment in breast cancer and is also detected in non small cell lung cancer patients.  Moreover, even in pre-invasive DCIS of the breast ASAH1 is associated with a luminal phenotype and a reduced frequency of recurrences.  Thus, high ASAH1 expression is generally associated with an improved prognosis in invasive breast cancer independent of adjuvant treatment and could also be valuable as prognostic factor for pre-invasive DCIS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS-ZgqV1oxQEkh5eUSa2oe_fW6udTcc2eZxANZkhvV1wrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M%252FisFamsQ%253D%253D&md5=907cdd9a1e931af3e80d58a3396bf915</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.molonc.2014.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molonc.2014.07.016%26sid%3Dliteratum%253Aachs%26aulast%3DSanger%26aufirst%3DN.%26aulast%3DRuckhaberle%26aufirst%3DE.%26aulast%3DGyorffy%26aufirst%3DB.%26aulast%3DEngels%26aufirst%3DK.%26aulast%3DHeinrich%26aufirst%3DT.%26aulast%3DFehm%26aufirst%3DT.%26aulast%3DGraf%26aufirst%3DA.%26aulast%3DHoltrich%26aufirst%3DU.%26aulast%3DBecker%26aufirst%3DS.%26aulast%3DKarn%26aufirst%3DT.%26atitle%3DAcid%2520ceramidase%2520is%2520associated%2520with%2520an%2520improved%2520prognosis%2520in%2520both%2520DCIS%2520and%2520invasive%2520breast%2520cancer%26jtitle%3DMol.%2520Oncol.%26date%3D2015%26volume%3D9%26spage%3D58%26epage%3D67%26doi%3D10.1016%2Fj.molonc.2014.07.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seelan, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokomizo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bostwick, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span> <span> </span><span class="NLM_article-title">Human acid ceramidase is overexpressed but not mutated in prostate cancer</span>. <i>Genes, Chromosomes Cancer</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">137</span>– <span class="NLM_lpage">146</span>, <span class="refDoi"> DOI: 10.1002/1098-2264(2000)9999:9999<::AID-GCC1018>3.0.CO;2-E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1002%2F1098-2264%282000%299999%3A9999%3C%3A%3AAID-GCC1018%3E3.0.CO%3B2-E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10959093" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntVWiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2000&pages=137-146&author=R.+S.+Seelanauthor=C.+Qianauthor=A.+Yokomizoauthor=D.+G.+Bostwickauthor=D.+I.+Smithauthor=W.+Liu&title=Human+acid+ceramidase+is+overexpressed+but+not+mutated+in+prostate+cancer&doi=10.1002%2F1098-2264%282000%299999%3A9999%3C%3A%3AAID-GCC1018%3E3.0.CO%3B2-E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Human acid ceramidase is overexpressed but not mutated in prostate cancer</span></div><div class="casAuthors">Seelan, Ratnam S.; Qian, Chiping; Yokomizo, Akira; Bostwick, David G.; Smith, David I.; Liu, Wanguo</div><div class="citationInfo"><span class="NLM_cas:title">Genes, Chromosomes & Cancer</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">137-146</span>CODEN:
                <span class="NLM_cas:coden">GCCAES</span>;
        ISSN:<span class="NLM_cas:issn">1045-2257</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The human acid ceramidase gene, that causes Farber disease, is located in 8p22, a region frequently altered in several cancers, including prostate cancer.  Acid ceramidase catalyzes the hydrolysis of ceramide, a potent lipid second messenger mol. that promotes apoptosis and inhibits cellular proliferation.  It is not known whether this gene, or its expression, is altered in prostate cancer.  Here, the authors report the structural organization of the human gene, its expression in human tissues, and the identification of several single nucleotide polymorphisms.  No cancer-related mutations were found in the gene in a panel of prostate tumor DNAs analyzed, but increased expression was obsd. in prostate tumor tissues when compared with matched normals.  This increase was obsd. in all three prostate tumor cell lines tested (DU145, LnCAP, and PC3) when compared to a BPH (benign prostatic hyperplasia) cell line and 15/36 prostate tumors.  These results suggest that acid ceramidase may play an important role in prostate carcinogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2Y-_n5vjRdbVg90H21EOLACvtfcHk0lgWuhMDqstQNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntVWiurg%253D&md5=9c690947f4f44a446d83608ffda02c54</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2F1098-2264%282000%299999%3A9999%3C%3A%3AAID-GCC1018%3E3.0.CO%3B2-E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1098-2264%25282000%25299999%253A9999%253C%253A%253AAID-GCC1018%253E3.0.CO%253B2-E%26sid%3Dliteratum%253Aachs%26aulast%3DSeelan%26aufirst%3DR.%2BS.%26aulast%3DQian%26aufirst%3DC.%26aulast%3DYokomizo%26aufirst%3DA.%26aulast%3DBostwick%26aufirst%3DD.%2BG.%26aulast%3DSmith%26aufirst%3DD.%2BI.%26aulast%3DLiu%26aufirst%3DW.%26atitle%3DHuman%2520acid%2520ceramidase%2520is%2520overexpressed%2520but%2520not%2520mutated%2520in%2520prostate%2520cancer%26jtitle%3DGenes%252C%2520Chromosomes%2520Cancer%26date%3D2000%26volume%3D29%26spage%3D137%26epage%3D146%26doi%3D10.1002%2F1098-2264%282000%299999%3A9999%3C%3A%3AAID-GCC1018%3E3.0.CO%3B2-E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klobucar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grbcic, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavelic, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonjic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visentin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedic, M.</span></span> <span> </span><span class="NLM_article-title">Acid ceramidase inhibition sensitizes human colon cancer cells to oxaliplatin through downregulation of transglutaminase 2 and beta1 integrin/FAK-mediated signalling</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>503</i></span>,  <span class="NLM_fpage">843</span>– <span class="NLM_lpage">848</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2018.06.085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1016%2Fj.bbrc.2018.06.085" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=503&publication_year=2018&pages=843-848&author=M.+Klobucarauthor=P.+Grbcicauthor=S.+K.+Pavelicauthor=N.+Jonjicauthor=S.+Visentinauthor=M.+Sedic&title=Acid+ceramidase+inhibition+sensitizes+human+colon+cancer+cells+to+oxaliplatin+through+downregulation+of+transglutaminase+2+and+beta1+integrin%2FFAK-mediated+signalling&doi=10.1016%2Fj.bbrc.2018.06.085"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2018.06.085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2018.06.085%26sid%3Dliteratum%253Aachs%26aulast%3DKlobucar%26aufirst%3DM.%26aulast%3DGrbcic%26aufirst%3DP.%26aulast%3DPavelic%26aufirst%3DS.%2BK.%26aulast%3DJonjic%26aufirst%3DN.%26aulast%3DVisentin%26aufirst%3DS.%26aulast%3DSedic%26aufirst%3DM.%26atitle%3DAcid%2520ceramidase%2520inhibition%2520sensitizes%2520human%2520colon%2520cancer%2520cells%2520to%2520oxaliplatin%2520through%2520downregulation%2520of%2520transglutaminase%25202%2520and%2520beta1%2520integrin%252FFAK-mediated%2520signalling%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2018%26volume%3D503%26spage%3D843%26epage%3D848%26doi%3D10.1016%2Fj.bbrc.2018.06.085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Realini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palese, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizzirani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pontis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bach, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Acid ceramidase in melanoma: expression, localization, and effects of pharmacological inhibition</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>291</i></span>,  <span class="NLM_fpage">2422</span>– <span class="NLM_lpage">2434</span>, <span class="refDoi"> DOI: 10.1074/jbc.M115.666909</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1074%2Fjbc.M115.666909" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=26553872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1Cqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=2422-2434&author=N.+Realiniauthor=F.+Paleseauthor=D.+Pizziraniauthor=S.+Pontisauthor=A.+Basitauthor=A.+Bachauthor=A.+Ganesanauthor=D.+Piomelli&title=Acid+ceramidase+in+melanoma%3A+expression%2C+localization%2C+and+effects+of+pharmacological+inhibition&doi=10.1074%2Fjbc.M115.666909"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Acid Ceramidase in Melanoma. Expression, location, and effects of pharmacological inhibitors</span></div><div class="casAuthors">Realini, Natalia; Palese, Francesca; Pizzirani, Daniela; Pontis, Silvia; Basit, Abdul; Bach, Anders; Ganesan, Anand; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2422-2434</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Acid ceramidase (AC) is a lysosomal cysteine amidase that controls sphingolipid signaling by lowering the levels of ceramides and concomitantly increasing those of sphingosine and its bioactive metabolite, sphingosine 1-phosphate.  In the present study, we evaluated the role of AC-regulated sphingolipid signaling in melanoma.  We found that AC expression is markedly elevated in normal human melanocytes and proliferative melanoma cell lines, compared with other skin cells (keratinocytes and fibroblasts) and non-melanoma cancer cells.  High AC expression was also obsd. in biopsies from human subjects with Stage II melanoma.  Immunofluorescence studies revealed that the subcellular localization of AC differs between melanocytes (where it is found in both cytosol and nucleus) and melanoma cells (where it is primarily localized to cytosol).  In addn. to having high AC levels, melanoma cells generate lower amts. of ceramides than normal melanocytes do.  This down-regulation in ceramide prodn. appears to result from suppression of the de novo biosynthesis pathway.  To test whether AC might contribute to melanoma cell proliferation, we blocked AC activity using a new potent (IC50 = 12 nm) and stable inhibitor.  AC inhibition increased cellular ceramide levels, decreased sphingosine 1-phosphate levels, and acted synergistically with several, albeit not all, antitumoral agents.  The results suggest that AC-controlled sphingolipid metab. may play an important role in the control of melanoma proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ1pGRTPNfObVg90H21EOLACvtfcHk0lg6Z6tGMTsQRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1Cqsbo%253D&md5=40dd33dee5301d0b79ee77c54b3b3fe3</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.666909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.666909%26sid%3Dliteratum%253Aachs%26aulast%3DRealini%26aufirst%3DN.%26aulast%3DPalese%26aufirst%3DF.%26aulast%3DPizzirani%26aufirst%3DD.%26aulast%3DPontis%26aufirst%3DS.%26aulast%3DBasit%26aufirst%3DA.%26aulast%3DBach%26aufirst%3DA.%26aulast%3DGanesan%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DAcid%2520ceramidase%2520in%2520melanoma%253A%2520expression%252C%2520localization%252C%2520and%2520effects%2520of%2520pharmacological%2520inhibition%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26spage%3D2422%26epage%3D2434%26doi%3D10.1074%2Fjbc.M115.666909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doan, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alhajala, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Gizawiy, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rand, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connelly, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochran, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chitambar, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmainda, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirza, S. P.</span></span> <span> </span><span class="NLM_article-title">Acid ceramidase and its inhibitors: a de novo drug target and a new class of drugs for killing glioblastoma cancer stem cells with high efficiency</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">112662</span>– <span class="NLM_lpage">112674</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.22637</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.18632%2Foncotarget.22637" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=29348854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A280%3ADC%252BC1Mvit1SrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=112662-112674&author=N.+B.+Doanauthor=H.+Alhajalaauthor=M.+M.+Al-Gizawiyauthor=W.+M.+Muellerauthor=S.+D.+Randauthor=J.+M.+Connellyauthor=E.+J.+Cochranauthor=C.+R.+Chitambarauthor=P.+Clarkauthor=J.+Kuoauthor=K.+M.+Schmaindaauthor=S.+P.+Mirza&title=Acid+ceramidase+and+its+inhibitors%3A+a+de+novo+drug+target+and+a+new+class+of+drugs+for+killing+glioblastoma+cancer+stem+cells+with+high+efficiency&doi=10.18632%2Foncotarget.22637"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Acid ceramidase and its inhibitors: a de novo drug target and a new class of drugs for killing glioblastoma cancer stem cells with high efficiency</span></div><div class="casAuthors">Doan Ninh B; Mirza Shama P; Doan Ninh B; Mueller Wade M; Alhajala Hisham; Chitambar Christopher R; Schmainda Kathleen M; Al-Gizawiy Mona M; Rand Scott D; Connelly Jennifer M; Cochran Elizabeth J; Clark Paul; Kuo John; Schmainda Kathleen M; Mirza Shama P; Mirza Shama P</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">68</span>),
    <span class="NLM_cas:pages">112662-112674</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Glioblastoma remains the most common, malignant primary cancer of the central nervous system with a low life expectancy and an overall survival of less than 1.5 years.  The treatment options are limited and there is no cure.  Moreover, almost all patients develop recurrent tumors, which typically are more aggressive.  Therapeutically resistant glioblastoma or glioblastoma stem-like cells (GSCs) are hypothesized to cause this inevitable recurrence.  Identifying prognostic biomarkers of glioblastoma will potentially advance knowledge about glioblastoma tumorigenesis and enable discovery of more effective therapies.  Proteomic analysis of more than 600 glioblastoma-specific proteins revealed, for the first time, that expression of acid ceramidase (ASAH1) is associated with poor glioblastoma survival.  CD133+ GSCs express significantly higher ASAH1 compared to CD133- GSCs and serum-cultured glioblastoma cell lines, such as U87MG.  These findings implicate ASAH1 as a plausible independent prognostic marker, providing a target for a therapy tailored toward GSCs.  We further demonstrate that ASAH1 inhibition increases cellular ceramide level and induces apoptosis.  Strikingly, U87MG cells, and three different patient-derived glioblastoma stem-like cancer cell lines were efficiently killed, through apoptosis, by three different known ASAH1 inhibitors with IC50's ranging from 11-104 μM.  In comparison, the standard glioblastoma chemotherapy agent, temozolomide, had minimal GSC-targeted effects at comparable or even higher concentrations (IC50 > 750 μM against GSCs).  ASAH1 is identified as a de novo glioblastoma drug target, and ASAH1 inhibitors, such as carmofur, are shown to be highly effective and to specifically target glioblastoma GSCs.  Carmofur is an ASAH1 inhibitor that crosses the blood-brain barrier, a major bottleneck in glioblastoma treatment.  It has been approved in Japan since 1981 for colorectal cancer therapy.  Therefore, it is poised for repurposing and translation to glioblastoma clinical trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTkPFERLjQD2MrRqEXsZufAfW6udTcc2eYqmsT-ytkfhbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mvit1SrtQ%253D%253D&md5=cf2b957e6c9b8664b919941d4a1eeddb</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.22637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.22637%26sid%3Dliteratum%253Aachs%26aulast%3DDoan%26aufirst%3DN.%2BB.%26aulast%3DAlhajala%26aufirst%3DH.%26aulast%3DAl-Gizawiy%26aufirst%3DM.%2BM.%26aulast%3DMueller%26aufirst%3DW.%2BM.%26aulast%3DRand%26aufirst%3DS.%2BD.%26aulast%3DConnelly%26aufirst%3DJ.%2BM.%26aulast%3DCochran%26aufirst%3DE.%2BJ.%26aulast%3DChitambar%26aufirst%3DC.%2BR.%26aulast%3DClark%26aufirst%3DP.%26aulast%3DKuo%26aufirst%3DJ.%26aulast%3DSchmainda%26aufirst%3DK.%2BM.%26aulast%3DMirza%26aufirst%3DS.%2BP.%26atitle%3DAcid%2520ceramidase%2520and%2520its%2520inhibitors%253A%2520a%2520de%2520novo%2520drug%2520target%2520and%2520a%2520new%2520class%2520of%2520drugs%2520for%2520killing%2520glioblastoma%2520cancer%2520stem%2520cells%2520with%2520high%2520efficiency%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D112662%26epage%3D112674%26doi%3D10.18632%2Foncotarget.22637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doan, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Gizawiy, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabbadini, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rand, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connelly, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chitambar, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmainda, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirza, S. P.</span></span> <span> </span><span class="NLM_article-title">Acid ceramidase confers radioresistance to glioblastoma cells</span>. <i>Oncol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1932</span>– <span class="NLM_lpage">1940</span>, <span class="refDoi"> DOI: 10.3892/or.2017.5855</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.3892%2For.2017.5855" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=28765947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVehsLvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2017&pages=1932-1940&author=N.+B.+Doanauthor=H.+S.+Nguyenauthor=M.+M.+Al-Gizawiyauthor=W.+M.+Muellerauthor=R.+A.+Sabbadiniauthor=S.+D.+Randauthor=J.+M.+Connellyauthor=C.+R.+Chitambarauthor=K.+M.+Schmaindaauthor=S.+P.+Mirza&title=Acid+ceramidase+confers+radioresistance+to+glioblastoma+cells&doi=10.3892%2For.2017.5855"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Acid ceramidase confers radioresistance to glioblastoma cells</span></div><div class="casAuthors">Doan, Ninh B.; Nguyen, Ha S.; Al-Gizawiy, Mona M.; Mueller, Wade M.; Sabbadini, Roger A.; Rand, Scott D.; Connelly, Jennifer M.; Chitambar, Christopher R.; Schmainda, Kathleen M.; Mirza, Shama P.</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1932-1940</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1791-2431</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Glioblastoma multiforme (GBM) is the most common primary, intracranial malignancy of the central nervous system.  The std. treatment protocol, which involves surgical resection, and concurrent radiation with adjuvant temozolomide (TMZ), still imparts a grim prognosis.  Ultimately, all GBMs exhibit recurrence or progression, developing resistance to std. treatment.  This study demonstrates that GBMs acquire resistance to radiation via upregulation of acid ceramidase (ASAH1) and sphingosine-1-phosphate (Sph-1P).  Moreover, inhibition of ASAH1 and Sph-1P, either with humanized monoclonal antibodies, small mol. drugs (i.e. carmofur), or a combination of both, led to suppression of GBM cell growth.  These results suggest that ASAH1 and Sph-1P may be excellent targets for the treatment of new GBMs and recurrent GBMs, esp. since the latter over-expresses ASAH1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLNypfI0P1ZLVg90H21EOLACvtfcHk0lg7QvLK-YZoWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVehsLvI&md5=26b1c037fc2501e8136f0ca6325ca1f5</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.3892%2For.2017.5855&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252For.2017.5855%26sid%3Dliteratum%253Aachs%26aulast%3DDoan%26aufirst%3DN.%2BB.%26aulast%3DNguyen%26aufirst%3DH.%2BS.%26aulast%3DAl-Gizawiy%26aufirst%3DM.%2BM.%26aulast%3DMueller%26aufirst%3DW.%2BM.%26aulast%3DSabbadini%26aufirst%3DR.%2BA.%26aulast%3DRand%26aufirst%3DS.%2BD.%26aulast%3DConnelly%26aufirst%3DJ.%2BM.%26aulast%3DChitambar%26aufirst%3DC.%2BR.%26aulast%3DSchmainda%26aufirst%3DK.%2BM.%26aulast%3DMirza%26aufirst%3DS.%2BP.%26atitle%3DAcid%2520ceramidase%2520confers%2520radioresistance%2520to%2520glioblastoma%2520cells%26jtitle%3DOncol.%2520Rep.%26date%3D2017%26volume%3D38%26spage%3D1932%26epage%3D1940%26doi%3D10.3892%2For.2017.5855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Realini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Ferla, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passalacqua, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matteoli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pistello, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzanti, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Complete acid ceramidase ablation prevents cancer-initiating cell formation in melanoma cells</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">7411</span>, <span class="refDoi"> DOI: 10.1038/s41598-017-07606-w</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1038%2Fs41598-017-07606-w" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=28785021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A280%3ADC%252BC1cflt1Krtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=7411&author=M.+Laiauthor=N.+Realiniauthor=M.+La+Ferlaauthor=I.+Passalacquaauthor=G.+Matteoliauthor=A.+Ganesanauthor=M.+Pistelloauthor=C.+M.+Mazzantiauthor=D.+Piomelli&title=Complete+acid+ceramidase+ablation+prevents+cancer-initiating+cell+formation+in+melanoma+cells&doi=10.1038%2Fs41598-017-07606-w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Complete Acid Ceramidase ablation prevents cancer-initiating cell formation in melanoma cells</span></div><div class="casAuthors">Lai Michele; Realini Natalia; Lai Michele; La Ferla Marco; Mazzanti Chiara Maria; Lai Michele; Passalacqua Ilaria; Matteoli Giulia; Pistello Mauro; Lai Michele; Piomelli Daniele; Ganesan Anand</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7411</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Acid ceramidase (AC) is a lysosomal cysteine hydrolase that catalyzes the conversion of ceramide into fatty acid and sphingosine.  This reaction lowers intracellular ceramide levels and concomitantly generates sphingosine used for sphingosine-1-phosphate (S1P) production.  Since increases in ceramide and consequent decreases of S1P reduce proliferation of various cancers, AC might offer a new target for anti-tumor therapy.  Here we used CrispR-Cas9-mediated gene editing to delete the gene encoding for AC, ASAH1, in human A375 melanoma cells.  ASAH1-null clones show significantly greater accumulation of long-chain saturated ceramides that are substrate for AC.  As seen with administration of exogenous ceramide, AC ablation blocks cell cycle progression and accelerates senescence.  Importantly, ASAH1-null cells also lose the ability to form cancer-initiating cells and to undergo self-renewal, which is suggestive of a key role for AC in maintaining malignancy and self-renewal of invasive melanoma cells.  The results suggest that AC inhibitors might find therapeutic use as adjuvant therapy for advanced melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQAhq12ltnyhNFxYDaSSP8XfW6udTcc2eYumBvwkqvXt7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cflt1Krtg%253D%253D&md5=14fcc4ec6cd5c5d87f81f9270cdb47cb</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-07606-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-07606-w%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DM.%26aulast%3DRealini%26aufirst%3DN.%26aulast%3DLa%2BFerla%26aufirst%3DM.%26aulast%3DPassalacqua%26aufirst%3DI.%26aulast%3DMatteoli%26aufirst%3DG.%26aulast%3DGanesan%26aufirst%3DA.%26aulast%3DPistello%26aufirst%3DM.%26aulast%3DMazzanti%26aufirst%3DC.%2BM.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DComplete%2520acid%2520ceramidase%2520ablation%2520prevents%2520cancer-initiating%2520cell%2520formation%2520in%2520melanoma%2520cells%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D7411%26doi%3D10.1038%2Fs41598-017-07606-w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doan, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montoure, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Gizawiy, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurpad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rand, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connelly, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chitambar, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmainda, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirza, S. P.</span></span> <span> </span><span class="NLM_article-title">Acid ceramidase is a novel drug target for pediatric brain tumors</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">24753</span>– <span class="NLM_lpage">24761</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.15800</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.18632%2Foncotarget.15800" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=24753-24761&author=N.+B.+Doanauthor=H.+S.+Nguyenauthor=A.+Montoureauthor=M.+M.+Al-Gizawiyauthor=W.+M.+Muellerauthor=S.+Kurpadauthor=S.+D.+Randauthor=J.+M.+Connellyauthor=C.+R.+Chitambarauthor=K.+M.+Schmaindaauthor=S.+P.+Mirza&title=Acid+ceramidase+is+a+novel+drug+target+for+pediatric+brain+tumors&doi=10.18632%2Foncotarget.15800"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.15800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.15800%26sid%3Dliteratum%253Aachs%26aulast%3DDoan%26aufirst%3DN.%2BB.%26aulast%3DNguyen%26aufirst%3DH.%2BS.%26aulast%3DMontoure%26aufirst%3DA.%26aulast%3DAl-Gizawiy%26aufirst%3DM.%2BM.%26aulast%3DMueller%26aufirst%3DW.%2BM.%26aulast%3DKurpad%26aufirst%3DS.%26aulast%3DRand%26aufirst%3DS.%2BD.%26aulast%3DConnelly%26aufirst%3DJ.%2BM.%26aulast%3DChitambar%26aufirst%3DC.%2BR.%26aulast%3DSchmainda%26aufirst%3DK.%2BM.%26aulast%3DMirza%26aufirst%3DS.%2BP.%26atitle%3DAcid%2520ceramidase%2520is%2520a%2520novel%2520drug%2520target%2520for%2520pediatric%2520brain%2520tumors%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D24753%26epage%3D24761%26doi%3D10.18632%2Foncotarget.15800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shabani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awad, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaushal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doan, N.</span></span> <span> </span><span class="NLM_article-title">Molecular markers of therapy-resistant glioblastoma and potential strategy to combat resistance</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1765</span>– <span class="NLM_lpage">1765</span>, <span class="refDoi"> DOI: 10.3390/ijms19061765</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.3390%2Fijms19061765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFWmtL7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=1765-1765&author=H.+S.+Nguyenauthor=S.+Shabaniauthor=A.+J.+Awadauthor=M.+Kaushalauthor=N.+Doan&title=Molecular+markers+of+therapy-resistant+glioblastoma+and+potential+strategy+to+combat+resistance&doi=10.3390%2Fijms19061765"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular markers of therapy-resistant glioblastoma and potential strategy to combat resistance</span></div><div class="casAuthors">Nguyen, Ha; Shabani, Saman; Awad, Ahmed; Kaushal, Mayank; Doan, Ninh</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1765/1-1765/23</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Glioblastoma (GBM) is the most common primary malignant tumor of the central nervous system.  With its overall dismal prognosis (the median survival is 14 mo), GBMs demonstrate a resounding resilience against all current treatment modalities.  The absence of a major progress in the treatment of GBM maybe a result of our poor understanding of both GBM tumor biol. and the mechanisms underlying the acquirement of treatment resistance in recurrent GBMs.  A comprehensive understanding of these markers is mandatory for the development of treatments against therapy-resistant GBMs.  This review also provides an overview of a novel marker called acid ceramidase and its implication in the development of radioresistant GBMs.  Multiple signaling pathways were found altered in radioresistant GBMs.  Given these global alterations of multiple signaling pathways found in radioresistant GBMs, an effective treatment for radioresistant GBMs may require a cocktail contg. multiple agents targeting multiple cancer-inducing pathways in order to have a chance to make a substantial impact on improving the overall GBM survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppnNX_rPFiqLVg90H21EOLACvtfcHk0lg7QvLK-YZoWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFWmtL7L&md5=927bd153b883e8e09562be3a88e4667a</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.3390%2Fijms19061765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms19061765%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DH.%2BS.%26aulast%3DShabani%26aufirst%3DS.%26aulast%3DAwad%26aufirst%3DA.%2BJ.%26aulast%3DKaushal%26aufirst%3DM.%26aulast%3DDoan%26aufirst%3DN.%26atitle%3DMolecular%2520markers%2520of%2520therapy-resistant%2520glioblastoma%2520and%2520potential%2520strategy%2520to%2520combat%2520resistance%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2018%26volume%3D19%26spage%3D1765%26epage%3D1765%26doi%3D10.3390%2Fijms19061765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alhajala, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shabani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Best, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaushal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Gizawiy, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, E. Y. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knipstein, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirza, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmainda, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chitambar, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doan, N. B.</span></span> <span> </span><span class="NLM_article-title">Irradiation of pediatric glioblastoma cells promotes radioresistance and enhances glioma malignancy via genome-wide transcriptome changes</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">34122</span>– <span class="NLM_lpage">34131</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.26137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.18632%2Foncotarget.26137" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=34122-34131&author=H.+S.+Alhajalaauthor=H.+S.+Nguyenauthor=S.+Shabaniauthor=B.+Bestauthor=M.+Kaushalauthor=M.+M.+Al-Gizawiyauthor=E.+Y.+E.+Ahnauthor=J.+A.+Knipsteinauthor=S.+Mirzaauthor=K.+M.+Schmaindaauthor=C.+R.+Chitambarauthor=N.+B.+Doan&title=Irradiation+of+pediatric+glioblastoma+cells+promotes+radioresistance+and+enhances+glioma+malignancy+via+genome-wide+transcriptome+changes&doi=10.18632%2Foncotarget.26137"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.26137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.26137%26sid%3Dliteratum%253Aachs%26aulast%3DAlhajala%26aufirst%3DH.%2BS.%26aulast%3DNguyen%26aufirst%3DH.%2BS.%26aulast%3DShabani%26aufirst%3DS.%26aulast%3DBest%26aufirst%3DB.%26aulast%3DKaushal%26aufirst%3DM.%26aulast%3DAl-Gizawiy%26aufirst%3DM.%2BM.%26aulast%3DAhn%26aufirst%3DE.%2BY.%2BE.%26aulast%3DKnipstein%26aufirst%3DJ.%2BA.%26aulast%3DMirza%26aufirst%3DS.%26aulast%3DSchmainda%26aufirst%3DK.%2BM.%26aulast%3DChitambar%26aufirst%3DC.%2BR.%26aulast%3DDoan%26aufirst%3DN.%2BB.%26atitle%3DIrradiation%2520of%2520pediatric%2520glioblastoma%2520cells%2520promotes%2520radioresistance%2520and%2520enhances%2520glioma%2520malignancy%2520via%2520genome-wide%2520transcriptome%2520changes%26jtitle%3DOncotarget%26date%3D2018%26volume%3D9%26spage%3D34122%26epage%3D34131%26doi%3D10.18632%2Foncotarget.26137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doan, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alhajala, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaber, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Gizawiy, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, E. Y.  E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chitambar, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirza, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmainda, K. M.</span></span> <span> </span><span class="NLM_article-title">Identification of radiation responsive genes and transcriptome profiling via complete RNA sequencing in a stable radioresistant U87 glioblastoma model</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">23532</span>– <span class="NLM_lpage">23542</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.25247</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.18632%2Foncotarget.25247" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=23532-23542&author=N.+B.+Doanauthor=H.+S.+Nguyenauthor=H.+S.+Alhajalaauthor=B.+Jaberauthor=M.+M.+Al-Gizawiyauthor=E.+Y.++E.+Ahnauthor=W.+M.+Muellerauthor=C.+R.+Chitambarauthor=S.+P.+Mirzaauthor=K.+M.+Schmainda&title=Identification+of+radiation+responsive+genes+and+transcriptome+profiling+via+complete+RNA+sequencing+in+a+stable+radioresistant+U87+glioblastoma+model&doi=10.18632%2Foncotarget.25247"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.25247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.25247%26sid%3Dliteratum%253Aachs%26aulast%3DDoan%26aufirst%3DN.%2BB.%26aulast%3DNguyen%26aufirst%3DH.%2BS.%26aulast%3DAlhajala%26aufirst%3DH.%2BS.%26aulast%3DJaber%26aufirst%3DB.%26aulast%3DAl-Gizawiy%26aufirst%3DM.%2BM.%26aulast%3DAhn%26aufirst%3DE.%2BY.%2BE.%26aulast%3DMueller%26aufirst%3DW.%2BM.%26aulast%3DChitambar%26aufirst%3DC.%2BR.%26aulast%3DMirza%26aufirst%3DS.%2BP.%26aulast%3DSchmainda%26aufirst%3DK.%2BM.%26atitle%3DIdentification%2520of%2520radiation%2520responsive%2520genes%2520and%2520transcriptome%2520profiling%2520via%2520complete%2520RNA%2520sequencing%2520in%2520a%2520stable%2520radioresistant%2520U87%2520glioblastoma%2520model%26jtitle%3DOncotarget%26date%3D2018%26volume%3D9%26spage%3D23532%26epage%3D23542%26doi%3D10.18632%2Foncotarget.25247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pizzirani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagliuca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Realini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Branduardi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottegoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarpelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandiera, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of a new class of highly potent inhibitors of acid ceramidase: synthesis and structure-activity relationship (SAR)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3518</span>– <span class="NLM_lpage">3530</span>, <span class="refDoi"> DOI: 10.1021/jm301879g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301879g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A528%3ADC%252BC3sXms1Wjtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3518-3530&author=D.+Pizziraniauthor=C.+Pagliucaauthor=N.+Realiniauthor=D.+Branduardiauthor=G.+Bottegoniauthor=M.+Morauthor=F.+Bertozziauthor=R.+Scarpelliauthor=D.+Piomelliauthor=T.+Bandiera&title=Discovery+of+a+new+class+of+highly+potent+inhibitors+of+acid+ceramidase%3A+synthesis+and+structure-activity+relationship+%28SAR%29&doi=10.1021%2Fjm301879g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a New Class of Highly Potent Inhibitors of Acid Ceramidase: Synthesis and Structure-Activity Relationship (SAR)</span></div><div class="casAuthors">Pizzirani, Daniela; Pagliuca, Chiara; Realini, Natalia; Branduardi, Davide; Bottegoni, Giovanni; Mor, Marco; Bertozzi, Fabio; Scarpelli, Rita; Piomelli, Daniele; Bandiera, Tiziano</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3518-3530</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">1-(Alkylamino)-2,4-pyrimidinediones such as I [R = H, F, MeO, F3C, Ph; R1 = Me(CH2)nNH; R2 = H, Me, MeO2C; n = 5, 7] were prepd. as inhibitors of acid ceramidase for potential use as antitumor agents.  Uracils bearing an electron-withdrawing substituent at position 5, a substituent such as Me at position 3, and an alkylaminocarbonyl moiety with a six- to eight-carbon alkyl group at position 1 were the most effective inhibitors of acid ceramidase of the compds. tested.  The acid ceramidase inhibition and stability of an alkylaminopyrimidinedione was correlated with the stabilization of the antibonding orbital of its N1-carbonyl bond.  I (R = H, F, Ph; R2 = H, Me; n = 5, 7) inhibited a human cancer cell line (SW403) with IC50 values of 20-24 μM.  I (R = F, F3C, MeO; R2 = H, MeO2C; n = 5, 7) inhibited acid ceramidase with single digit-nanomolar IC50 values (IC50 = 4-7 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSG4lPgE1b1bVg90H21EOLACvtfcHk0livu6vaXPQbig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXms1Wjtbo%253D&md5=e8b1cb63aa40e8654de70985febc56dd</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm301879g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301879g%26sid%3Dliteratum%253Aachs%26aulast%3DPizzirani%26aufirst%3DD.%26aulast%3DPagliuca%26aufirst%3DC.%26aulast%3DRealini%26aufirst%3DN.%26aulast%3DBranduardi%26aufirst%3DD.%26aulast%3DBottegoni%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DScarpelli%26aufirst%3DR.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DBandiera%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520a%2520new%2520class%2520of%2520highly%2520potent%2520inhibitors%2520of%2520acid%2520ceramidase%253A%2520synthesis%2520and%2520structure-activity%2520relationship%2520%2528SAR%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3518%26epage%3D3530%26doi%3D10.1021%2Fjm301879g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Realini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solorzano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagliuca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizzirani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luciani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costi, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandiera, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Discovery of highly potent acid ceramidase inhibitors with in vitro tumor chemosensitizing activity</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1035</span>, <span class="refDoi"> DOI: 10.1038/srep01035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1038%2Fsrep01035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=23301156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFaqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=1035&author=N.+Realiniauthor=C.+Solorzanoauthor=C.+Pagliucaauthor=D.+Pizziraniauthor=A.+Armirottiauthor=R.+Lucianiauthor=M.+P.+Costiauthor=T.+Bandieraauthor=D.+Piomelli&title=Discovery+of+highly+potent+acid+ceramidase+inhibitors+with+in+vitro+tumor+chemosensitizing+activity&doi=10.1038%2Fsrep01035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of highly potent acid ceramidase inhibitors with in vitro tumor chemosensitizing activity</span></div><div class="casAuthors">Realini, Natalia; Solorzano, Carlos; Pagliuca, Chiara; Pizzirani, Daniela; Armirotti, Andrea; Luciani, Rosaria; Costi, Maria Paola; Bandiera, Tiziano; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">srep01035, 7 pp.</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The expression of acid ceramidase (AC) - a cysteine amidase that hydrolyzes the proapoptotic lipid ceramide - is abnormally high in several human tumors, which is suggestive of a role in chemoresistance.  Available AC inhibitors lack, however, the potency and drug-likeness necessary to test this idea.  Here we show that the antineoplastic drug carmofur, which is used in the clinic to treat colorectal cancers, is a potent AC inhibitor and that this property is essential to its anti-proliferative effects.  Modifications in the chem. scaffold of carmofur yield new AC inhibitors that act synergistically with std. antitumoral drugs to prevent cancer cell proliferation.  These findings identify AC as an unexpected target for carmofur, and suggest that this mol. can be used as starting point for the design of novel chemosensitizing agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoknWbdLSLhRbVg90H21EOLACvtfcHk0lgnN0dKY3kIvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFaqt7w%253D&md5=7ff74388fc2bea42c0e97fa8cbcfe61f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fsrep01035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep01035%26sid%3Dliteratum%253Aachs%26aulast%3DRealini%26aufirst%3DN.%26aulast%3DSolorzano%26aufirst%3DC.%26aulast%3DPagliuca%26aufirst%3DC.%26aulast%3DPizzirani%26aufirst%3DD.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DLuciani%26aufirst%3DR.%26aulast%3DCosti%26aufirst%3DM.%2BP.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520highly%2520potent%2520acid%2520ceramidase%2520inhibitors%2520with%2520in%2520vitro%2520tumor%2520chemosensitizing%2520activity%26jtitle%3DSci.%2520Rep.%26date%3D2013%26volume%3D3%26spage%3D1035%26doi%3D10.1038%2Fsrep01035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pizzirani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bach, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Realini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mengatto, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girotto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagliuca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Vivo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribeiro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Benzoxazolone carboxamides: potent and systemically active inhibitors of intracellular acid ceramidase</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">366</span>, <span class="refDoi"> DOI: 10.1002/anie.201410931</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1002%2Fanie.201410931" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=366&author=D.+Pizziraniauthor=A.+Bachauthor=N.+Realiniauthor=A.+Armirottiauthor=L.+Mengattoauthor=I.+Bauerauthor=S.+Girottoauthor=C.+Pagliucaauthor=M.+De+Vivoauthor=M.+Summaauthor=A.+Ribeiroauthor=D.+Piomelli&title=Benzoxazolone+carboxamides%3A+potent+and+systemically+active+inhibitors+of+intracellular+acid+ceramidase&doi=10.1002%2Fanie.201410931"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1002%2Fanie.201410931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201410931%26sid%3Dliteratum%253Aachs%26aulast%3DPizzirani%26aufirst%3DD.%26aulast%3DBach%26aufirst%3DA.%26aulast%3DRealini%26aufirst%3DN.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DMengatto%26aufirst%3DL.%26aulast%3DBauer%26aufirst%3DI.%26aulast%3DGirotto%26aufirst%3DS.%26aulast%3DPagliuca%26aufirst%3DC.%26aulast%3DDe%2BVivo%26aufirst%3DM.%26aulast%3DSumma%26aufirst%3DM.%26aulast%3DRibeiro%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DBenzoxazolone%2520carboxamides%253A%2520potent%2520and%2520systemically%2520active%2520inhibitors%2520of%2520intracellular%2520acid%2520ceramidase%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2015%26volume%3D54%26spage%3D366%26doi%3D10.1002%2Fanie.201410931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gebai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorelik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Illes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagar, B.</span></span> <span> </span><span class="NLM_article-title">Structural basis for the activation of acid ceramidase</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1621</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-03844-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1038%2Fs41467-018-03844-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=29692406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A280%3ADC%252BC1Mjmtl2rtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1621&author=A.+Gebaiauthor=A.+Gorelikauthor=Z.+Liauthor=K.+Illesauthor=B.+Nagar&title=Structural+basis+for+the+activation+of+acid+ceramidase&doi=10.1038%2Fs41467-018-03844-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for the activation of acid ceramidase</span></div><div class="casAuthors">Gebai Ahmad; Gorelik Alexei; Li Zixian; Illes Katalin; Nagar Bhushan</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1621</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Acid ceramidase (aCDase, ASAH1) hydrolyzes lysosomal membrane ceramide into sphingosine, the backbone of all sphingolipids, to regulate many cellular processes.  Abnormal function of aCDase leads to Farber disease, spinal muscular atrophy with progressive myoclonic epilepsy, and is associated with Alzheimer's, diabetes, and cancer.  Here, we present crystal structures of mammalian aCDases in both proenzyme and autocleaved forms.  In the proenzyme, the catalytic center is buried and protected from solvent.  Autocleavage triggers a conformational change exposing a hydrophobic channel leading to the active site.  Substrate modeling suggests distinct catalytic mechanisms for substrate hydrolysis versus autocleavage.  A hydrophobic surface surrounding the substrate binding channel appears to be a site of membrane attachment where the enzyme accepts substrates facilitated by the accessory protein, saposin-D.  Structural mapping of disease mutations reveals that most would destabilize the protein fold.  These results will inform the rational design of aCDase inhibitors and recombinant aCDase for disease therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT6RpR0JSKnbwHqQV89nF-2fW6udTcc2eaFVyfb3JCLnbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mjmtl2rtg%253D%253D&md5=a7fb6f187dc50d25c9a14597053718c1</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-03844-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-03844-2%26sid%3Dliteratum%253Aachs%26aulast%3DGebai%26aufirst%3DA.%26aulast%3DGorelik%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DIlles%26aufirst%3DK.%26aulast%3DNagar%26aufirst%3DB.%26atitle%3DStructural%2520basis%2520for%2520the%2520activation%2520of%2520acid%2520ceramidase%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D1621%26doi%3D10.1038%2Fs41467-018-03844-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shtraizent, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eliyahu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shalgi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuchman, E. H.</span></span> <span> </span><span class="NLM_article-title">Autoproteolytic cleavage and activation of human acid ceramidase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">11253</span>– <span class="NLM_lpage">11259</span>, <span class="refDoi"> DOI: 10.1074/jbc.M709166200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1074%2Fjbc.M709166200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=11253-11259&author=N.+Shtraizentauthor=E.+Eliyahuauthor=J.+H.+Parkauthor=X.+Heauthor=R.+Shalgiauthor=E.+H.+Schuchman&title=Autoproteolytic+cleavage+and+activation+of+human+acid+ceramidase&doi=10.1074%2Fjbc.M709166200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M709166200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M709166200%26sid%3Dliteratum%253Aachs%26aulast%3DShtraizent%26aufirst%3DN.%26aulast%3DEliyahu%26aufirst%3DE.%26aulast%3DPark%26aufirst%3DJ.%2BH.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DShalgi%26aufirst%3DR.%26aulast%3DSchuchman%26aufirst%3DE.%2BH.%26atitle%3DAutoproteolytic%2520cleavage%2520and%2520activation%2520of%2520human%2520acid%2520ceramidase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D11253%26epage%3D11259%26doi%3D10.1074%2Fjbc.M709166200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gorelik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gebai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Illes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagar, B.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanism of activation of the immunoregulatory amidase NAAA</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">E10032</span>– <span class="NLM_lpage">E10040</span>, <span class="refDoi"> DOI: 10.1073/pnas.1811759115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1073%2Fpnas.1811759115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=30301806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVyhsLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2018&pages=E10032-E10040&author=A.+Gorelikauthor=A.+Gebaiauthor=K.+Illesauthor=D.+Piomelliauthor=B.+Nagar&title=Molecular+mechanism+of+activation+of+the+immunoregulatory+amidase+NAAA&doi=10.1073%2Fpnas.1811759115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanism of activation of the immunoregulatory amidase NAAA</span></div><div class="casAuthors">Gorelik, Alexei; Gebai, Ahmad; Illes, Katalin; Piomelli, Daniele; Nagar, Bhushan</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">E10032-E10040</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Palmitoylethanolamide is a bioactive lipid that strongly alleviates pain and inflammation in animal models and in humans.  Its signaling activity is terminated through degrdn. by N-acylethanolamine acid amidase (NAAA), a cysteine hydrolase expressed at high levels in immune cells.  Pharmacol. inhibitors of NAAA activity exert profound analgesic and antiinflammatory effects in rodent models, pointing to this protein as a potential target for therapeutic drug discovery.  To facilitate these efforts and to better understand the mol. mechanism of action of NAAA, we detd. crystal structures of this enzyme in various activation states and in complex with several ligands, including both a covalent and a reversible inhibitor.  Self-proteolysis exposes the otherwise buried active site of NAAA to allow catalysis.  Formation of a stable substrate- or inhibitor-binding site appears to be conformationally coupled to the interaction of a pair of hydrophobic helixes in the enzyme with lipid membranes, resulting in the creation of a linear hydrophobic cavity near the active site that accommodates the liganda's acyl chain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe4SyudaY7MrVg90H21EOLACvtfcHk0lgnN0dKY3kIvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVyhsLvP&md5=9debd68d3239a82bd60849c9cf98e8ae</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1811759115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1811759115%26sid%3Dliteratum%253Aachs%26aulast%3DGorelik%26aufirst%3DA.%26aulast%3DGebai%26aufirst%3DA.%26aulast%3DIlles%26aufirst%3DK.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DNagar%26aufirst%3DB.%26atitle%3DMolecular%2520mechanism%2520of%2520activation%2520of%2520the%2520immunoregulatory%2520amidase%2520NAAA%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2018%26volume%3D115%26spage%3DE10032%26epage%3DE10040%26doi%3D10.1073%2Fpnas.1811759115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Al, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiffany, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomes de Mesquita, D.
S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moser, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tager, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schram, A. W.</span></span> <span> </span><span class="NLM_article-title">Properties of acid ceramidase from human spleen</span>. <i>Biochim. Biophys. Acta, Lipids Lipid Metab.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>1004</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">251</span>, <span class="refDoi"> DOI: 10.1016/0005-2760(89)90274-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1016%2F0005-2760%2889%2990274-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=2526656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A528%3ADyaL1MXlsV2htbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1004&publication_year=1989&pages=245-251&author=B.+J.+Alauthor=C.+W.+Tiffanyauthor=D.%0AS.+Gomes+de+Mesquitaauthor=H.+W.+Moserauthor=J.+M.+Tagerauthor=A.+W.+Schram&title=Properties+of+acid+ceramidase+from+human+spleen&doi=10.1016%2F0005-2760%2889%2990274-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Properties of acid ceramidase from human spleen</span></div><div class="casAuthors">Al, Bert J. M.; Tiffany, Carol W.; Gomes de Mesquita, Daniel S.; Moser, Hugo W.; Tager, Joseph M.; Schram, Andre W.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Lipids and Lipid Metabolism</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">1004</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">245-51</span>CODEN:
                <span class="NLM_cas:coden">BBLLA6</span>;
        ISSN:<span class="NLM_cas:issn">0005-2760</span>.
    </div><div class="casAbstract">Ceramidase activity in exts. of human spleen from control subjects and from patients with Gaucher disease was characterized.  In Triton X-100 exts. of control spleens, a broad optimum pH 3.5-5.0 was found; no ceramidase activity was detectable at neutral or alk. pH.  About 45-60% of acid ceramidase could be extd. from spleen without detergents, but for complete extn. Triton X-100 was required.  For the radiolabeled substrate oleoylsphingosine, a Km of 0.22 mM and a Vmax of 57 H nmol/h per mg protein was calcd. in spleen from a control subject.  Flat-bed isoelec. focussing in the presence of Triton X 100 revealed a pI of 6.0-7.0 for acid ceramidase; values were similar for sphingomyelinase and glucerebrosidase.  HPLC-gel filtration indicated that in the presence of Triton X 100, acid ceramidase has an Mr of ∼100 kDa.  In the absence of detergents, the enzyme forms high-mol.-wt. aggregates.  Similar aggregation behavior was obsd. for sphingomyelinase, whereas the elution of β-hexosaminidase was not affected by detergents.  The elution profile of glucocerebrosidase was only slightly altered by Triton X 100.  There was no difference in the properties of acid ceramidase in spleen from control subjects and from patients with type I Gaucher disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHT137-2vCKLVg90H21EOLACvtfcHk0lh0R1FJlp0KjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXlsV2htbw%253D&md5=dff6290c6bd9e65ffd881132f145be7b</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2F0005-2760%2889%2990274-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0005-2760%252889%252990274-9%26sid%3Dliteratum%253Aachs%26aulast%3DAl%26aufirst%3DB.%2BJ.%26aulast%3DTiffany%26aufirst%3DC.%2BW.%26aulast%3DGomes%2Bde%2BMesquita%26aufirst%3DD.%2BS.%26aulast%3DMoser%26aufirst%3DH.%2BW.%26aulast%3DTager%26aufirst%3DJ.%2BM.%26aulast%3DSchram%26aufirst%3DA.%2BW.%26atitle%3DProperties%2520of%2520acid%2520ceramidase%2520from%2520human%2520spleen%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Lipids%2520Lipid%2520Metab.%26date%3D1989%26volume%3D1004%26spage%3D245%26epage%3D251%26doi%3D10.1016%2F0005-2760%2889%2990274-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckham, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrison, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yount, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartlett, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keane, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armeson, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keane, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drake, R. R.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bielawska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norris, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span> <span> </span><span class="NLM_article-title">Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">4344</span>– <span class="NLM_lpage">4358</span>, <span class="refDoi"> DOI: 10.1172/JCI64791</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1172%2FJCI64791" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2013&pages=4344-4358&author=J.+C.+Chengauthor=A.+Baiauthor=T.+H.+Beckhamauthor=S.+T.+Marrisonauthor=C.+L.+Yountauthor=K.+Youngauthor=P.+Luauthor=A.+M.+Bartlettauthor=B.+X.+Wuauthor=B.+J.+Keaneauthor=K.+E.+Armesonauthor=D.+T.+Marshallauthor=T.+E.+Keaneauthor=M.+T.+Smithauthor=E.+E.+Jonesauthor=R.+R.+Drakeauthor=A.+Bielawskaauthor=J.+S.+Norrisauthor=X.+Liu&title=Radiation-induced+acid+ceramidase+confers+prostate+cancer+resistance+and+tumor+relapse&doi=10.1172%2FJCI64791"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1172%2FJCI64791&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI64791%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DJ.%2BC.%26aulast%3DBai%26aufirst%3DA.%26aulast%3DBeckham%26aufirst%3DT.%2BH.%26aulast%3DMarrison%26aufirst%3DS.%2BT.%26aulast%3DYount%26aufirst%3DC.%2BL.%26aulast%3DYoung%26aufirst%3DK.%26aulast%3DLu%26aufirst%3DP.%26aulast%3DBartlett%26aufirst%3DA.%2BM.%26aulast%3DWu%26aufirst%3DB.%2BX.%26aulast%3DKeane%26aufirst%3DB.%2BJ.%26aulast%3DArmeson%26aufirst%3DK.%2BE.%26aulast%3DMarshall%26aufirst%3DD.%2BT.%26aulast%3DKeane%26aufirst%3DT.%2BE.%26aulast%3DSmith%26aufirst%3DM.%2BT.%26aulast%3DJones%26aufirst%3DE.%2BE.%26aulast%3DDrake%26aufirst%3DR.%2BR.%26aulast%3DBielawska%26aufirst%3DA.%26aulast%3DNorris%26aufirst%3DJ.%2BS.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DRadiation-induced%2520acid%2520ceramidase%2520confers%2520prostate%2520cancer%2520resistance%2520and%2520tumor%2520relapse%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2013%26volume%3D123%26spage%3D4344%26epage%3D4358%26doi%3D10.1172%2FJCI64791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doan, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montoure, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Gizawiy, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurpad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rand, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connelly, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chitambar, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmainda, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirza, S. P.</span></span> <span> </span><span class="NLM_article-title">Acid ceramidase is a novel drug target for pediatric brain tumors</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">24753</span>– <span class="NLM_lpage">24761</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.15800</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.18632%2Foncotarget.15800" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=24753-24761&author=N.+B.+Doanauthor=H.+S.+Nguyenauthor=A.+Montoureauthor=M.+M.+Al-Gizawiyauthor=W.+M.+Muellerauthor=S.+Kurpadauthor=S.+D.+Randauthor=J.+M.+Connellyauthor=C.+R.+Chitambarauthor=K.+M.+Schmaindaauthor=S.+P.+Mirza&title=Acid+ceramidase+is+a+novel+drug+target+for+pediatric+brain+tumors&doi=10.18632%2Foncotarget.15800"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.15800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.15800%26sid%3Dliteratum%253Aachs%26aulast%3DDoan%26aufirst%3DN.%2BB.%26aulast%3DNguyen%26aufirst%3DH.%2BS.%26aulast%3DMontoure%26aufirst%3DA.%26aulast%3DAl-Gizawiy%26aufirst%3DM.%2BM.%26aulast%3DMueller%26aufirst%3DW.%2BM.%26aulast%3DKurpad%26aufirst%3DS.%26aulast%3DRand%26aufirst%3DS.%2BD.%26aulast%3DConnelly%26aufirst%3DJ.%2BM.%26aulast%3DChitambar%26aufirst%3DC.%2BR.%26aulast%3DSchmainda%26aufirst%3DK.%2BM.%26aulast%3DMirza%26aufirst%3DS.%2BP.%26atitle%3DAcid%2520ceramidase%2520is%2520a%2520novel%2520drug%2520target%2520for%2520pediatric%2520brain%2520tumors%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D24753%26epage%3D24761%26doi%3D10.18632%2Foncotarget.15800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elojeimy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahdy, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeidan, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bielawska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bielawski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Zawahry, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannun, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holman, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubinchik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szulc, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keane, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavassoli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norris, J. S.</span></span> <span> </span><span class="NLM_article-title">Acid ceramidase inhibition: a novel target for cancer therapy</span>. <i>Front. Biosci., Landmark Ed.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2293</span>– <span class="NLM_lpage">2298</span>, <span class="refDoi"> DOI: 10.2741/2843</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.2741%2F2843" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=17981711" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=2293-2298&author=X.+Liuauthor=S.+Elojeimyauthor=L.+S.+Turnerauthor=A.+E.+Mahdyauthor=Y.+H.+Zeidanauthor=A.+Bielawskaauthor=J.+Bielawskiauthor=J.+Y.+Dongauthor=A.+M.+El-Zawahryauthor=G.+W.+Guoauthor=Y.+A.+Hannunauthor=D.+H.+Holmanauthor=S.+Rubinchikauthor=Z.+Szulcauthor=T.+E.+Keaneauthor=M.+Tavassoliauthor=J.+S.+Norris&title=Acid+ceramidase+inhibition%3A+a+novel+target+for+cancer+therapy&doi=10.2741%2F2843"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.2741%2F2843&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F2843%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DElojeimy%26aufirst%3DS.%26aulast%3DTurner%26aufirst%3DL.%2BS.%26aulast%3DMahdy%26aufirst%3DA.%2BE.%26aulast%3DZeidan%26aufirst%3DY.%2BH.%26aulast%3DBielawska%26aufirst%3DA.%26aulast%3DBielawski%26aufirst%3DJ.%26aulast%3DDong%26aufirst%3DJ.%2BY.%26aulast%3DEl-Zawahry%26aufirst%3DA.%2BM.%26aulast%3DGuo%26aufirst%3DG.%2BW.%26aulast%3DHannun%26aufirst%3DY.%2BA.%26aulast%3DHolman%26aufirst%3DD.%2BH.%26aulast%3DRubinchik%26aufirst%3DS.%26aulast%3DSzulc%26aufirst%3DZ.%26aulast%3DKeane%26aufirst%3DT.%2BE.%26aulast%3DTavassoli%26aufirst%3DM.%26aulast%3DNorris%26aufirst%3DJ.%2BS.%26atitle%3DAcid%2520ceramidase%2520inhibition%253A%2520a%2520novel%2520target%2520for%2520cancer%2520therapy%26jtitle%3DFront.%2520Biosci.%252C%2520Landmark%2520Ed.%26date%3D2008%26volume%3D13%26spage%3D2293%26epage%3D2298%26doi%3D10.2741%2F2843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mahdy, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elojeimy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meacham, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gault, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPherson, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckham, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bielawska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bielawski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannun, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keane, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taha, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammouda, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norris, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span> <span> </span><span class="NLM_article-title">Acid ceramidase upregulation in prostate cancer cells confers resistance to radiation: AC inhibition, a potential radiosensitizer</span>. <i>Mol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">430</span>– <span class="NLM_lpage">438</span>, <span class="refDoi"> DOI: 10.1038/mt.2008.281</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1038%2Fmt.2008.281" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=19107118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFart7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=430-438&author=A.+E.+Mahdyauthor=J.+C.+Chengauthor=J.+Liauthor=S.+Elojeimyauthor=W.+D.+Meachamauthor=L.+S.+Turnerauthor=A.+Baiauthor=C.+R.+Gaultauthor=A.+S.+McPhersonauthor=N.+Garciaauthor=T.+H.+Beckhamauthor=A.+Saadauthor=A.+Bielawskaauthor=J.+Bielawskiauthor=Y.+A.+Hannunauthor=T.+E.+Keaneauthor=M.+I.+Tahaauthor=H.+M.+Hammoudaauthor=J.+S.+Norrisauthor=X.+Liu&title=Acid+ceramidase+upregulation+in+prostate+cancer+cells+confers+resistance+to+radiation%3A+AC+inhibition%2C+a+potential+radiosensitizer&doi=10.1038%2Fmt.2008.281"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Acid Ceramidase Upregulation in Prostate Cancer Cells Confers Resistance to Radiation: AC Inhibition, a Potential Radiosensitizer</span></div><div class="casAuthors">Mahdy, Ayman E. M.; Cheng, Joseph C.; Li, Jun; Elojeimy, Saeed; Meacham, William D.; Turner, Lorianne S.; Bai, Aiping; Gault, Christopher R.; McPherson, Alex S.; Garcia, Nicole; Beckham, Thomas H.; Saad, Antonio; Bielawska, Alicja; Bielawski, Jacek; Hannun, Yusuf A.; Keane, Thomas E.; Taha, Mohhammed I.; Hammouda, Hisham M.; Norris, James S.; Liu, Xiang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Therapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">430-438</span>CODEN:
                <span class="NLM_cas:coden">MTOHCK</span>;
        ISSN:<span class="NLM_cas:issn">1525-0016</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Radiation resistance in a subset of prostate tumors remains a challenge to prostate cancer radiotherapy.  The current study on the effects of radiation on prostate cancer cells reveals that radiation programs an unpredicted resistance mechanism by upregulating acid ceramidase (AC).  Irradiated cells demonstrated limited changes of ceramide levels while elevating levels of sphingosine and sphingosine-1-phosphate.  By genetically downregulating AC with small interfering RNA (siRNA), we obsd. radiosensitization of cells using clonogenic and cytotoxicity assays.  Conversely, AC overexpression further decreased sensitivity to radiation.  We also obsd. that radiation-induced AC upregulation was sufficient to create cross-resistance to chemotherapy as demonstrated by decreased sensitivity to Taxol and C6 ceramide compared to controls.  Lower levels of caspase 3/7 activity were detected in cells pretreated with radiation, also indicating increased resistance.  Finally, utilization of the small mol. AC inhibitor, LCL385, sensitized PPC-1 cells to radiation and significantly decreased tumor xenograft growth.  These data suggest a new mechanism of cancer cell resistance to radiation, through upregulation of AC i.e., in part, mediated by application of the therapy itself.  An improved understanding of radiotherapy and the application of combination therapy achieved in this study offer new opportunities for the modulation of radiation effects in the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcfZKQJLJrLbVg90H21EOLACvtfcHk0lhZdTzvvgO9Og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFart7fF&md5=96aa1d9b77ef926f93655a78e610e20a</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fmt.2008.281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmt.2008.281%26sid%3Dliteratum%253Aachs%26aulast%3DMahdy%26aufirst%3DA.%2BE.%26aulast%3DCheng%26aufirst%3DJ.%2BC.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DElojeimy%26aufirst%3DS.%26aulast%3DMeacham%26aufirst%3DW.%2BD.%26aulast%3DTurner%26aufirst%3DL.%2BS.%26aulast%3DBai%26aufirst%3DA.%26aulast%3DGault%26aufirst%3DC.%2BR.%26aulast%3DMcPherson%26aufirst%3DA.%2BS.%26aulast%3DGarcia%26aufirst%3DN.%26aulast%3DBeckham%26aufirst%3DT.%2BH.%26aulast%3DSaad%26aufirst%3DA.%26aulast%3DBielawska%26aufirst%3DA.%26aulast%3DBielawski%26aufirst%3DJ.%26aulast%3DHannun%26aufirst%3DY.%2BA.%26aulast%3DKeane%26aufirst%3DT.%2BE.%26aulast%3DTaha%26aufirst%3DM.%2BI.%26aulast%3DHammouda%26aufirst%3DH.%2BM.%26aulast%3DNorris%26aufirst%3DJ.%2BS.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DAcid%2520ceramidase%2520upregulation%2520in%2520prostate%2520cancer%2520cells%2520confers%2520resistance%2520to%2520radiation%253A%2520AC%2520inhibition%252C%2520a%2520potential%2520radiosensitizer%26jtitle%3DMol.%2520Ther.%26date%3D2009%26volume%3D17%26spage%3D430%26epage%3D438%26doi%3D10.1038%2Fmt.2008.281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Otwinowski, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minor, W.</span></span> <span> </span><span class="NLM_article-title">Processing of x-ray diffraction data collected in oscillation mode</span>. <i>Methods Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">307</span>– <span class="NLM_lpage">326</span>, <span class="refDoi"> DOI: 10.1016/S0076-6879(97)76066-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1016%2FS0076-6879%2897%2976066-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=27754618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=1997&pages=307-326&author=Z.+Otwinowskiauthor=W.+Minor&title=Processing+of+x-ray+diffraction+data+collected+in+oscillation+mode&doi=10.1016%2FS0076-6879%2897%2976066-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Processing of x-ray diffraction data collected in oscillation mode</span></div><div class="casAuthors">Otwinowski, Zbyszek; Minor, Wladek</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">Macromolecular Crystallography, Part A</span>),
    <span class="NLM_cas:pages">307-326</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Macromol. crystallog. is an iterative process.  Rarely do the first crystals provide all the necessary data to solve the biol. problem being studied.  Each step benefits from experience learned in previous steps.  To monitor the progress, the HKL package provides 2 tools: (1) statistics, both weighted (χ2) and unweighted (R-merge), are provided, and the Bayesian reasoning and multicomponent error model facilitates obtaining the proper error ests. and (2) visualization of the process plays a double role by helping the operator to confirm that the process of data redn., including the resulting statistics, is correct, and allowing one to evaluate problems for which there are no good statistical criteria.  Visualization also provides confidence that the point of diminishing returns in data collection and redn. has been reached.  At that point, the effort should be directed to solving the structure.  The methods presented here have been applied to solve a large variety of problems, from inorg. mols. with 5 Å unit cell to rotavirus of 700 Å diam. crystd. in 700 × 1000 × 1400 Å cell.  Overall quality of the method was tested by many researchers by successful application of the programs to MAD structure detns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA3fvBOHqhhrVg90H21EOLACvtfcHk0lhZdTzvvgO9Og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D&md5=c9536971d4e32cc35352c40fb9368131</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2897%2976066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252897%252976066-X%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26aulast%3DMinor%26aufirst%3DW.%26atitle%3DProcessing%2520of%2520x-ray%2520diffraction%2520data%2520collected%2520in%2520oscillation%2520mode%26jtitle%3DMethods%2520Enzymol.%26date%3D1997%26volume%3D276%26spage%3D307%26epage%3D326%26doi%3D10.1016%2FS0076-6879%2897%2976066-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storoni, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span> <span> </span><span class="NLM_article-title">Phaser crystallographic software</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">658</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0lh7ckiPhlSbiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodson, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keegan, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krissinel, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNicholas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannu, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potterton, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, K. S.</span></span> <span> </span><span class="NLM_article-title">Overview of the CCP4 suite and current developments</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">242</span>, <span class="refDoi"> DOI: 10.1107/S0907444910045749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1107%2FS0907444910045749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=21460441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=235-242&author=M.+D.+Winnauthor=C.+C.+Ballardauthor=K.+D.+Cowtanauthor=E.+J.+Dodsonauthor=P.+Emsleyauthor=P.+R.+Evansauthor=R.+M.+Keeganauthor=E.+B.+Krissinelauthor=A.+G.+Leslieauthor=A.+McCoyauthor=S.+J.+McNicholasauthor=G.+N.+Murshudovauthor=N.+S.+Pannuauthor=E.+A.+Pottertonauthor=H.+R.+Powellauthor=R.+J.+Readauthor=A.+Vaginauthor=K.+S.+Wilson&title=Overview+of+the+CCP4+suite+and+current+developments&doi=10.1107%2FS0907444910045749"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the CCP4 suite and current developments</span></div><div class="casAuthors">Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.; Dodson, Eleanor J.; Emsley, Paul; Evans, Phil R.; Keegan, Ronan M.; Krissinel, Eugene B.; Leslie, Andrew G. W.; McCoy, Airlie; McNicholas, Stuart J.; Murshudov, Garib N.; Pannu, Navraj S.; Potterton, Elizabeth A.; Powell, Harold R.; Read, Randy J.; Vagin, Alexei; Wilson, Keith S.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  The CCP4 (Collaborative Computational Project, No. 4) software suite is a collection of programs and assocd. data and software libraries which can be used for macromol. structure detn. by X-ray crystallog.  The suite is designed to be flexible, allowing users a no. of methods of achieving their aims.  The programs are from a wide variety of sources but are connected by a common infrastructure provided by std. file formats, data objects and graphical interfaces.  Structure soln. by macromol. crystallog. is becoming increasingly automated and the CCP4 suite includes several automation pipelines.  After giving a brief description of the evolution of CCP4 over the last 30 years, an overview of the current suite is given.  While detailed descriptions are given in the accompanying articles, here it is shown how the individual programs contribute to a complete software package.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_wWMMIol6UrVg90H21EOLACvtfcHk0lh7ckiPhlSbiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D&md5=c407e4d47bef46864be336d60147c17d</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1107%2FS0907444910045749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910045749%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DBallard%26aufirst%3DC.%2BC.%26aulast%3DCowtan%26aufirst%3DK.%2BD.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DKeegan%26aufirst%3DR.%2BM.%26aulast%3DKrissinel%26aufirst%3DE.%2BB.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%26aulast%3DMcCoy%26aufirst%3DA.%26aulast%3DMcNicholas%26aufirst%3DS.%2BJ.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DPotterton%26aufirst%3DE.%2BA.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26atitle%3DOverview%2520of%2520the%2520CCP4%2520suite%2520and%2520current%2520developments%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D235%26epage%3D242%26doi%3D10.1107%2FS0907444910045749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afonine, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunkoczi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echols, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Headd, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapral, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oeffner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwart, P. H.</span></span> <span> </span><span class="NLM_article-title">PHENIX: a comprehensive python-based system for macromolecular structure solution</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1107/S0907444909052925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunkocziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.+W.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grosse-Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=PHENIX%3A+a+comprehensive+python-based+system+for+macromolecular+structure+solution&doi=10.1107%2FS0907444909052925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0liixjSPIt0Yew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunkoczi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.%2BW.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DPHENIX%253A%2520a%2520comprehensive%2520python-based%2520system%2520for%2520macromolecular%2520structure%2520solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D213%26epage%3D221%26doi%3D10.1107%2FS0907444909052925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 16 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Samantha Caputo, Simona Di Martino, Vincenzo Cilibrasi, Piero Tardia, Marco Mazzonna, Debora Russo, Ilaria Penna, Maria Summa, Sine Mandrup Bertozzi, Natalia Realini, Natasha Margaroli, Marco Migliore, Giuliana Ottonello, Min Liu, Peter Lansbury, Andrea Armirotti, Rosalia Bertorelli, Soumya S. Ray, Renato Skerlj, <span class="NLM_string-name hlFld-ContribAuthor">Rita Scarpelli</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of a Series of Oxazolone Carboxamides as a Novel Class of Acid Ceramidase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (24)
                                     , 15821-15851. <a href="https://doi.org/10.1021/acs.jmedchem.0c01561" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01561</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01561%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252Ba%252BSeries%252Bof%252BOxazolone%252BCarboxamides%252Bas%252Ba%252BNovel%252BClass%252Bof%252BAcid%252BCeramidase%252BInhibitors%26aulast%3DCaputo%26aufirst%3DSamantha%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D07092020%26date%3D08122020%26volume%3D63%26issue%3D24%26spage%3D15821%26epage%3D15851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Chunlong Ma, Yanmei Hu, Julia Alma Townsend, Panagiotis I. Lagarias, Michael Thomas Marty, Antonios Kolocouris, <span class="NLM_string-name hlFld-ContribAuthor">Jun Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV-2 Main Protease Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Pharmacology & Translational Science</span><span> <strong>2020,</strong> <em>3 </em>
                                    (6)
                                     , 1265-1277. <a href="https://doi.org/10.1021/acsptsci.0c00130" title="DOI URL">https://doi.org/10.1021/acsptsci.0c00130</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsptsci.0c00130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsptsci.0c00130%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Pharmacology%2520%2526%2520Translational%2520Science%26atitle%3DEbselen%25252C%252BDisulfiram%25252C%252BCarmofur%25252C%252BPX-12%25252C%252BTideglusib%25252C%252Band%252BShikonin%252BAre%252BNonspecific%252BPromiscuous%252BSARS-CoV-2%252BMain%252BProtease%252BInhibitors%26aulast%3DMa%26aufirst%3DChunlong%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D08092020%26date%3D09102020%26volume%3D3%26issue%3D6%26spage%3D1265%26epage%3D1277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Simona Di Martino, Piero Tardia, Vincenzo Cilibrasi, Samantha Caputo, Marco Mazzonna, Debora Russo, Ilaria Penna, Natalia Realini, Natasha Margaroli, Marco Migliore, Daniela Pizzirani, Giuliana Ottonello, Sine Mandrup Bertozzi, Andrea Armirotti, Duc Nguyen, Ying Sun, Ernesto R. Bongarzone, Peter Lansbury, Min Liu, Renato Skerlj, <span class="NLM_string-name hlFld-ContribAuthor">Rita Scarpelli</span>. </span><span class="cited-content_cbyCitation_article-title">Lead Optimization of Benzoxazolone Carboxamides as Orally Bioavailable and CNS Penetrant Acid Ceramidase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (7)
                                     , 3634-3664. <a href="https://doi.org/10.1021/acs.jmedchem.9b02004" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b02004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b02004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b02004%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLead%252BOptimization%252Bof%252BBenzoxazolone%252BCarboxamides%252Bas%252BOrally%252BBioavailable%252Band%252BCNS%252BPenetrant%252BAcid%252BCeramidase%252BInhibitors%26aulast%3DDi%2BMartino%26aufirst%3DSimona%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D18122019%26date%3D26032020%26date%3D16032020%26volume%3D63%26issue%3D7%26spage%3D3634%26epage%3D3664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ran Zhang, Xue-Qing Song, Rui-Ping Liu, Zhong-Ying Ma, <span class="NLM_string-name hlFld-ContribAuthor">Jing-Yuan Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Fuplatin: An Efficient and Low-Toxic Dual-Prodrug. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (9)
                                     , 4543-4554. <a href="https://doi.org/10.1021/acs.jmedchem.9b00128" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00128</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00128%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFuplatin%25253A%252BAn%252BEfficient%252Band%252BLow-Toxic%252BDual-Prodrug%26aulast%3DZhang%26aufirst%3DRan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D22012019%26date%3D30042019%26date%3D19042019%26volume%3D62%26issue%3D9%26spage%3D4543%26epage%3D4554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruobing  Ren</span>, <span class="hlFld-ContribAuthor ">Bin  Pang</span>, <span class="hlFld-ContribAuthor ">Yufei  Han</span>, <span class="hlFld-ContribAuthor ">Yihao  Li</span>. </span><span class="cited-content_cbyCitation_article-title">A Glimpse of the Structural Biology of the Metabolism of Sphingosine-1-Phosphate. </span><span class="cited-content_cbyCitation_journal-name">Contact</span><span> <strong>2021,</strong> <em>4 </em>, 251525642199560. <a href="https://doi.org/10.1177/2515256421995601" title="DOI URL">https://doi.org/10.1177/2515256421995601</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/2515256421995601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F2515256421995601%26sid%3Dliteratum%253Aachs%26jtitle%3DContact%26atitle%3DA%252BGlimpse%252Bof%252Bthe%252BStructural%252BBiology%252Bof%252Bthe%252BMetabolism%252Bof%252BSphingosine-1-Phosphate%26aulast%3DRen%26aufirst%3DRuobing%26date%3D2021%26date%3D2021%26volume%3D4%26spage%3D251525642199560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen  Cui</span>, <span class="hlFld-ContribAuthor ">Kailin  Yang</span>, <span class="hlFld-ContribAuthor ">Haitao  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Progress in the Drug Development Targeting SARS-CoV-2 Main Protease as Treatment for COVID-19. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Molecular Biosciences</span><span> <strong>2020,</strong> <em>7 </em><a href="https://doi.org/10.3389/fmolb.2020.616341" title="DOI URL">https://doi.org/10.3389/fmolb.2020.616341</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmolb.2020.616341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmolb.2020.616341%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Molecular%2520Biosciences%26atitle%3DRecent%252BProgress%252Bin%252Bthe%252BDrug%252BDevelopment%252BTargeting%252BSARS-CoV-2%252BMain%252BProtease%252Bas%252BTreatment%252Bfor%252BCOVID-19%26aulast%3DCui%26aufirst%3DWen%26date%3D2020%26date%3D2020%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Khalid  El Bairi</span>, <span class="hlFld-ContribAuthor ">Dario  Trapani</span>, <span class="hlFld-ContribAuthor ">Angelica  Petrillo</span>, <span class="hlFld-ContribAuthor ">Cécile  Le Page</span>, <span class="hlFld-ContribAuthor ">Hanaa  Zbakh</span>, <span class="hlFld-ContribAuthor ">Bruno  Daniele</span>, <span class="hlFld-ContribAuthor ">Rhizlane  Belbaraka</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Curigliano</span>, <span class="hlFld-ContribAuthor ">Said  Afqir</span>. </span><span class="cited-content_cbyCitation_article-title">Repurposing anticancer drugs for the management of COVID-19. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Cancer</span><span> <strong>2020,</strong> <em>141 </em>, 40-61. <a href="https://doi.org/10.1016/j.ejca.2020.09.014" title="DOI URL">https://doi.org/10.1016/j.ejca.2020.09.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejca.2020.09.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejca.2020.09.014%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Cancer%26atitle%3DRepurposing%252Banticancer%252Bdrugs%252Bfor%252Bthe%252Bmanagement%252Bof%252BCOVID-19%26aulast%3DEl%2BBairi%26aufirst%3DKhalid%26date%3D2020%26volume%3D141%26spage%3D40%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rachael E.  Clifford</span>, <span class="hlFld-ContribAuthor ">Naren  Govindarajah</span>, <span class="hlFld-ContribAuthor ">David  Bowden</span>, <span class="hlFld-ContribAuthor ">Paul  Sutton</span>, <span class="hlFld-ContribAuthor ">Mark  Glenn</span>, <span class="hlFld-ContribAuthor ">Mahnaz  Darvish-Damavandi</span>, <span class="hlFld-ContribAuthor ">Simon  Buczacki</span>, <span class="hlFld-ContribAuthor ">Ultan  McDermott</span>, <span class="hlFld-ContribAuthor ">Zdzislaw  Szulc</span>, <span class="hlFld-ContribAuthor ">Besim  Ogretmen</span>, <span class="hlFld-ContribAuthor ">Jason L.  Parsons</span>, <span class="hlFld-ContribAuthor ">Dale  Vimalachandran</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Acid Ceramidase to Improve the Radiosensitivity of Rectal Cancer. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2020,</strong> <em>9 </em>
                                    (12)
                                     , 2693. <a href="https://doi.org/10.3390/cells9122693" title="DOI URL">https://doi.org/10.3390/cells9122693</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells9122693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells9122693%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DTargeting%252BAcid%252BCeramidase%252Bto%252BImprove%252Bthe%252BRadiosensitivity%252Bof%252BRectal%252BCancer%26aulast%3DClifford%26aufirst%3DRachael%2BE.%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D12%26spage%3D2693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Naroa  Insausti-Urkia</span>, <span class="hlFld-ContribAuthor ">Estel  Solsona-Vilarrasa</span>, <span class="hlFld-ContribAuthor ">Carmen  Garcia-Ruiz</span>, <span class="hlFld-ContribAuthor ">Jose C.  Fernandez-Checa</span>. </span><span class="cited-content_cbyCitation_article-title">Sphingomyelinases and Liver Diseases. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2020,</strong> <em>10 </em>
                                    (11)
                                     , 1497. <a href="https://doi.org/10.3390/biom10111497" title="DOI URL">https://doi.org/10.3390/biom10111497</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom10111497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom10111497%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DSphingomyelinases%252Band%252BLiver%252BDiseases%26aulast%3DInsausti-Urkia%26aufirst%3DNaroa%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D11%26spage%3D1497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cyntanna C.  Hawkins</span>, <span class="hlFld-ContribAuthor ">Tomader  Ali</span>, <span class="hlFld-ContribAuthor ">Sasanka  Ramanadham</span>, <span class="hlFld-ContribAuthor ">Anita B.  Hjelmeland</span>. </span><span class="cited-content_cbyCitation_article-title">Sphingolipid Metabolism in Glioblastoma and Metastatic Brain Tumors: A Review of Sphingomyelinases and Sphingosine-1-Phosphate. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2020,</strong> <em>10 </em>
                                    (10)
                                     , 1357. <a href="https://doi.org/10.3390/biom10101357" title="DOI URL">https://doi.org/10.3390/biom10101357</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom10101357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom10101357%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DSphingolipid%252BMetabolism%252Bin%252BGlioblastoma%252Band%252BMetastatic%252BBrain%252BTumors%25253A%252BA%252BReview%252Bof%252BSphingomyelinases%252Band%252BSphingosine-1-Phosphate%26aulast%3DHawkins%26aufirst%3DCyntanna%2BC.%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D10%26spage%3D1357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adish  Tyagi</span>, <span class="hlFld-ContribAuthor ">Sandeep  Nigam</span>, <span class="hlFld-ContribAuthor ">Rohit Singh  Chauhan</span>. </span><span class="cited-content_cbyCitation_article-title">A Concise Review of Baseline Facts of SARS‐CoV‐2 for Interdisciplinary Research. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2020,</strong> <em>5 </em>
                                    (35)
                                     , 10897-10923. <a href="https://doi.org/10.1002/slct.202002420" title="DOI URL">https://doi.org/10.1002/slct.202002420</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202002420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202002420%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DA%252BConcise%252BReview%252Bof%252BBaseline%252BFacts%252Bof%252BSARS%2525E2%252580%252590CoV%2525E2%252580%2525902%252Bfor%252BInterdisciplinary%252BResearch%26aulast%3DTyagi%26aufirst%3DAdish%26date%3D2020%26date%3D2020%26volume%3D5%26issue%3D35%26spage%3D10897%26epage%3D10923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhenming  Jin</span>, <span class="hlFld-ContribAuthor ">Yao  Zhao</span>, <span class="hlFld-ContribAuthor ">Yuan  Sun</span>, <span class="hlFld-ContribAuthor ">Bing  Zhang</span>, <span class="hlFld-ContribAuthor ">Haofeng  Wang</span>, <span class="hlFld-ContribAuthor ">Yan  Wu</span>, <span class="hlFld-ContribAuthor ">Yan  Zhu</span>, <span class="hlFld-ContribAuthor ">Chen  Zhu</span>, <span class="hlFld-ContribAuthor ">Tianyu  Hu</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Du</span>, <span class="hlFld-ContribAuthor ">Yinkai  Duan</span>, <span class="hlFld-ContribAuthor ">Jing  Yu</span>, <span class="hlFld-ContribAuthor ">Xiaobao  Yang</span>, <span class="hlFld-ContribAuthor ">Xiuna  Yang</span>, <span class="hlFld-ContribAuthor ">Kailin  Yang</span>, <span class="hlFld-ContribAuthor ">Xiang  Liu</span>, <span class="hlFld-ContribAuthor ">Luke W.  Guddat</span>, <span class="hlFld-ContribAuthor ">Gengfu  Xiao</span>, <span class="hlFld-ContribAuthor ">Leike  Zhang</span>, <span class="hlFld-ContribAuthor ">Haitao  Yang</span>, <span class="hlFld-ContribAuthor ">Zihe  Rao</span>. </span><span class="cited-content_cbyCitation_article-title">Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur. </span><span class="cited-content_cbyCitation_journal-name">Nature Structural & Molecular Biology</span><span> <strong>2020,</strong> <em>27 </em>
                                    (6)
                                     , 529-532. <a href="https://doi.org/10.1038/s41594-020-0440-6" title="DOI URL">https://doi.org/10.1038/s41594-020-0440-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41594-020-0440-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41594-020-0440-6%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Structural%2520%2526%2520Molecular%2520Biology%26atitle%3DStructural%252Bbasis%252Bfor%252Bthe%252Binhibition%252Bof%252BSARS-CoV-2%252Bmain%252Bprotease%252Bby%252Bantineoplastic%252Bdrug%252Bcarmofur%26aulast%3DJin%26aufirst%3DZhenming%26date%3D2020%26date%3D2020%26volume%3D27%26issue%3D6%26spage%3D529%26epage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias  Rothemund</span>, <span class="hlFld-ContribAuthor ">Alexander  Bär</span>, <span class="hlFld-ContribAuthor ">Felix  Klatt</span>, <span class="hlFld-ContribAuthor ">Sascha  Weidler</span>, <span class="hlFld-ContribAuthor ">Leonhard  Köhler</span>, <span class="hlFld-ContribAuthor ">Carlo  Unverzagt</span>, <span class="hlFld-ContribAuthor ">Claus-D.  Kuhn</span>, <span class="hlFld-ContribAuthor ">Rainer  Schobert</span>. </span><span class="cited-content_cbyCitation_article-title">N-Metallocenoylsphingosines as targeted ceramidase inhibitors: Syntheses and antitumoral effects. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>97 </em>, 103703. <a href="https://doi.org/10.1016/j.bioorg.2020.103703" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103703</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103703%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DN-Metallocenoylsphingosines%252Bas%252Btargeted%252Bceramidase%252Binhibitors%25253A%252BSyntheses%252Band%252Bantitumoral%252Beffects%26aulast%3DRothemund%26aufirst%3DMatthias%26date%3D2020%26volume%3D97%26spage%3D103703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dominik  Awad</span>, <span class="hlFld-ContribAuthor ">Michael  Prattes</span>, <span class="hlFld-ContribAuthor ">Lisa  Kofler</span>, <span class="hlFld-ContribAuthor ">Ingrid  Rössler</span>, <span class="hlFld-ContribAuthor ">Mathias  Loibl</span>, <span class="hlFld-ContribAuthor ">Melanie  Pertl</span>, <span class="hlFld-ContribAuthor ">Gertrude  Zisser</span>, <span class="hlFld-ContribAuthor ">Heimo  Wolinski</span>, <span class="hlFld-ContribAuthor ">Brigitte  Pertschy</span>, <span class="hlFld-ContribAuthor ">Helmut  Bergler</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibiting eukaryotic ribosome biogenesis. </span><span class="cited-content_cbyCitation_journal-name">BMC Biology</span><span> <strong>2019,</strong> <em>17 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12915-019-0664-2" title="DOI URL">https://doi.org/10.1186/s12915-019-0664-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12915-019-0664-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12915-019-0664-2%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Biology%26atitle%3DInhibiting%252Beukaryotic%252Bribosome%252Bbiogenesis%26aulast%3DAwad%26aufirst%3DDominik%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shai  White-Gilbertson</span>, <span class="hlFld-ContribAuthor ">Ping  Lu</span>, <span class="hlFld-ContribAuthor ">James S.  Norris</span>, <span class="hlFld-ContribAuthor ">Christina  Voelkel-Johnson</span>. </span><span class="cited-content_cbyCitation_article-title">Genetic and pharmacological inhibition of acid ceramidase prevents asymmetric cell division by neosis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Lipid Research</span><span> <strong>2019,</strong> <em>60 </em>
                                    (7)
                                     , 1225-1235. <a href="https://doi.org/10.1194/jlr.M092247" title="DOI URL">https://doi.org/10.1194/jlr.M092247</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1194/jlr.M092247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1194%2Fjlr.M092247%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Lipid%2520Research%26atitle%3DGenetic%252Band%252Bpharmacological%252Binhibition%252Bof%252Bacid%252Bceramidase%252Bprevents%252Basymmetric%252Bcell%252Bdivision%252Bby%252Bneosis%26aulast%3DWhite-Gilbertson%26aufirst%3DShai%26date%3D2019%26volume%3D60%26issue%3D7%26spage%3D1225%26epage%3D1235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michele  Lai</span>, <span class="hlFld-ContribAuthor ">Veronica  La Rocca</span>, <span class="hlFld-ContribAuthor ">Rachele  Amato</span>, <span class="hlFld-ContribAuthor ">Giulia  Freer</span>, <span class="hlFld-ContribAuthor ">Mauro  Pistello</span>. </span><span class="cited-content_cbyCitation_article-title">Sphingolipid/Ceramide Pathways and Autophagy in the Onset and Progression of Melanoma: Novel Therapeutic Targets and Opportunities. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (14)
                                     , 3436. <a href="https://doi.org/10.3390/ijms20143436" title="DOI URL">https://doi.org/10.3390/ijms20143436</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20143436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20143436%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DSphingolipid%25252FCeramide%252BPathways%252Band%252BAutophagy%252Bin%252Bthe%252BOnset%252Band%252BProgression%252Bof%252BMelanoma%25253A%252BNovel%252BTherapeutic%252BTargets%252Band%252BOpportunities%26aulast%3DLai%26aufirst%3DMichele%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D14%26spage%3D3436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01723/20190116/images/medium/jm-2018-017236_0004.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01723/20190116/images/large/jm-2018-017236_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01723&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01723/20190116/images/medium/jm-2018-017236_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01723/20190116/images/large/jm-2018-017236_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Crystal structure of human AC in covalent complex with the carmofur fatty acid moiety. (A) Ribbon diagram (α-subunit in magenta, β-subunit in cyan) of the covalent complex. The inhibitor fatty acid moiety is shown in yellow sticks. The side chains of <i>N</i>-glycosylated Asn173, Asn259, Asn286, and Asn342 are shown in cyan sticks, and modeled sugar units are shown in orange sticks. One disulfide bond, Cys31–Cys340, is shown in yellow. The N- and C-termini are labeled. (B) Superposition of the covalent complex (cyan) and apo-form of AC (magenta) crystal structures. The two structures are superimposed by aligning all Cα atoms of β-subunits and are presented as cartoon diagrams.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01723/20190116/images/large/jm-2018-017236_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01723&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01723/20190116/images/medium/jm-2018-017236_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01723/20190116/images/large/jm-2018-017236_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Binding interactions of the inhibitor fatty acid to AC active site. (A) Close-up view of the binding area in the complex (magenta and cyan ribbons for α- and β-subunits, respectively). The inhibitor moiety (yellow sticks) and the residues defining the interaction with the inhibitor (cyan sticks) are shown. The electron density map (gray) around the bound inhibitor is contoured at 1σ. Hydrogen bonds are indicated by gray dotted lines. (B) The part of the protein surface (in the same colors as in A) showing the deep channel into the active site with Cys143 covalently modified by the fatty acid (in yellow sticks) is presented.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01723/20190116/images/large/jm-2018-017236_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01723&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01723/20190116/images/medium/jm-2018-017236_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01723/20190116/images/large/jm-2018-017236_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Hydrophobic surface of AC with a modeled ceramide substrate. (A) The surface representation of the hydrophobic areas of the AC in ribbon diagram are colored yellow, and the remaining residues are colored in magenta (α-subunit) and in cyan (β-subunit). The locations of the residues mutated in our previous work (black) and that of the residues forming plausible hydrophobic contacts with the substrate d17 moiety (red) are labeled.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> (B) Close-up view of the modeled C8 ceramide substrate (d17:1/8:0, ball and stick in orange) interacting with enzyme residues in the substrate-binding area. The positions of several AC catalytic residues, which can form hypothetical interactions with the substrate in the tetrahedral complex, are indicated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01723/20190116/images/large/jm-2018-017236_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01723&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i16">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26441" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26441" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 41 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, H.</span></span> <span> </span><span class="NLM_article-title">Recent studies of 5-fluorouracil resistance in pancreatic cancer</span>. <i>World J. Gastroenterol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">15682</span>– <span class="NLM_lpage">15690</span>, <span class="refDoi"> DOI: 10.3748/wjg.v20.i42.15682</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.3748%2Fwjg.v20.i42.15682" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=25400452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvF2qu7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=15682-15690&author=W.+B.+Wangauthor=Y.+Yangauthor=Y.+P.+Zhaoauthor=T.+P.+Zhangauthor=Q.+Liaoauthor=H.+Shu&title=Recent+studies+of+5-fluorouracil+resistance+in+pancreatic+cancer&doi=10.3748%2Fwjg.v20.i42.15682"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Recent studies of 5-fluorouracil resistance in pancreatic cancer</span></div><div class="casAuthors">Wang, Wei-Bin; Yang, Yu; Zhao, Yu-Pei; Zhang, Tai-Ping; Liao, Quan; Shu, Hong</div><div class="citationInfo"><span class="NLM_cas:title">World Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">15682-15690</span>CODEN:
                <span class="NLM_cas:coden">WJGAF2</span>;
        ISSN:<span class="NLM_cas:issn">1007-9327</span>.
    
            (<span class="NLM_cas:orgname">Baishideng Publishing Group Inc.</span>)
        </div><div class="casAbstract">A review.  Resistance to 5-fluorouracil (5-FU), an important anticancer drug, is a serious challenge in the treatment of pancreatic cancer.  Equilibrative nucleoside transporter 1 and multidrug-resistance protein (MRP) 5 and MRP8, rather than P-glycoprotein, play important roles in 5-FU transport.  Thymidylate synthase, dihydropyrimidine dehydrogenase, methylenetetrahydrofolate reductase and thymidine phosphorylase are four key enzymes involved in 5-FU metab.  Other metabolic enzymes, including uridine monophosphate synthetase, also contribute to chemoresistance.  Intracellular signaling pathways are an integrated network, and nuclear factor kappa-light-chain-enhancer of activated B cells, AKT and extracellular signal-regulated kinases are signaling pathways that are particularly relevant to 5-FU resistance.  In addn., recent reports indicate that STAT-3 is a crucial survival protein.  Proteomic assays provide a powerful tool for identifying target proteins and understanding the role of microRNAs and stromal factors to facilitate the development of strategies to combat 5-FU resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2tpmAau6fWrVg90H21EOLACvtfcHk0liEYTeWTOhPgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvF2qu7bM&md5=6272404fe2a49682df2b67dc9e9ca5cb</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3748%2Fwjg.v20.i42.15682&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3748%252Fwjg.v20.i42.15682%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%2BB.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DY.%2BP.%26aulast%3DZhang%26aufirst%3DT.%2BP.%26aulast%3DLiao%26aufirst%3DQ.%26aulast%3DShu%26aufirst%3DH.%26atitle%3DRecent%2520studies%2520of%25205-fluorouracil%2520resistance%2520in%2520pancreatic%2520cancer%26jtitle%3DWorld%2520J.%2520Gastroenterol.%26date%3D2014%26volume%3D20%26spage%3D15682%26epage%3D15690%26doi%3D10.3748%2Fwjg.v20.i42.15682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sara, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khodadadi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakrabarti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lerman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grothey, A.</span></span> <span> </span><span class="NLM_article-title">5-fluorouracil and cardiotoxicity: a review</span>. <i>Ther. Adv. Med. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1</span>, <span class="refDoi"> DOI: 10.1177/1758835918780140</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1177%2F1758835918780140" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=1&author=J.+D.+Saraauthor=J.+Kaurauthor=R.+Khodadadiauthor=M.+Rehmanauthor=R.+Loboauthor=S.+Chakrabartiauthor=J.+Herrmannauthor=A.+Lermanauthor=A.+Grothey&title=5-fluorouracil+and+cardiotoxicity%3A+a+review&doi=10.1177%2F1758835918780140"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1177%2F1758835918780140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1758835918780140%26sid%3Dliteratum%253Aachs%26aulast%3DSara%26aufirst%3DJ.%2BD.%26aulast%3DKaur%26aufirst%3DJ.%26aulast%3DKhodadadi%26aufirst%3DR.%26aulast%3DRehman%26aufirst%3DM.%26aulast%3DLobo%26aufirst%3DR.%26aulast%3DChakrabarti%26aufirst%3DS.%26aulast%3DHerrmann%26aufirst%3DJ.%26aulast%3DLerman%26aufirst%3DA.%26aulast%3DGrothey%26aufirst%3DA.%26atitle%3D5-fluorouracil%2520and%2520cardiotoxicity%253A%2520a%2520review%26jtitle%3DTher.%2520Adv.%2520Med.%2520Oncol.%26date%3D2018%26volume%3D10%26spage%3D1%26doi%3D10.1177%2F1758835918780140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamada, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buyse, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burzykowski, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piedbois, P.</span></span> <span> </span><span class="NLM_article-title">Efficacy of oral adjuvant therapy after resection of colorectal cancer: 5-year results from three randomized trials</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">484</span>– <span class="NLM_lpage">492</span>, <span class="refDoi"> DOI: 10.1200/JCO.2004.04.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1200%2FJCO.2004.04.065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=14752071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A280%3ADC%252BD2c%252Fms1Omug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2004&pages=484-492&author=J.+Sakamotoauthor=Y.+Ohashiauthor=C.+Hamadaauthor=M.+Buyseauthor=T.+Burzykowskiauthor=P.+Piedbois&title=Efficacy+of+oral+adjuvant+therapy+after+resection+of+colorectal+cancer%3A+5-year+results+from+three+randomized+trials&doi=10.1200%2FJCO.2004.04.065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy of oral adjuvant therapy after resection of colorectal cancer: 5-year results from three randomized trials</span></div><div class="casAuthors">Sakamoto Junichi; Ohashi Yasuo; Hamada Chikuma; Buyse Marc; Burzykowski Tomasz; Piedbois Pascal</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">484-92</span>
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    </div><div class="casAbstract">PURPOSE:  Adjuvant therapy of colorectal cancer with oral fluorinated pyrimidines is attractive because of its ease of administration and good tolerability.  The purpose of this meta-analysis is to assess the survival and disease-free survival benefits of treating patients after surgical resection of a primary colorectal tumor with oral fluoropyrimidines for 1 year.  PATIENTS AND METHODS:  This meta-analysis was performed on individual data from three randomized trials conducted by the Japanese Foundation for Multidisciplinary Treatment for Cancer involving a total of 5,233 patients with stages I to III colorectal cancer.  RESULTS:  The overall hazard ratio in favor of oral therapy was 0.89 for survival (95% CI, 0.80 to 0.99; P =.04), and 0.85 for disease-free survival (95% CI, 0.77 to 0.93; P <.001).  Thus oral therapy reduced the risk of death by 11% and the risk of recurrence or death by 15%.  There was no significant heterogeneity between trials, nor did the benefit of oral therapy depend on tumor stage (I, II, or III), tumor site (rectum or colon), patient age, or patient sex.  CONCLUSION:  Oral fluoropyrimidines improve disease-free survival and survival of patients after resection of early-stage colorectal cancer.  These observations support the use of these agents alone after resection of early-stage disease, as well as further testing of oral agents in combination with new drugs that have recently shown antitumor activity in advanced colorectal cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ0OoBH9nuTIyjiVMCqkKxVfW6udTcc2eYwlUcx-Sm0Zbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c%252Fms1Omug%253D%253D&md5=4c2b2e65f0bb9083c4d4278e3e41246d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1200%2FJCO.2004.04.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2004.04.065%26sid%3Dliteratum%253Aachs%26aulast%3DSakamoto%26aufirst%3DJ.%26aulast%3DOhashi%26aufirst%3DY.%26aulast%3DHamada%26aufirst%3DC.%26aulast%3DBuyse%26aufirst%3DM.%26aulast%3DBurzykowski%26aufirst%3DT.%26aulast%3DPiedbois%26aufirst%3DP.%26atitle%3DEfficacy%2520of%2520oral%2520adjuvant%2520therapy%2520after%2520resection%2520of%2520colorectal%2520cancer%253A%25205-year%2520results%2520from%2520three%2520randomized%2520trials%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2004%26volume%3D22%26spage%3D484%26epage%3D492%26doi%3D10.1200%2FJCO.2004.04.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kusumoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maehara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugimachi, K.</span></span> <span> </span><span class="NLM_article-title">Hyperthermia enhances the in vitro activity of 1-hexylcarbamoyl-5-fluorouracil compared to that of 5-fluorouracil</span>. <i>Eur. J. Cancer Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">477</span>– <span class="NLM_lpage">481</span>, <span class="refDoi"> DOI: 10.1016/0277-5379(89)90260-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1016%2F0277-5379%2889%2990260-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=2703002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A528%3ADyaL1MXhvVGnu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1989&pages=477-481&author=T.+Kusumotoauthor=Y.+Maeharaauthor=Y.+Sakaguchiauthor=K.+Sugimachi&title=Hyperthermia+enhances+the+in+vitro+activity+of+1-hexylcarbamoyl-5-fluorouracil+compared+to+that+of+5-fluorouracil&doi=10.1016%2F0277-5379%2889%2990260-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Hyperthermia enhances the in vitro activity of 1-hexylcarbamoyl-5-fluorouracil compared to that of 5-fluorouracil</span></div><div class="casAuthors">Kusumoto, Tetsuya; Maehara, Yoshihiko; Sakaguchi, Yoshihisa; Sugimachi, Keizo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Cancer & Clinical Oncology</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">477-81</span>CODEN:
                <span class="NLM_cas:coden">EJCODS</span>;
        ISSN:<span class="NLM_cas:issn">0277-5379</span>.
    </div><div class="casAbstract">The synergic effects of 1-hexylcarbomoyl-5-fluorouracil (HCFU), a lipophilic masked compd. of 5-fluorouracil (5-FU), and hyperthermia on HeLa cells were investigated, with the following results: (1) after the cells had been exposed to the drug at 77 μM for 1 to 3 days, with or without heat (43°) for 2 h, treatment with HCFU and heat inhibited cell growth by 9.2% on day 3, compared to control cells, HCFU alone, heat alone or 5-FU plus heat.  (2) The cells were exposed to the drugs at 77 μM or heat (43°) for 15-45 min, and the colonies counted on day 14.  Combined treatment with HCFU plus heat inhibited the clonogenicity of HeLa cells to 22.4% of control cells.  The combination of 5-FU, n-hexylamine and heat had much the same effect as the combined effect of the treatment of HCFU plus heat.  (3) Intracellular levels of the drugs did not increase with hyperthermic treatment.  These findings suggest that the synergic effect between HCFU and hyperthermia is related to the hexylcarbamoyl structure of HCFU.  This combination may have pos. effects for treating patients with malignancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtzYZTLIcs5bVg90H21EOLACvtfcHk0lhZ9dKFhvxakw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhvVGnu70%253D&md5=9b653b825c4bcc73fbffa618ffb84989</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2F0277-5379%2889%2990260-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0277-5379%252889%252990260-5%26sid%3Dliteratum%253Aachs%26aulast%3DKusumoto%26aufirst%3DT.%26aulast%3DMaehara%26aufirst%3DY.%26aulast%3DSakaguchi%26aufirst%3DY.%26aulast%3DSugimachi%26aufirst%3DK.%26atitle%3DHyperthermia%2520enhances%2520the%2520in%2520vitro%2520activity%2520of%25201-hexylcarbamoyl-5-fluorouracil%2520compared%2520to%2520that%2520of%25205-fluorouracil%26jtitle%3DEur.%2520J.%2520Cancer%2520Clin.%2520Oncol.%26date%3D1989%26volume%3D25%26spage%3D477%26epage%3D481%26doi%3D10.1016%2F0277-5379%2889%2990260-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ooi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohkubo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashigawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawasaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakito, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, M.</span></span> <span> </span><span class="NLM_article-title">Plasma, intestine and tumor levels of 5-fluorouracil in mice bearing L1210 ascites tumor following oral administration of 5-fluorouracil, UFT (mixed compound of tegafur and uracil), carmofur and 5′-deoxy-5-fluorouridine</span>. <i>Biol. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1329</span>– <span class="NLM_lpage">1331</span>, <span class="refDoi"> DOI: 10.1248/bpb.24.1329</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1248%2Fbpb.24.1329" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=11725974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotFans70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2001&pages=1329-1331&author=A.+Ooiauthor=T.+Ohkuboauthor=M.+Higashigawaauthor=H.+Kawasakiauthor=H.+Kakitoauthor=Y.+Kagawaauthor=M.+Kojimaauthor=M.+Sakurai&title=Plasma%2C+intestine+and+tumor+levels+of+5-fluorouracil+in+mice+bearing+L1210+ascites+tumor+following+oral+administration+of+5-fluorouracil%2C+UFT+%28mixed+compound+of+tegafur+and+uracil%29%2C+carmofur+and+5%E2%80%B2-deoxy-5-fluorouridine&doi=10.1248%2Fbpb.24.1329"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma, intestine and tumor levels of 5-fluorouracil in mice bearing L1210 ascites tumor following oral administration of 5-fluorouracil, UFT (mixed compound of Tegafur and uracil), Carmofur and 5'-deoxy-5-fluorouridine</span></div><div class="casAuthors">Ooi, Kazuya; Ohkubo, Toshiki; Higashigawa, Masamune; Kawasaki, Hajime; Kakito, Hideshi; Kagawa, Yoshiyuki; Kojima, Michio; Sakurai, Minoru</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1329-1331</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">Several 5-fluorouracil (5-FU) derivs., 1-hexylcarbamoyl-5-fluorouracil (HCFU), 5'-deoxy-5-fluorouridine (5'-DFUR) and UFT (mixed compd. of Tegafur and uracil), have been developed and clin. widely used.  However, comparative pharmacokinetic studies of the parent compd. and other fluorinated derivs. have not been precisely reported.  The dosage of the oral clin. use for human cancer of 5-FU, HCFU, 5'-DFUR and UFT as Tegafur (FT) is 200-300 mg/d, 600 mg/d, 800-1200 mg/d and 300-600 mg/d resp.  These amts. of the drugs are almost equimolar.  Previously, we reported the effect of oral equimolar administration of each four drugs on thymidylate synthase activity, deoxyribonucleotide metab. and cell cycle progression in L1210 ascites tumor.  In this study, we examd. the antitumor effect and 5-FU concn. in the plasma, intestine and tumor after oral equimolar administrations of each drug using BDF1 mice bearing L1210 ascites tumor.  In our study, UFT showed the best life prolongation among these four drugs.  The intestine 5-FU level was highest by treatment with 5-FU during the initial 4 h.  The plasma 5-FU level was highest by treatment with HCFU for 4 h.  But the tumor 5-FU level was highest by treatment with UFT over the 24 h.  In spite of the high plasma 5-FU concn. after the treatment with HCFU, the 5-FU concn. in the tumor was below the detectable level until 24 h.  These findings suggested that the highest specific accumulation of 5-FU in tumor cells may explain the best therapeutic results of UFT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrO5GC3dR1XBLVg90H21EOLACvtfcHk0lh9Qvs_-DNPzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotFans70%253D&md5=4e1e56c9513722e49b6ec72f7f22afb0</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1248%2Fbpb.24.1329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.24.1329%26sid%3Dliteratum%253Aachs%26aulast%3DOoi%26aufirst%3DA.%26aulast%3DOhkubo%26aufirst%3DT.%26aulast%3DHigashigawa%26aufirst%3DM.%26aulast%3DKawasaki%26aufirst%3DH.%26aulast%3DKakito%26aufirst%3DH.%26aulast%3DKagawa%26aufirst%3DY.%26aulast%3DKojima%26aufirst%3DM.%26aulast%3DSakurai%26aufirst%3DM.%26atitle%3DPlasma%252C%2520intestine%2520and%2520tumor%2520levels%2520of%25205-fluorouracil%2520in%2520mice%2520bearing%2520L1210%2520ascites%2520tumor%2520following%2520oral%2520administration%2520of%25205-fluorouracil%252C%2520UFT%2520%2528mixed%2520compound%2520of%2520tegafur%2520and%2520uracil%2529%252C%2520carmofur%2520and%25205%25E2%2580%25B2-deoxy-5-fluorouridine%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2001%26volume%3D24%26spage%3D1329%26epage%3D1331%26doi%3D10.1248%2Fbpb.24.1329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuwano, M.</span></span> <span> </span><span class="NLM_article-title">Anti-tumor effects of carmofur on human 5-FU resistant cells</span>. <i>Cancer Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1613</span>– <span class="NLM_lpage">1616</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A280%3ADC%252BD3c%252FitV2qsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1999&pages=1613-1616&author=S.+Satoauthor=T.+Ueyamaauthor=H.+Fukuiauthor=K.+Miyazakiauthor=M.+Kuwano&title=Anti-tumor+effects+of+carmofur+on+human+5-FU+resistant+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-tumor effects of carmofur on human 5-FU resistant cells</span></div><div class="casAuthors">Sato S; Ueyama T; Fukui H; Miyazaki K; Kuwano M</div><div class="citationInfo"><span class="NLM_cas:title">Gan to kagaku ryoho. Cancer & chemotherapy</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1613-6</span>
        ISSN:<span class="NLM_cas:issn">0385-0684</span>.
    </div><div class="casAbstract">As a part of studies to clarify the efficacy mechanism of carmofur (HCFU), a 5-FU analog, the degree of cross-resistance to HCFU of cell lines of cultured human colon cancer DLD-1 and a stomach cancer NUGC-3, both of which had acquired resistance to 5-FU, was studied in vitro and in vivo.  In vitro, both resistant cell lines showed no or little cross-resistance to HCFU under a short-term drug exposure, and very low cross-resistance to HCFU, as compared to resistance to 5-FU, under a long-term drug exposure.  In therapeutic experiments using nude mice bearing parent or subcutaneously transplanted 5-FU-resistant DLD-1 cells, HCFU exerted almost the same growth-inhibitory effects on both tumors.  These results suggest that HCFU itself may have its own anti-tumor mechanism, different from that of 5-FU.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR3MnUxYytFDoIRAdBLKY41fW6udTcc2eZJ5tjkta1TNrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c%252FitV2qsQ%253D%253D&md5=3275eda2e6b1896911317dc2deedc195</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DS.%26aulast%3DUeyama%26aufirst%3DT.%26aulast%3DFukui%26aufirst%3DH.%26aulast%3DMiyazaki%26aufirst%3DK.%26aulast%3DKuwano%26aufirst%3DM.%26atitle%3DAnti-tumor%2520effects%2520of%2520carmofur%2520on%2520human%25205-FU%2520resistant%2520cells%26jtitle%3DCancer%2520Chemother.%26date%3D1999%26volume%3D26%26spage%3D1613%26epage%3D1616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span>; <span class="NLM_string-name">Ma, S.</span>; <span class="NLM_string-name">Liu, H.</span>; <span class="NLM_string-name">Han, H.</span>; <span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">HCFU inhibits cervical cancer cells growth and metastasis by inactivating wnt/beta-catenin pathway</span>.  <i>J. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>, DOI: <span class="refDoi"> DOI: 10.1002/jcb.26570</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1002%2Fjcb.26570" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=P.+Liu&author=S.+Ma&author=H.+Liu&author=H.+Han&author=S.+Wang&title=HCFU+inhibits+cervical+cancer+cells+growth+and+metastasis+by+inactivating+wnt%2Fbeta-catenin+pathway&doi=10.1002%2Fjcb.26570"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fjcb.26570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.26570%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DP.%26atitle%3DHCFU%2520inhibits%2520cervical%2520cancer%2520cells%2520growth%2520and%2520metastasis%2520by%2520inactivating%2520wnt%252Fbeta-catenin%2520pathway%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2017%26doi%3D10.1002%2Fjcb.26570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sueyoshi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ema, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takaishi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hisatomi, H.</span></span> <span> </span><span class="NLM_article-title">Induction of oxidative stress by anticancer drugs in the presence and absence of cells</span>. <i>Oncol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">6066</span>– <span class="NLM_lpage">6070</span>, <span class="refDoi"> DOI: 10.3892/ol.2017.6931</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.3892%2Fol.2017.6931" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=29113247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A280%3ADC%252BC1M7oslOhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2017&pages=6066-6070&author=C.+Yokoyamaauthor=Y.+Sueyoshiauthor=M.+Emaauthor=Y.+Moriauthor=K.+Takaishiauthor=H.+Hisatomi&title=Induction+of+oxidative+stress+by+anticancer+drugs+in+the+presence+and+absence+of+cells&doi=10.3892%2Fol.2017.6931"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of oxidative stress by anticancer drugs in the presence and absence of cells</span></div><div class="casAuthors">Yokoyama Chikako; Yokoyama Chikako; Sueyoshi Yuto; Ema Mika; Mori Yumi; Hisatomi Hisashi; Takaishi Kazuto</div><div class="citationInfo"><span class="NLM_cas:title">Oncology letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">6066-6070</span>
        ISSN:<span class="NLM_cas:issn">1792-1074</span>.
    </div><div class="casAbstract">Reactive oxygen species (ROS) are generated in the cell through multiple mechanisms.  Intracellular ROS are rapidly detoxified by various enzymatic and non-enzymatic mechanisms; however, disruption of the oxidant-antioxidant balance causes oxidative stress and elicits cell damage.  The oxidative stress induced by chemotherapy is known to cause side effects in patients with cancer.  However, few studies have examined whether anticancer drugs induce oxidative stress in cancer cells.  Furthermore, the precise mechanism by which anticancer drugs induce the generation of ROS remains unclear.  In the present study, to investigate whether anticancer drugs induce oxidative stress, DLD-1 human colorectal cancer cells were treated with 20 different anticancer drugs and then stained with CellROX(®) ROS detection reagent.  Furthermore, an oxygen radical absorbance capacity assay in the presence of copper was performed to estimate the oxidative activities of the anticancer drugs in the absence of cells.  The data of the present study using assay methods in the presence and absence of cells suggest that nimustine, actinomycin D, doxorubicin, mitomycin C, mitoxantrone, carmofur, gemcitabine, mercaptopurine, camptothecin, paclitaxel, vinblastine, and vinorelbine are able to induce oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTWi2bvABUN7J6KlWarZTAzfW6udTcc2eZJ5tjkta1TNrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M7oslOhuw%253D%253D&md5=8950812e07435f9d17d134c7e42b9365</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3892%2Fol.2017.6931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fol.2017.6931%26sid%3Dliteratum%253Aachs%26aulast%3DYokoyama%26aufirst%3DC.%26aulast%3DSueyoshi%26aufirst%3DY.%26aulast%3DEma%26aufirst%3DM.%26aulast%3DMori%26aufirst%3DY.%26aulast%3DTakaishi%26aufirst%3DK.%26aulast%3DHisatomi%26aufirst%3DH.%26atitle%3DInduction%2520of%2520oxidative%2520stress%2520by%2520anticancer%2520drugs%2520in%2520the%2520presence%2520and%2520absence%2520of%2520cells%26jtitle%3DOncol.%2520Lett.%26date%3D2017%26volume%3D14%26spage%3D6066%26epage%3D6070%26doi%3D10.3892%2Fol.2017.6931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamada, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodaira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakazato, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasutomi, M.</span></span> <span> </span><span class="NLM_article-title">An individual patient data meta-analysis of adjuvant therapy with carmofur in patients with curatively resected colon cancer</span>. <i>Jpn. J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">536</span>– <span class="NLM_lpage">544</span>, <span class="refDoi"> DOI: 10.1093/jjco/hyi147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1093%2Fjjco%2Fhyi147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=16155120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A280%3ADC%252BD2MrisFSktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2005&pages=536-544&author=J.+Sakamotoauthor=C.+Hamadaauthor=M.+Rahmanauthor=S.+Kodairaauthor=K.+Itoauthor=H.+Nakazatoauthor=Y.+Ohashiauthor=M.+Yasutomi&title=An+individual+patient+data+meta-analysis+of+adjuvant+therapy+with+carmofur+in+patients+with+curatively+resected+colon+cancer&doi=10.1093%2Fjjco%2Fhyi147"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">An individual patient data meta-analysis of adjuvant therapy with carmofur in patients with curatively resected colon cancer</span></div><div class="casAuthors">Sakamoto Junichi; Hamada Chikuma; Rahman Mahbubur; Kodaira Susumu; Ito Katsuki; Nakazato Hiroaki; Ohashi Yasuo; Yasutomi Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Japanese journal of clinical oncology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">536-44</span>
        ISSN:<span class="NLM_cas:issn">0368-2811</span>.
    </div><div class="casAbstract">BACKGROUND:  Oral carmofur, either as a single or in combination with other chemotherapeutic agents, has been used as adjuvant chemotherapy for curatively resected colon cancer patients.  Past trials and meta-analyses indicate that it is somewhat effective in extending survival of patients with this cancer.  The objective of this study was to perform a reappraisal of randomized clinical trials conducted in this regard.  METHODS:  We designed an individual patient-based meta-analysis of relevant clinical trials to examine the benefit of oral carmofur for curatively resected colon cancer in terms of overall survival (OS) and disease-free survival (DFS).  RESULTS:  We analyzed individual patient data of three randomized clinical trials, which met the predetermined inclusion criteria.  These three trials had a combined total of 2152 patients, carmofur as adjuvant chemotherapy compared with surgery-alone, 5 years follow-up, intention-to-treat-based analytic strategy and similar end points (OS and DFS).  In a pooled analysis, 5 year OS rates were 80.4 and 76.4%, and 5 year DFS rates 76.9 and 71.0%, respectively, in carmofur and surgery-alone group.  Oral carmofur had significant advantage over surgery-alone in terms of both OS [pooled hazard ratio, 0.82; 95% confidence interval (CI) = 0.68-0.99; P = 0.043] and DFS (pooled hazard ratio, 0.77; 95% CI = 0.65-0.91; P = 0.003).  CONCLUSIONS:  This individual patient-based meta-analysis demonstrated that oral carmofur significantly improves both OS and DFS in patients with curatively resected colon cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQfLp2ktEb9SjDnmmyUf5qOfW6udTcc2eZsrEB60xa_Ebntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MrisFSktw%253D%253D&md5=fce3e26f1b534beb0ea58df08031c294</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1093%2Fjjco%2Fhyi147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjjco%252Fhyi147%26sid%3Dliteratum%253Aachs%26aulast%3DSakamoto%26aufirst%3DJ.%26aulast%3DHamada%26aufirst%3DC.%26aulast%3DRahman%26aufirst%3DM.%26aulast%3DKodaira%26aufirst%3DS.%26aulast%3DIto%26aufirst%3DK.%26aulast%3DNakazato%26aufirst%3DH.%26aulast%3DOhashi%26aufirst%3DY.%26aulast%3DYasutomi%26aufirst%3DM.%26atitle%3DAn%2520individual%2520patient%2520data%2520meta-analysis%2520of%2520adjuvant%2520therapy%2520with%2520carmofur%2520in%2520patients%2520with%2520curatively%2520resected%2520colon%2520cancer%26jtitle%3DJpn.%2520J.%2520Clin.%2520Oncol.%26date%3D2005%26volume%3D35%26spage%3D536%26epage%3D544%26doi%3D10.1093%2Fjjco%2Fhyi147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grohn, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinonen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumpulainen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lansimies, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lantto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyrhonen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Numminen, S.</span></span> <span> </span><span class="NLM_article-title">Oral carmofur in advanced gastrointestinal cancer</span>. <i>Am. J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">477</span>– <span class="NLM_lpage">479</span>, <span class="refDoi"> DOI: 10.1097/00000421-199012000-00005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1097%2F00000421-199012000-00005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=2239802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A280%3ADyaK3M%252FltFemug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1990&pages=477-479&author=P.+Grohnauthor=E.+Heinonenauthor=E.+Kumpulainenauthor=H.+Lansimiesauthor=A.+Lanttoauthor=R.+Salmiauthor=S.+Pyrhonenauthor=S.+Numminen&title=Oral+carmofur+in+advanced+gastrointestinal+cancer&doi=10.1097%2F00000421-199012000-00005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Oral carmofur in advanced gastrointestinal cancer</span></div><div class="casAuthors">Grohn P; Heinonen E; Kumpulainen E; Lansimies H; Lantto A; Salmi R; Pyrhonen S; Numminen S</div><div class="citationInfo"><span class="NLM_cas:title">American journal of clinical oncology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">477-9</span>
        ISSN:<span class="NLM_cas:issn">0277-3732</span>.
    </div><div class="casAbstract">One hundred and twenty-four patients with a diagnosis of metastatic gastrointestinal cancer and no prior therapy were included in this clinical study of carmofur monotherapy, 300-500 mg/m2 daily for 6 weeks.  For the 115 evaluable patients, the response rates were 19.4% in gastric cancer, 27.2% in cancer of mobile colon, and 12.5% in rectal cancer.  No objective responses were seen in 38 patients with pancreatic cancer, although the disease of 13 of these patients has remained stable over a considerably long period of follow-up.  The toxicity profile was interesting; the main adverse effects were urinary bladder symptoms and flush.  Hematologic toxicity was minimal.  The treatment proved to be safe and could be used for outpatients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRksPOiCQ3-LUkUaC_kzhvyfW6udTcc2eZsrEB60xa_Ebntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M%252FltFemug%253D%253D&md5=303aa178260fdb0ca91ca009befc825c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1097%2F00000421-199012000-00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00000421-199012000-00005%26sid%3Dliteratum%253Aachs%26aulast%3DGrohn%26aufirst%3DP.%26aulast%3DHeinonen%26aufirst%3DE.%26aulast%3DKumpulainen%26aufirst%3DE.%26aulast%3DLansimies%26aufirst%3DH.%26aulast%3DLantto%26aufirst%3DA.%26aulast%3DSalmi%26aufirst%3DR.%26aulast%3DPyrhonen%26aufirst%3DS.%26aulast%3DNumminen%26aufirst%3DS.%26atitle%3DOral%2520carmofur%2520in%2520advanced%2520gastrointestinal%2520cancer%26jtitle%3DAm.%2520J.%2520Clin.%2520Oncol.%26date%3D1990%26volume%3D13%26spage%3D477%26epage%3D479%26doi%3D10.1097%2F00000421-199012000-00005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maehara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusumoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusumoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugimachi, K.</span></span> <span> </span><span class="NLM_article-title">Colorectal carcinoma in vitro is more sensitive to 1-hexylcarbamoyl-5-fluorouracil compared with six other antitumor drugs: carboquone, adriamycin, mitomycin C, aclacinomycin A, cisplatin, 5-fluorouracil</span>. <i>Dis. Colon Rectum</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">62</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1007/BF02552573</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1007%2FBF02552573" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=3130239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A280%3ADyaL1c3htFeltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1988&pages=62-67&author=Y.+Maeharaauthor=H.+Anaiauthor=H.+Kusumotoauthor=T.+Kusumotoauthor=K.+Sugimachi&title=Colorectal+carcinoma+in+vitro+is+more+sensitive+to+1-hexylcarbamoyl-5-fluorouracil+compared+with+six+other+antitumor+drugs%3A+carboquone%2C+adriamycin%2C+mitomycin+C%2C+aclacinomycin+A%2C+cisplatin%2C+5-fluorouracil&doi=10.1007%2FBF02552573"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Colorectal carcinoma in vitro is more sensitive to 1-hexylcarbamoyl-5-fluorouracil compared with six other antitumor drugs: carboquone, Adriamycin, mitomycin C, aclacinomycin A, cisplatin, 5-fluorouracil</span></div><div class="casAuthors">Maehara Y; Anai H; Kusumoto H; Kusumoto T; Sugimachi K</div><div class="citationInfo"><span class="NLM_cas:title">Diseases of the colon and rectum</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">62-7</span>
        ISSN:<span class="NLM_cas:issn">0012-3706</span>.
    </div><div class="casAbstract">The sensitivity to 1-hexylcarbamoyl-5-fluorouracil (HCFU) of 25 colorectal cancer tissues was compared with that of six antitumor drugs: carboquone (CQ), Adriamycin (ADM), mitomycin C (MMC), aclacinomycin A (ACR), cisplatin (DDP), and 5-fluorouracil (5-FU), using the in vitro succinate dehydrogenase inhibition (SDI) test.  Chemosensitivity was determined to be positive when the succinate dehydrogenase (SD) activity of the drug-exposed cells, at ten times the peak plasma concentration, was decreased to below 50 percent of that of control cells on day 3 of exposure.  Decrease in SD activity was remarkable in cases of exposure to HCFU, compared with six other drugs.  The sensitivity rates were 32 percent for CQ, 40 percent for ADM, 24 percent for MMC, 28 percent for ACR, 32 percent for DDP, 16 percent for 5-FU, and 68 percent for HCFU.  The sensitivity rate for at least one of the six drugs (CQ, ADM, MMC, ACR, DDP, and 5-FU) was 52 percent, but was 80 percent when HCFU was taken into account.  Since colorectal cancer tissues are resistant to various antitumor drugs, the chemosensitivity test of HCFU should aid in determining the effects of a particular drug for an individual patient.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTj8qWwivgaw7qxQ2mb9Pu8fW6udTcc2eZsrEB60xa_Ebntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1c3htFeltQ%253D%253D&md5=ef2f5bd767f47712b77fa0782997b6b0</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2FBF02552573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02552573%26sid%3Dliteratum%253Aachs%26aulast%3DMaehara%26aufirst%3DY.%26aulast%3DAnai%26aufirst%3DH.%26aulast%3DKusumoto%26aufirst%3DH.%26aulast%3DKusumoto%26aufirst%3DT.%26aulast%3DSugimachi%26aufirst%3DK.%26atitle%3DColorectal%2520carcinoma%2520in%2520vitro%2520is%2520more%2520sensitive%2520to%25201-hexylcarbamoyl-5-fluorouracil%2520compared%2520with%2520six%2520other%2520antitumor%2520drugs%253A%2520carboquone%252C%2520adriamycin%252C%2520mitomycin%2520C%252C%2520aclacinomycin%2520A%252C%2520cisplatin%252C%25205-fluorouracil%26jtitle%3DDis.%2520Colon%2520Rectum%26date%3D1988%26volume%3D31%26spage%3D62%26epage%3D67%26doi%3D10.1007%2FBF02552573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okino, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhami, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dagan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulze, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandhoff, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuchman, E. H.</span></span> <span> </span><span class="NLM_article-title">Purification and characterization of recombinant, human acid ceramidase: catalytic reactions and interactions with acid sphingomyelinase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">32978</span>– <span class="NLM_lpage">32986</span>, <span class="refDoi"> DOI: 10.1074/jbc.M301936200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1074%2Fjbc.M301936200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=32978-32986&author=X.+Heauthor=N.+Okinoauthor=R.+Dhamiauthor=A.+Daganauthor=S.+Gattauthor=H.+Schulzeauthor=K.+Sandhoffauthor=E.+H.+Schuchman&title=Purification+and+characterization+of+recombinant%2C+human+acid+ceramidase%3A+catalytic+reactions+and+interactions+with+acid+sphingomyelinase&doi=10.1074%2Fjbc.M301936200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M301936200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M301936200%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DX.%26aulast%3DOkino%26aufirst%3DN.%26aulast%3DDhami%26aufirst%3DR.%26aulast%3DDagan%26aufirst%3DA.%26aulast%3DGatt%26aufirst%3DS.%26aulast%3DSchulze%26aufirst%3DH.%26aulast%3DSandhoff%26aufirst%3DK.%26aulast%3DSchuchman%26aufirst%3DE.%2BH.%26atitle%3DPurification%2520and%2520characterization%2520of%2520recombinant%252C%2520human%2520acid%2520ceramidase%253A%2520catalytic%2520reactions%2520and%2520interactions%2520with%2520acid%2520sphingomyelinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D32978%26epage%3D32986%26doi%3D10.1074%2Fjbc.M301936200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awad, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shabani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doan, N.</span></span> <span> </span><span class="NLM_article-title">Molecular targeting of acid ceramidase in glioblastoma: a review of its role, potential treatment, and challenges</span>. <i>Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.3390/pharmaceutics10020045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.3390%2Fpharmaceutics10020045" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=45-45&author=H.+S.+Nguyenauthor=A.+J.+Awadauthor=S.+Shabaniauthor=N.+Doan&title=Molecular+targeting+of+acid+ceramidase+in+glioblastoma%3A+a+review+of+its+role%2C+potential+treatment%2C+and+challenges&doi=10.3390%2Fpharmaceutics10020045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3390%2Fpharmaceutics10020045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fpharmaceutics10020045%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DH.%2BS.%26aulast%3DAwad%26aufirst%3DA.%2BJ.%26aulast%3DShabani%26aufirst%3DS.%26aulast%3DDoan%26aufirst%3DN.%26atitle%3DMolecular%2520targeting%2520of%2520acid%2520ceramidase%2520in%2520glioblastoma%253A%2520a%2520review%2520of%2520its%2520role%252C%2520potential%2520treatment%252C%2520and%2520challenges%26jtitle%3DPharmaceutics%26date%3D2018%26volume%3D10%26spage%3D45%26epage%3D45%26doi%3D10.3390%2Fpharmaceutics10020045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuchman, E. H.</span></span> <span> </span><span class="NLM_article-title">Acid ceramidase and human disease</span>. <i>Biochim. Biophys. Acta, Biomembr.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1758</i></span>,  <span class="NLM_fpage">2133</span>– <span class="NLM_lpage">2138</span>, <span class="refDoi"> DOI: 10.1016/j.bbamem.2006.08.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1016%2Fj.bbamem.2006.08.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=17064658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12kt73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1758&publication_year=2006&pages=2133-2138&author=J.+H.+Parkauthor=E.+H.+Schuchman&title=Acid+ceramidase+and+human+disease&doi=10.1016%2Fj.bbamem.2006.08.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Acid ceramidase and human disease</span></div><div class="casAuthors">Park, Jae-Ho; Schuchman, Edward H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1758</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2133-2138</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Acid ceramidase (N-acylsphingosine deacylase, EC 3.5.1.23; AC) is the lipid hydrolase responsible for the degrdn. of ceramide into sphingosine and free fatty acids within lysosomes.  The enzymic activity was first identified over four decades ago, and is deficient in the inherited lipid storage disorder, Farber Lipogranulomatosis (Farber disease).  Importantly, AC not only hydrolyzes ceramide into sphingosine, but also can synthesize ceramide from sphingosine and free fatty acids in vitro and in situ.  This "reverse" enzymic activity occurs at a distinct pH from the hydrolysis ("forward") reaction (6.0 vs. 4.5, resp.), suggesting that the enzyme may have diverse functions within cells dependent on its subcellular location and the local pH.  Most information concerning the role of AC in human disease stems from work on Farber disease.  This lipid storage disease is caused by mutations in the gene encoding AC, leading to a profound redn. in enzymic activity.  Recent studies have also shown that AC activity is aberrantly expressed in several human cancers, and that the enzyme may be a useful cancer drug target.  For example, AC inhibitors have been used to slow the growth of cancer cells, alone or in combination with other established, anti-oncogenic treatments.  Aberrant AC activity also has been described in Alzheimer's disease, and overexpression of AC may prevent insulin resistant (Type II) diabetes induced by free fatty acids.  Current information concerning the biol. of this enzyme and its role in human disease is reviewed within.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrexBzUOOWihrVg90H21EOLACvtfcHk0lijolBd6KsJHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12kt73I&md5=d6ba8e8a62727eab934b939c2e49fe0e</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2006.08.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2006.08.019%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DJ.%2BH.%26aulast%3DSchuchman%26aufirst%3DE.%2BH.%26atitle%3DAcid%2520ceramidase%2520and%2520human%2520disease%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2006%26volume%3D1758%26spage%3D2133%26epage%3D2138%26doi%3D10.1016%2Fj.bbamem.2006.08.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obeid, L. M.</span></span> <span> </span><span class="NLM_article-title">Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate</span>. <i>Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>1781</i></span>,  <span class="NLM_fpage">424</span>– <span class="NLM_lpage">434</span>, <span class="refDoi"> DOI: 10.1016/j.bbalip.2008.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1016%2Fj.bbalip.2008.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=18619555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVKjtbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1781&publication_year=2008&pages=424-434&author=C.+Maoauthor=L.+M.+Obeid&title=Ceramidases%3A+regulators+of+cellular+responses+mediated+by+ceramide%2C+sphingosine%2C+and+sphingosine-1-phosphate&doi=10.1016%2Fj.bbalip.2008.06.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate</span></div><div class="casAuthors">Mao, Cungui; Obeid, Lina M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1781</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">424-434</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Ceramidases catalyze hydrolysis of ceramides to generate sphingosine (SPH), which is phosphorylated to form sphingosine-1-phosphate (S1P).  Ceramide, SPH, and S1P are bioactive lipids that mediate cell proliferation, differentiation, apoptosis, adhesion, and migration.  Presently, 5 human ceramidases encoded by 5 distinct genes have been cloned: acid ceramidase (AC), neutral ceramidase (NC), alk. ceramidase 1 (ACER1), alk. ceramidase 2 (ACER2), and alk. ceramidase 3 (ACER3).  Each human ceramidase has a mouse counterpart.  AC, NC, and ACER1-3 have maximal activities in acidic, neutral, and alk. environments, resp.  ACER1-3 have similar protein sequences but no homol. to AC and NC.  AC and NC also have distinct protein sequences.  The human AC (hAC) was implicated in Farber disease, and hAC may be important for cell survival.  The mouse AC (mAC) is needed for early embryo survival.  NC is protective against inflammatory cytokines, and the mouse NC (mNC) is required for the catabolism of ceramides in the digestive tract.  ACER1 is crit. in mediating cell differentiation by controlling the generation of SPH and S1P and that ACER2's role in cell proliferation and survival depends on its expression or the cell type in which it is found.  Here, we discuss the role of each ceramidase in regulating cellular responses mediated by ceramides, SPH, and S1P.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEgvBkM7CJsLVg90H21EOLACvtfcHk0lijolBd6KsJHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVKjtbrM&md5=0ff10423032645e5c8a9baa1c442b85d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2008.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2008.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DC.%26aulast%3DObeid%26aufirst%3DL.%2BM.%26atitle%3DCeramidases%253A%2520regulators%2520of%2520cellular%2520responses%2520mediated%2520by%2520ceramide%252C%2520sphingosine%252C%2520and%2520sphingosine-1-phosphate%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2008%26volume%3D1781%26spage%3D424%26epage%3D434%26doi%3D10.1016%2Fj.bbalip.2008.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanger, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruckhaberle, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gyorffy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engels, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrich, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fehm, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holtrich, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karn, T.</span></span> <span> </span><span class="NLM_article-title">Acid ceramidase is associated with an improved prognosis in both DCIS and invasive breast cancer</span>. <i>Mol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">58</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1016/j.molonc.2014.07.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1016%2Fj.molonc.2014.07.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=25131496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A280%3ADC%252BC2M%252FisFamsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=58-67&author=N.+Sangerauthor=E.+Ruckhaberleauthor=B.+Gyorffyauthor=K.+Engelsauthor=T.+Heinrichauthor=T.+Fehmauthor=A.+Grafauthor=U.+Holtrichauthor=S.+Beckerauthor=T.+Karn&title=Acid+ceramidase+is+associated+with+an+improved+prognosis+in+both+DCIS+and+invasive+breast+cancer&doi=10.1016%2Fj.molonc.2014.07.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Acid ceramidase is associated with an improved prognosis in both DCIS and invasive breast cancer</span></div><div class="casAuthors">Sanger Nicole; Heinrich Tomas; Graf Anna; Holtrich Uwe; Becker Sven; Ruckhaberle Eugen; Fehm Tanja; Gyorffy Balazs; Engels Knut; Karn Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Molecular oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">58-67</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Acid ceramidase (ASAH1) a key enzyme of sphingolipid metabolism converting pro-apoptotic ceramide to sphingosine has been shown to be overexpressed in various cancers.  We previously demonstrated higher expression of ASAH1 in ER positive compared to ER negative breast cancer.  In the current study we performed subtype specific analyses of ASAH1 gene expression in invasive and non invasive breast cancer.  We show that expression of ASAH1 is mainly associated with luminal A - like cancers which are known to have the best prognosis of all breast cancer subtypes.  Moreover tumors with high ASAH1 expression among the other subtypes are also characterized by an improved prognosis.  The good prognosis of tumors with high ASAH1 is independent of the type of adjuvant treatment in breast cancer and is also detected in non small cell lung cancer patients.  Moreover, even in pre-invasive DCIS of the breast ASAH1 is associated with a luminal phenotype and a reduced frequency of recurrences.  Thus, high ASAH1 expression is generally associated with an improved prognosis in invasive breast cancer independent of adjuvant treatment and could also be valuable as prognostic factor for pre-invasive DCIS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS-ZgqV1oxQEkh5eUSa2oe_fW6udTcc2eaMXpYQGMzWvrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M%252FisFamsQ%253D%253D&md5=907cdd9a1e931af3e80d58a3396bf915</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.molonc.2014.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molonc.2014.07.016%26sid%3Dliteratum%253Aachs%26aulast%3DSanger%26aufirst%3DN.%26aulast%3DRuckhaberle%26aufirst%3DE.%26aulast%3DGyorffy%26aufirst%3DB.%26aulast%3DEngels%26aufirst%3DK.%26aulast%3DHeinrich%26aufirst%3DT.%26aulast%3DFehm%26aufirst%3DT.%26aulast%3DGraf%26aufirst%3DA.%26aulast%3DHoltrich%26aufirst%3DU.%26aulast%3DBecker%26aufirst%3DS.%26aulast%3DKarn%26aufirst%3DT.%26atitle%3DAcid%2520ceramidase%2520is%2520associated%2520with%2520an%2520improved%2520prognosis%2520in%2520both%2520DCIS%2520and%2520invasive%2520breast%2520cancer%26jtitle%3DMol.%2520Oncol.%26date%3D2015%26volume%3D9%26spage%3D58%26epage%3D67%26doi%3D10.1016%2Fj.molonc.2014.07.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seelan, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokomizo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bostwick, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span> <span> </span><span class="NLM_article-title">Human acid ceramidase is overexpressed but not mutated in prostate cancer</span>. <i>Genes, Chromosomes Cancer</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">137</span>– <span class="NLM_lpage">146</span>, <span class="refDoi"> DOI: 10.1002/1098-2264(2000)9999:9999<::AID-GCC1018>3.0.CO;2-E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1002%2F1098-2264%282000%299999%3A9999%3C%3A%3AAID-GCC1018%3E3.0.CO%3B2-E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10959093" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntVWiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2000&pages=137-146&author=R.+S.+Seelanauthor=C.+Qianauthor=A.+Yokomizoauthor=D.+G.+Bostwickauthor=D.+I.+Smithauthor=W.+Liu&title=Human+acid+ceramidase+is+overexpressed+but+not+mutated+in+prostate+cancer&doi=10.1002%2F1098-2264%282000%299999%3A9999%3C%3A%3AAID-GCC1018%3E3.0.CO%3B2-E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Human acid ceramidase is overexpressed but not mutated in prostate cancer</span></div><div class="casAuthors">Seelan, Ratnam S.; Qian, Chiping; Yokomizo, Akira; Bostwick, David G.; Smith, David I.; Liu, Wanguo</div><div class="citationInfo"><span class="NLM_cas:title">Genes, Chromosomes & Cancer</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">137-146</span>CODEN:
                <span class="NLM_cas:coden">GCCAES</span>;
        ISSN:<span class="NLM_cas:issn">1045-2257</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The human acid ceramidase gene, that causes Farber disease, is located in 8p22, a region frequently altered in several cancers, including prostate cancer.  Acid ceramidase catalyzes the hydrolysis of ceramide, a potent lipid second messenger mol. that promotes apoptosis and inhibits cellular proliferation.  It is not known whether this gene, or its expression, is altered in prostate cancer.  Here, the authors report the structural organization of the human gene, its expression in human tissues, and the identification of several single nucleotide polymorphisms.  No cancer-related mutations were found in the gene in a panel of prostate tumor DNAs analyzed, but increased expression was obsd. in prostate tumor tissues when compared with matched normals.  This increase was obsd. in all three prostate tumor cell lines tested (DU145, LnCAP, and PC3) when compared to a BPH (benign prostatic hyperplasia) cell line and 15/36 prostate tumors.  These results suggest that acid ceramidase may play an important role in prostate carcinogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2Y-_n5vjRdbVg90H21EOLACvtfcHk0lim_IV5jc9WdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntVWiurg%253D&md5=9c690947f4f44a446d83608ffda02c54</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2F1098-2264%282000%299999%3A9999%3C%3A%3AAID-GCC1018%3E3.0.CO%3B2-E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1098-2264%25282000%25299999%253A9999%253C%253A%253AAID-GCC1018%253E3.0.CO%253B2-E%26sid%3Dliteratum%253Aachs%26aulast%3DSeelan%26aufirst%3DR.%2BS.%26aulast%3DQian%26aufirst%3DC.%26aulast%3DYokomizo%26aufirst%3DA.%26aulast%3DBostwick%26aufirst%3DD.%2BG.%26aulast%3DSmith%26aufirst%3DD.%2BI.%26aulast%3DLiu%26aufirst%3DW.%26atitle%3DHuman%2520acid%2520ceramidase%2520is%2520overexpressed%2520but%2520not%2520mutated%2520in%2520prostate%2520cancer%26jtitle%3DGenes%252C%2520Chromosomes%2520Cancer%26date%3D2000%26volume%3D29%26spage%3D137%26epage%3D146%26doi%3D10.1002%2F1098-2264%282000%299999%3A9999%3C%3A%3AAID-GCC1018%3E3.0.CO%3B2-E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klobucar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grbcic, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavelic, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonjic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visentin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedic, M.</span></span> <span> </span><span class="NLM_article-title">Acid ceramidase inhibition sensitizes human colon cancer cells to oxaliplatin through downregulation of transglutaminase 2 and beta1 integrin/FAK-mediated signalling</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>503</i></span>,  <span class="NLM_fpage">843</span>– <span class="NLM_lpage">848</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2018.06.085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1016%2Fj.bbrc.2018.06.085" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=503&publication_year=2018&pages=843-848&author=M.+Klobucarauthor=P.+Grbcicauthor=S.+K.+Pavelicauthor=N.+Jonjicauthor=S.+Visentinauthor=M.+Sedic&title=Acid+ceramidase+inhibition+sensitizes+human+colon+cancer+cells+to+oxaliplatin+through+downregulation+of+transglutaminase+2+and+beta1+integrin%2FFAK-mediated+signalling&doi=10.1016%2Fj.bbrc.2018.06.085"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2018.06.085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2018.06.085%26sid%3Dliteratum%253Aachs%26aulast%3DKlobucar%26aufirst%3DM.%26aulast%3DGrbcic%26aufirst%3DP.%26aulast%3DPavelic%26aufirst%3DS.%2BK.%26aulast%3DJonjic%26aufirst%3DN.%26aulast%3DVisentin%26aufirst%3DS.%26aulast%3DSedic%26aufirst%3DM.%26atitle%3DAcid%2520ceramidase%2520inhibition%2520sensitizes%2520human%2520colon%2520cancer%2520cells%2520to%2520oxaliplatin%2520through%2520downregulation%2520of%2520transglutaminase%25202%2520and%2520beta1%2520integrin%252FFAK-mediated%2520signalling%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2018%26volume%3D503%26spage%3D843%26epage%3D848%26doi%3D10.1016%2Fj.bbrc.2018.06.085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Realini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palese, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizzirani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pontis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bach, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Acid ceramidase in melanoma: expression, localization, and effects of pharmacological inhibition</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>291</i></span>,  <span class="NLM_fpage">2422</span>– <span class="NLM_lpage">2434</span>, <span class="refDoi"> DOI: 10.1074/jbc.M115.666909</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1074%2Fjbc.M115.666909" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=26553872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1Cqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=2422-2434&author=N.+Realiniauthor=F.+Paleseauthor=D.+Pizziraniauthor=S.+Pontisauthor=A.+Basitauthor=A.+Bachauthor=A.+Ganesanauthor=D.+Piomelli&title=Acid+ceramidase+in+melanoma%3A+expression%2C+localization%2C+and+effects+of+pharmacological+inhibition&doi=10.1074%2Fjbc.M115.666909"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Acid Ceramidase in Melanoma. Expression, location, and effects of pharmacological inhibitors</span></div><div class="casAuthors">Realini, Natalia; Palese, Francesca; Pizzirani, Daniela; Pontis, Silvia; Basit, Abdul; Bach, Anders; Ganesan, Anand; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2422-2434</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Acid ceramidase (AC) is a lysosomal cysteine amidase that controls sphingolipid signaling by lowering the levels of ceramides and concomitantly increasing those of sphingosine and its bioactive metabolite, sphingosine 1-phosphate.  In the present study, we evaluated the role of AC-regulated sphingolipid signaling in melanoma.  We found that AC expression is markedly elevated in normal human melanocytes and proliferative melanoma cell lines, compared with other skin cells (keratinocytes and fibroblasts) and non-melanoma cancer cells.  High AC expression was also obsd. in biopsies from human subjects with Stage II melanoma.  Immunofluorescence studies revealed that the subcellular localization of AC differs between melanocytes (where it is found in both cytosol and nucleus) and melanoma cells (where it is primarily localized to cytosol).  In addn. to having high AC levels, melanoma cells generate lower amts. of ceramides than normal melanocytes do.  This down-regulation in ceramide prodn. appears to result from suppression of the de novo biosynthesis pathway.  To test whether AC might contribute to melanoma cell proliferation, we blocked AC activity using a new potent (IC50 = 12 nm) and stable inhibitor.  AC inhibition increased cellular ceramide levels, decreased sphingosine 1-phosphate levels, and acted synergistically with several, albeit not all, antitumoral agents.  The results suggest that AC-controlled sphingolipid metab. may play an important role in the control of melanoma proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ1pGRTPNfObVg90H21EOLACvtfcHk0lhbY6ySRsSSeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1Cqsbo%253D&md5=40dd33dee5301d0b79ee77c54b3b3fe3</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.666909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.666909%26sid%3Dliteratum%253Aachs%26aulast%3DRealini%26aufirst%3DN.%26aulast%3DPalese%26aufirst%3DF.%26aulast%3DPizzirani%26aufirst%3DD.%26aulast%3DPontis%26aufirst%3DS.%26aulast%3DBasit%26aufirst%3DA.%26aulast%3DBach%26aufirst%3DA.%26aulast%3DGanesan%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DAcid%2520ceramidase%2520in%2520melanoma%253A%2520expression%252C%2520localization%252C%2520and%2520effects%2520of%2520pharmacological%2520inhibition%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26spage%3D2422%26epage%3D2434%26doi%3D10.1074%2Fjbc.M115.666909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doan, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alhajala, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Gizawiy, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rand, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connelly, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochran, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chitambar, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmainda, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirza, S. P.</span></span> <span> </span><span class="NLM_article-title">Acid ceramidase and its inhibitors: a de novo drug target and a new class of drugs for killing glioblastoma cancer stem cells with high efficiency</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">112662</span>– <span class="NLM_lpage">112674</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.22637</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.18632%2Foncotarget.22637" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=29348854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A280%3ADC%252BC1Mvit1SrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=112662-112674&author=N.+B.+Doanauthor=H.+Alhajalaauthor=M.+M.+Al-Gizawiyauthor=W.+M.+Muellerauthor=S.+D.+Randauthor=J.+M.+Connellyauthor=E.+J.+Cochranauthor=C.+R.+Chitambarauthor=P.+Clarkauthor=J.+Kuoauthor=K.+M.+Schmaindaauthor=S.+P.+Mirza&title=Acid+ceramidase+and+its+inhibitors%3A+a+de+novo+drug+target+and+a+new+class+of+drugs+for+killing+glioblastoma+cancer+stem+cells+with+high+efficiency&doi=10.18632%2Foncotarget.22637"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Acid ceramidase and its inhibitors: a de novo drug target and a new class of drugs for killing glioblastoma cancer stem cells with high efficiency</span></div><div class="casAuthors">Doan Ninh B; Mirza Shama P; Doan Ninh B; Mueller Wade M; Alhajala Hisham; Chitambar Christopher R; Schmainda Kathleen M; Al-Gizawiy Mona M; Rand Scott D; Connelly Jennifer M; Cochran Elizabeth J; Clark Paul; Kuo John; Schmainda Kathleen M; Mirza Shama P; Mirza Shama P</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">68</span>),
    <span class="NLM_cas:pages">112662-112674</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Glioblastoma remains the most common, malignant primary cancer of the central nervous system with a low life expectancy and an overall survival of less than 1.5 years.  The treatment options are limited and there is no cure.  Moreover, almost all patients develop recurrent tumors, which typically are more aggressive.  Therapeutically resistant glioblastoma or glioblastoma stem-like cells (GSCs) are hypothesized to cause this inevitable recurrence.  Identifying prognostic biomarkers of glioblastoma will potentially advance knowledge about glioblastoma tumorigenesis and enable discovery of more effective therapies.  Proteomic analysis of more than 600 glioblastoma-specific proteins revealed, for the first time, that expression of acid ceramidase (ASAH1) is associated with poor glioblastoma survival.  CD133+ GSCs express significantly higher ASAH1 compared to CD133- GSCs and serum-cultured glioblastoma cell lines, such as U87MG.  These findings implicate ASAH1 as a plausible independent prognostic marker, providing a target for a therapy tailored toward GSCs.  We further demonstrate that ASAH1 inhibition increases cellular ceramide level and induces apoptosis.  Strikingly, U87MG cells, and three different patient-derived glioblastoma stem-like cancer cell lines were efficiently killed, through apoptosis, by three different known ASAH1 inhibitors with IC50's ranging from 11-104 μM.  In comparison, the standard glioblastoma chemotherapy agent, temozolomide, had minimal GSC-targeted effects at comparable or even higher concentrations (IC50 > 750 μM against GSCs).  ASAH1 is identified as a de novo glioblastoma drug target, and ASAH1 inhibitors, such as carmofur, are shown to be highly effective and to specifically target glioblastoma GSCs.  Carmofur is an ASAH1 inhibitor that crosses the blood-brain barrier, a major bottleneck in glioblastoma treatment.  It has been approved in Japan since 1981 for colorectal cancer therapy.  Therefore, it is poised for repurposing and translation to glioblastoma clinical trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTkPFERLjQD2MrRqEXsZufAfW6udTcc2eb0uNpKuLVXNLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mvit1SrtQ%253D%253D&md5=cf2b957e6c9b8664b919941d4a1eeddb</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.22637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.22637%26sid%3Dliteratum%253Aachs%26aulast%3DDoan%26aufirst%3DN.%2BB.%26aulast%3DAlhajala%26aufirst%3DH.%26aulast%3DAl-Gizawiy%26aufirst%3DM.%2BM.%26aulast%3DMueller%26aufirst%3DW.%2BM.%26aulast%3DRand%26aufirst%3DS.%2BD.%26aulast%3DConnelly%26aufirst%3DJ.%2BM.%26aulast%3DCochran%26aufirst%3DE.%2BJ.%26aulast%3DChitambar%26aufirst%3DC.%2BR.%26aulast%3DClark%26aufirst%3DP.%26aulast%3DKuo%26aufirst%3DJ.%26aulast%3DSchmainda%26aufirst%3DK.%2BM.%26aulast%3DMirza%26aufirst%3DS.%2BP.%26atitle%3DAcid%2520ceramidase%2520and%2520its%2520inhibitors%253A%2520a%2520de%2520novo%2520drug%2520target%2520and%2520a%2520new%2520class%2520of%2520drugs%2520for%2520killing%2520glioblastoma%2520cancer%2520stem%2520cells%2520with%2520high%2520efficiency%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D112662%26epage%3D112674%26doi%3D10.18632%2Foncotarget.22637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doan, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Gizawiy, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabbadini, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rand, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connelly, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chitambar, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmainda, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirza, S. P.</span></span> <span> </span><span class="NLM_article-title">Acid ceramidase confers radioresistance to glioblastoma cells</span>. <i>Oncol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1932</span>– <span class="NLM_lpage">1940</span>, <span class="refDoi"> DOI: 10.3892/or.2017.5855</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.3892%2For.2017.5855" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=28765947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVehsLvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2017&pages=1932-1940&author=N.+B.+Doanauthor=H.+S.+Nguyenauthor=M.+M.+Al-Gizawiyauthor=W.+M.+Muellerauthor=R.+A.+Sabbadiniauthor=S.+D.+Randauthor=J.+M.+Connellyauthor=C.+R.+Chitambarauthor=K.+M.+Schmaindaauthor=S.+P.+Mirza&title=Acid+ceramidase+confers+radioresistance+to+glioblastoma+cells&doi=10.3892%2For.2017.5855"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Acid ceramidase confers radioresistance to glioblastoma cells</span></div><div class="casAuthors">Doan, Ninh B.; Nguyen, Ha S.; Al-Gizawiy, Mona M.; Mueller, Wade M.; Sabbadini, Roger A.; Rand, Scott D.; Connelly, Jennifer M.; Chitambar, Christopher R.; Schmainda, Kathleen M.; Mirza, Shama P.</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1932-1940</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1791-2431</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Glioblastoma multiforme (GBM) is the most common primary, intracranial malignancy of the central nervous system.  The std. treatment protocol, which involves surgical resection, and concurrent radiation with adjuvant temozolomide (TMZ), still imparts a grim prognosis.  Ultimately, all GBMs exhibit recurrence or progression, developing resistance to std. treatment.  This study demonstrates that GBMs acquire resistance to radiation via upregulation of acid ceramidase (ASAH1) and sphingosine-1-phosphate (Sph-1P).  Moreover, inhibition of ASAH1 and Sph-1P, either with humanized monoclonal antibodies, small mol. drugs (i.e. carmofur), or a combination of both, led to suppression of GBM cell growth.  These results suggest that ASAH1 and Sph-1P may be excellent targets for the treatment of new GBMs and recurrent GBMs, esp. since the latter over-expresses ASAH1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLNypfI0P1ZLVg90H21EOLACvtfcHk0lhbY6ySRsSSeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVehsLvI&md5=26b1c037fc2501e8136f0ca6325ca1f5</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.3892%2For.2017.5855&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252For.2017.5855%26sid%3Dliteratum%253Aachs%26aulast%3DDoan%26aufirst%3DN.%2BB.%26aulast%3DNguyen%26aufirst%3DH.%2BS.%26aulast%3DAl-Gizawiy%26aufirst%3DM.%2BM.%26aulast%3DMueller%26aufirst%3DW.%2BM.%26aulast%3DSabbadini%26aufirst%3DR.%2BA.%26aulast%3DRand%26aufirst%3DS.%2BD.%26aulast%3DConnelly%26aufirst%3DJ.%2BM.%26aulast%3DChitambar%26aufirst%3DC.%2BR.%26aulast%3DSchmainda%26aufirst%3DK.%2BM.%26aulast%3DMirza%26aufirst%3DS.%2BP.%26atitle%3DAcid%2520ceramidase%2520confers%2520radioresistance%2520to%2520glioblastoma%2520cells%26jtitle%3DOncol.%2520Rep.%26date%3D2017%26volume%3D38%26spage%3D1932%26epage%3D1940%26doi%3D10.3892%2For.2017.5855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Realini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Ferla, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passalacqua, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matteoli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pistello, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzanti, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Complete acid ceramidase ablation prevents cancer-initiating cell formation in melanoma cells</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">7411</span>, <span class="refDoi"> DOI: 10.1038/s41598-017-07606-w</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1038%2Fs41598-017-07606-w" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=28785021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A280%3ADC%252BC1cflt1Krtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=7411&author=M.+Laiauthor=N.+Realiniauthor=M.+La+Ferlaauthor=I.+Passalacquaauthor=G.+Matteoliauthor=A.+Ganesanauthor=M.+Pistelloauthor=C.+M.+Mazzantiauthor=D.+Piomelli&title=Complete+acid+ceramidase+ablation+prevents+cancer-initiating+cell+formation+in+melanoma+cells&doi=10.1038%2Fs41598-017-07606-w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Complete Acid Ceramidase ablation prevents cancer-initiating cell formation in melanoma cells</span></div><div class="casAuthors">Lai Michele; Realini Natalia; Lai Michele; La Ferla Marco; Mazzanti Chiara Maria; Lai Michele; Passalacqua Ilaria; Matteoli Giulia; Pistello Mauro; Lai Michele; Piomelli Daniele; Ganesan Anand</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7411</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Acid ceramidase (AC) is a lysosomal cysteine hydrolase that catalyzes the conversion of ceramide into fatty acid and sphingosine.  This reaction lowers intracellular ceramide levels and concomitantly generates sphingosine used for sphingosine-1-phosphate (S1P) production.  Since increases in ceramide and consequent decreases of S1P reduce proliferation of various cancers, AC might offer a new target for anti-tumor therapy.  Here we used CrispR-Cas9-mediated gene editing to delete the gene encoding for AC, ASAH1, in human A375 melanoma cells.  ASAH1-null clones show significantly greater accumulation of long-chain saturated ceramides that are substrate for AC.  As seen with administration of exogenous ceramide, AC ablation blocks cell cycle progression and accelerates senescence.  Importantly, ASAH1-null cells also lose the ability to form cancer-initiating cells and to undergo self-renewal, which is suggestive of a key role for AC in maintaining malignancy and self-renewal of invasive melanoma cells.  The results suggest that AC inhibitors might find therapeutic use as adjuvant therapy for advanced melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQAhq12ltnyhNFxYDaSSP8XfW6udTcc2eacDwdgo4jxfLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cflt1Krtg%253D%253D&md5=14fcc4ec6cd5c5d87f81f9270cdb47cb</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-07606-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-07606-w%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DM.%26aulast%3DRealini%26aufirst%3DN.%26aulast%3DLa%2BFerla%26aufirst%3DM.%26aulast%3DPassalacqua%26aufirst%3DI.%26aulast%3DMatteoli%26aufirst%3DG.%26aulast%3DGanesan%26aufirst%3DA.%26aulast%3DPistello%26aufirst%3DM.%26aulast%3DMazzanti%26aufirst%3DC.%2BM.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DComplete%2520acid%2520ceramidase%2520ablation%2520prevents%2520cancer-initiating%2520cell%2520formation%2520in%2520melanoma%2520cells%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D7411%26doi%3D10.1038%2Fs41598-017-07606-w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doan, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montoure, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Gizawiy, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurpad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rand, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connelly, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chitambar, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmainda, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirza, S. P.</span></span> <span> </span><span class="NLM_article-title">Acid ceramidase is a novel drug target for pediatric brain tumors</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">24753</span>– <span class="NLM_lpage">24761</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.15800</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.18632%2Foncotarget.15800" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=24753-24761&author=N.+B.+Doanauthor=H.+S.+Nguyenauthor=A.+Montoureauthor=M.+M.+Al-Gizawiyauthor=W.+M.+Muellerauthor=S.+Kurpadauthor=S.+D.+Randauthor=J.+M.+Connellyauthor=C.+R.+Chitambarauthor=K.+M.+Schmaindaauthor=S.+P.+Mirza&title=Acid+ceramidase+is+a+novel+drug+target+for+pediatric+brain+tumors&doi=10.18632%2Foncotarget.15800"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.15800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.15800%26sid%3Dliteratum%253Aachs%26aulast%3DDoan%26aufirst%3DN.%2BB.%26aulast%3DNguyen%26aufirst%3DH.%2BS.%26aulast%3DMontoure%26aufirst%3DA.%26aulast%3DAl-Gizawiy%26aufirst%3DM.%2BM.%26aulast%3DMueller%26aufirst%3DW.%2BM.%26aulast%3DKurpad%26aufirst%3DS.%26aulast%3DRand%26aufirst%3DS.%2BD.%26aulast%3DConnelly%26aufirst%3DJ.%2BM.%26aulast%3DChitambar%26aufirst%3DC.%2BR.%26aulast%3DSchmainda%26aufirst%3DK.%2BM.%26aulast%3DMirza%26aufirst%3DS.%2BP.%26atitle%3DAcid%2520ceramidase%2520is%2520a%2520novel%2520drug%2520target%2520for%2520pediatric%2520brain%2520tumors%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D24753%26epage%3D24761%26doi%3D10.18632%2Foncotarget.15800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shabani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awad, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaushal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doan, N.</span></span> <span> </span><span class="NLM_article-title">Molecular markers of therapy-resistant glioblastoma and potential strategy to combat resistance</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1765</span>– <span class="NLM_lpage">1765</span>, <span class="refDoi"> DOI: 10.3390/ijms19061765</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.3390%2Fijms19061765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFWmtL7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=1765-1765&author=H.+S.+Nguyenauthor=S.+Shabaniauthor=A.+J.+Awadauthor=M.+Kaushalauthor=N.+Doan&title=Molecular+markers+of+therapy-resistant+glioblastoma+and+potential+strategy+to+combat+resistance&doi=10.3390%2Fijms19061765"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular markers of therapy-resistant glioblastoma and potential strategy to combat resistance</span></div><div class="casAuthors">Nguyen, Ha; Shabani, Saman; Awad, Ahmed; Kaushal, Mayank; Doan, Ninh</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1765/1-1765/23</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Glioblastoma (GBM) is the most common primary malignant tumor of the central nervous system.  With its overall dismal prognosis (the median survival is 14 mo), GBMs demonstrate a resounding resilience against all current treatment modalities.  The absence of a major progress in the treatment of GBM maybe a result of our poor understanding of both GBM tumor biol. and the mechanisms underlying the acquirement of treatment resistance in recurrent GBMs.  A comprehensive understanding of these markers is mandatory for the development of treatments against therapy-resistant GBMs.  This review also provides an overview of a novel marker called acid ceramidase and its implication in the development of radioresistant GBMs.  Multiple signaling pathways were found altered in radioresistant GBMs.  Given these global alterations of multiple signaling pathways found in radioresistant GBMs, an effective treatment for radioresistant GBMs may require a cocktail contg. multiple agents targeting multiple cancer-inducing pathways in order to have a chance to make a substantial impact on improving the overall GBM survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppnNX_rPFiqLVg90H21EOLACvtfcHk0ljW7wncyZJkpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFWmtL7L&md5=927bd153b883e8e09562be3a88e4667a</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.3390%2Fijms19061765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms19061765%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DH.%2BS.%26aulast%3DShabani%26aufirst%3DS.%26aulast%3DAwad%26aufirst%3DA.%2BJ.%26aulast%3DKaushal%26aufirst%3DM.%26aulast%3DDoan%26aufirst%3DN.%26atitle%3DMolecular%2520markers%2520of%2520therapy-resistant%2520glioblastoma%2520and%2520potential%2520strategy%2520to%2520combat%2520resistance%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2018%26volume%3D19%26spage%3D1765%26epage%3D1765%26doi%3D10.3390%2Fijms19061765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alhajala, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shabani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Best, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaushal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Gizawiy, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, E. Y. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knipstein, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirza, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmainda, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chitambar, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doan, N. B.</span></span> <span> </span><span class="NLM_article-title">Irradiation of pediatric glioblastoma cells promotes radioresistance and enhances glioma malignancy via genome-wide transcriptome changes</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">34122</span>– <span class="NLM_lpage">34131</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.26137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.18632%2Foncotarget.26137" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=34122-34131&author=H.+S.+Alhajalaauthor=H.+S.+Nguyenauthor=S.+Shabaniauthor=B.+Bestauthor=M.+Kaushalauthor=M.+M.+Al-Gizawiyauthor=E.+Y.+E.+Ahnauthor=J.+A.+Knipsteinauthor=S.+Mirzaauthor=K.+M.+Schmaindaauthor=C.+R.+Chitambarauthor=N.+B.+Doan&title=Irradiation+of+pediatric+glioblastoma+cells+promotes+radioresistance+and+enhances+glioma+malignancy+via+genome-wide+transcriptome+changes&doi=10.18632%2Foncotarget.26137"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.26137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.26137%26sid%3Dliteratum%253Aachs%26aulast%3DAlhajala%26aufirst%3DH.%2BS.%26aulast%3DNguyen%26aufirst%3DH.%2BS.%26aulast%3DShabani%26aufirst%3DS.%26aulast%3DBest%26aufirst%3DB.%26aulast%3DKaushal%26aufirst%3DM.%26aulast%3DAl-Gizawiy%26aufirst%3DM.%2BM.%26aulast%3DAhn%26aufirst%3DE.%2BY.%2BE.%26aulast%3DKnipstein%26aufirst%3DJ.%2BA.%26aulast%3DMirza%26aufirst%3DS.%26aulast%3DSchmainda%26aufirst%3DK.%2BM.%26aulast%3DChitambar%26aufirst%3DC.%2BR.%26aulast%3DDoan%26aufirst%3DN.%2BB.%26atitle%3DIrradiation%2520of%2520pediatric%2520glioblastoma%2520cells%2520promotes%2520radioresistance%2520and%2520enhances%2520glioma%2520malignancy%2520via%2520genome-wide%2520transcriptome%2520changes%26jtitle%3DOncotarget%26date%3D2018%26volume%3D9%26spage%3D34122%26epage%3D34131%26doi%3D10.18632%2Foncotarget.26137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doan, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alhajala, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaber, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Gizawiy, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, E. Y.  E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chitambar, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirza, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmainda, K. M.</span></span> <span> </span><span class="NLM_article-title">Identification of radiation responsive genes and transcriptome profiling via complete RNA sequencing in a stable radioresistant U87 glioblastoma model</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">23532</span>– <span class="NLM_lpage">23542</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.25247</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.18632%2Foncotarget.25247" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=23532-23542&author=N.+B.+Doanauthor=H.+S.+Nguyenauthor=H.+S.+Alhajalaauthor=B.+Jaberauthor=M.+M.+Al-Gizawiyauthor=E.+Y.++E.+Ahnauthor=W.+M.+Muellerauthor=C.+R.+Chitambarauthor=S.+P.+Mirzaauthor=K.+M.+Schmainda&title=Identification+of+radiation+responsive+genes+and+transcriptome+profiling+via+complete+RNA+sequencing+in+a+stable+radioresistant+U87+glioblastoma+model&doi=10.18632%2Foncotarget.25247"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.25247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.25247%26sid%3Dliteratum%253Aachs%26aulast%3DDoan%26aufirst%3DN.%2BB.%26aulast%3DNguyen%26aufirst%3DH.%2BS.%26aulast%3DAlhajala%26aufirst%3DH.%2BS.%26aulast%3DJaber%26aufirst%3DB.%26aulast%3DAl-Gizawiy%26aufirst%3DM.%2BM.%26aulast%3DAhn%26aufirst%3DE.%2BY.%2BE.%26aulast%3DMueller%26aufirst%3DW.%2BM.%26aulast%3DChitambar%26aufirst%3DC.%2BR.%26aulast%3DMirza%26aufirst%3DS.%2BP.%26aulast%3DSchmainda%26aufirst%3DK.%2BM.%26atitle%3DIdentification%2520of%2520radiation%2520responsive%2520genes%2520and%2520transcriptome%2520profiling%2520via%2520complete%2520RNA%2520sequencing%2520in%2520a%2520stable%2520radioresistant%2520U87%2520glioblastoma%2520model%26jtitle%3DOncotarget%26date%3D2018%26volume%3D9%26spage%3D23532%26epage%3D23542%26doi%3D10.18632%2Foncotarget.25247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pizzirani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagliuca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Realini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Branduardi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottegoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarpelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandiera, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of a new class of highly potent inhibitors of acid ceramidase: synthesis and structure-activity relationship (SAR)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3518</span>– <span class="NLM_lpage">3530</span>, <span class="refDoi"> DOI: 10.1021/jm301879g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301879g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A528%3ADC%252BC3sXms1Wjtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3518-3530&author=D.+Pizziraniauthor=C.+Pagliucaauthor=N.+Realiniauthor=D.+Branduardiauthor=G.+Bottegoniauthor=M.+Morauthor=F.+Bertozziauthor=R.+Scarpelliauthor=D.+Piomelliauthor=T.+Bandiera&title=Discovery+of+a+new+class+of+highly+potent+inhibitors+of+acid+ceramidase%3A+synthesis+and+structure-activity+relationship+%28SAR%29&doi=10.1021%2Fjm301879g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a New Class of Highly Potent Inhibitors of Acid Ceramidase: Synthesis and Structure-Activity Relationship (SAR)</span></div><div class="casAuthors">Pizzirani, Daniela; Pagliuca, Chiara; Realini, Natalia; Branduardi, Davide; Bottegoni, Giovanni; Mor, Marco; Bertozzi, Fabio; Scarpelli, Rita; Piomelli, Daniele; Bandiera, Tiziano</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3518-3530</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">1-(Alkylamino)-2,4-pyrimidinediones such as I [R = H, F, MeO, F3C, Ph; R1 = Me(CH2)nNH; R2 = H, Me, MeO2C; n = 5, 7] were prepd. as inhibitors of acid ceramidase for potential use as antitumor agents.  Uracils bearing an electron-withdrawing substituent at position 5, a substituent such as Me at position 3, and an alkylaminocarbonyl moiety with a six- to eight-carbon alkyl group at position 1 were the most effective inhibitors of acid ceramidase of the compds. tested.  The acid ceramidase inhibition and stability of an alkylaminopyrimidinedione was correlated with the stabilization of the antibonding orbital of its N1-carbonyl bond.  I (R = H, F, Ph; R2 = H, Me; n = 5, 7) inhibited a human cancer cell line (SW403) with IC50 values of 20-24 μM.  I (R = F, F3C, MeO; R2 = H, MeO2C; n = 5, 7) inhibited acid ceramidase with single digit-nanomolar IC50 values (IC50 = 4-7 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSG4lPgE1b1bVg90H21EOLACvtfcHk0lgYSW527tGP0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXms1Wjtbo%253D&md5=e8b1cb63aa40e8654de70985febc56dd</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm301879g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301879g%26sid%3Dliteratum%253Aachs%26aulast%3DPizzirani%26aufirst%3DD.%26aulast%3DPagliuca%26aufirst%3DC.%26aulast%3DRealini%26aufirst%3DN.%26aulast%3DBranduardi%26aufirst%3DD.%26aulast%3DBottegoni%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DScarpelli%26aufirst%3DR.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DBandiera%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520a%2520new%2520class%2520of%2520highly%2520potent%2520inhibitors%2520of%2520acid%2520ceramidase%253A%2520synthesis%2520and%2520structure-activity%2520relationship%2520%2528SAR%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3518%26epage%3D3530%26doi%3D10.1021%2Fjm301879g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Realini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solorzano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagliuca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizzirani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luciani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costi, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandiera, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Discovery of highly potent acid ceramidase inhibitors with in vitro tumor chemosensitizing activity</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1035</span>, <span class="refDoi"> DOI: 10.1038/srep01035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1038%2Fsrep01035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=23301156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFaqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=1035&author=N.+Realiniauthor=C.+Solorzanoauthor=C.+Pagliucaauthor=D.+Pizziraniauthor=A.+Armirottiauthor=R.+Lucianiauthor=M.+P.+Costiauthor=T.+Bandieraauthor=D.+Piomelli&title=Discovery+of+highly+potent+acid+ceramidase+inhibitors+with+in+vitro+tumor+chemosensitizing+activity&doi=10.1038%2Fsrep01035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of highly potent acid ceramidase inhibitors with in vitro tumor chemosensitizing activity</span></div><div class="casAuthors">Realini, Natalia; Solorzano, Carlos; Pagliuca, Chiara; Pizzirani, Daniela; Armirotti, Andrea; Luciani, Rosaria; Costi, Maria Paola; Bandiera, Tiziano; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">srep01035, 7 pp.</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The expression of acid ceramidase (AC) - a cysteine amidase that hydrolyzes the proapoptotic lipid ceramide - is abnormally high in several human tumors, which is suggestive of a role in chemoresistance.  Available AC inhibitors lack, however, the potency and drug-likeness necessary to test this idea.  Here we show that the antineoplastic drug carmofur, which is used in the clinic to treat colorectal cancers, is a potent AC inhibitor and that this property is essential to its anti-proliferative effects.  Modifications in the chem. scaffold of carmofur yield new AC inhibitors that act synergistically with std. antitumoral drugs to prevent cancer cell proliferation.  These findings identify AC as an unexpected target for carmofur, and suggest that this mol. can be used as starting point for the design of novel chemosensitizing agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoknWbdLSLhRbVg90H21EOLACvtfcHk0lgYSW527tGP0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFaqt7w%253D&md5=7ff74388fc2bea42c0e97fa8cbcfe61f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fsrep01035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep01035%26sid%3Dliteratum%253Aachs%26aulast%3DRealini%26aufirst%3DN.%26aulast%3DSolorzano%26aufirst%3DC.%26aulast%3DPagliuca%26aufirst%3DC.%26aulast%3DPizzirani%26aufirst%3DD.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DLuciani%26aufirst%3DR.%26aulast%3DCosti%26aufirst%3DM.%2BP.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520highly%2520potent%2520acid%2520ceramidase%2520inhibitors%2520with%2520in%2520vitro%2520tumor%2520chemosensitizing%2520activity%26jtitle%3DSci.%2520Rep.%26date%3D2013%26volume%3D3%26spage%3D1035%26doi%3D10.1038%2Fsrep01035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pizzirani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bach, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Realini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mengatto, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girotto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagliuca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Vivo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribeiro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Benzoxazolone carboxamides: potent and systemically active inhibitors of intracellular acid ceramidase</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">366</span>, <span class="refDoi"> DOI: 10.1002/anie.201410931</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1002%2Fanie.201410931" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=366&author=D.+Pizziraniauthor=A.+Bachauthor=N.+Realiniauthor=A.+Armirottiauthor=L.+Mengattoauthor=I.+Bauerauthor=S.+Girottoauthor=C.+Pagliucaauthor=M.+De+Vivoauthor=M.+Summaauthor=A.+Ribeiroauthor=D.+Piomelli&title=Benzoxazolone+carboxamides%3A+potent+and+systemically+active+inhibitors+of+intracellular+acid+ceramidase&doi=10.1002%2Fanie.201410931"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1002%2Fanie.201410931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201410931%26sid%3Dliteratum%253Aachs%26aulast%3DPizzirani%26aufirst%3DD.%26aulast%3DBach%26aufirst%3DA.%26aulast%3DRealini%26aufirst%3DN.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DMengatto%26aufirst%3DL.%26aulast%3DBauer%26aufirst%3DI.%26aulast%3DGirotto%26aufirst%3DS.%26aulast%3DPagliuca%26aufirst%3DC.%26aulast%3DDe%2BVivo%26aufirst%3DM.%26aulast%3DSumma%26aufirst%3DM.%26aulast%3DRibeiro%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DBenzoxazolone%2520carboxamides%253A%2520potent%2520and%2520systemically%2520active%2520inhibitors%2520of%2520intracellular%2520acid%2520ceramidase%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2015%26volume%3D54%26spage%3D366%26doi%3D10.1002%2Fanie.201410931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gebai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorelik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Illes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagar, B.</span></span> <span> </span><span class="NLM_article-title">Structural basis for the activation of acid ceramidase</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1621</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-03844-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1038%2Fs41467-018-03844-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=29692406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A280%3ADC%252BC1Mjmtl2rtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1621&author=A.+Gebaiauthor=A.+Gorelikauthor=Z.+Liauthor=K.+Illesauthor=B.+Nagar&title=Structural+basis+for+the+activation+of+acid+ceramidase&doi=10.1038%2Fs41467-018-03844-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for the activation of acid ceramidase</span></div><div class="casAuthors">Gebai Ahmad; Gorelik Alexei; Li Zixian; Illes Katalin; Nagar Bhushan</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1621</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Acid ceramidase (aCDase, ASAH1) hydrolyzes lysosomal membrane ceramide into sphingosine, the backbone of all sphingolipids, to regulate many cellular processes.  Abnormal function of aCDase leads to Farber disease, spinal muscular atrophy with progressive myoclonic epilepsy, and is associated with Alzheimer's, diabetes, and cancer.  Here, we present crystal structures of mammalian aCDases in both proenzyme and autocleaved forms.  In the proenzyme, the catalytic center is buried and protected from solvent.  Autocleavage triggers a conformational change exposing a hydrophobic channel leading to the active site.  Substrate modeling suggests distinct catalytic mechanisms for substrate hydrolysis versus autocleavage.  A hydrophobic surface surrounding the substrate binding channel appears to be a site of membrane attachment where the enzyme accepts substrates facilitated by the accessory protein, saposin-D.  Structural mapping of disease mutations reveals that most would destabilize the protein fold.  These results will inform the rational design of aCDase inhibitors and recombinant aCDase for disease therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT6RpR0JSKnbwHqQV89nF-2fW6udTcc2eZR3tJtuXLBaLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mjmtl2rtg%253D%253D&md5=a7fb6f187dc50d25c9a14597053718c1</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-03844-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-03844-2%26sid%3Dliteratum%253Aachs%26aulast%3DGebai%26aufirst%3DA.%26aulast%3DGorelik%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DIlles%26aufirst%3DK.%26aulast%3DNagar%26aufirst%3DB.%26atitle%3DStructural%2520basis%2520for%2520the%2520activation%2520of%2520acid%2520ceramidase%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D1621%26doi%3D10.1038%2Fs41467-018-03844-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shtraizent, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eliyahu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shalgi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuchman, E. H.</span></span> <span> </span><span class="NLM_article-title">Autoproteolytic cleavage and activation of human acid ceramidase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">11253</span>– <span class="NLM_lpage">11259</span>, <span class="refDoi"> DOI: 10.1074/jbc.M709166200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1074%2Fjbc.M709166200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=11253-11259&author=N.+Shtraizentauthor=E.+Eliyahuauthor=J.+H.+Parkauthor=X.+Heauthor=R.+Shalgiauthor=E.+H.+Schuchman&title=Autoproteolytic+cleavage+and+activation+of+human+acid+ceramidase&doi=10.1074%2Fjbc.M709166200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M709166200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M709166200%26sid%3Dliteratum%253Aachs%26aulast%3DShtraizent%26aufirst%3DN.%26aulast%3DEliyahu%26aufirst%3DE.%26aulast%3DPark%26aufirst%3DJ.%2BH.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DShalgi%26aufirst%3DR.%26aulast%3DSchuchman%26aufirst%3DE.%2BH.%26atitle%3DAutoproteolytic%2520cleavage%2520and%2520activation%2520of%2520human%2520acid%2520ceramidase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D11253%26epage%3D11259%26doi%3D10.1074%2Fjbc.M709166200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gorelik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gebai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Illes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagar, B.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanism of activation of the immunoregulatory amidase NAAA</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">E10032</span>– <span class="NLM_lpage">E10040</span>, <span class="refDoi"> DOI: 10.1073/pnas.1811759115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1073%2Fpnas.1811759115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=30301806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVyhsLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2018&pages=E10032-E10040&author=A.+Gorelikauthor=A.+Gebaiauthor=K.+Illesauthor=D.+Piomelliauthor=B.+Nagar&title=Molecular+mechanism+of+activation+of+the+immunoregulatory+amidase+NAAA&doi=10.1073%2Fpnas.1811759115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanism of activation of the immunoregulatory amidase NAAA</span></div><div class="casAuthors">Gorelik, Alexei; Gebai, Ahmad; Illes, Katalin; Piomelli, Daniele; Nagar, Bhushan</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">E10032-E10040</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Palmitoylethanolamide is a bioactive lipid that strongly alleviates pain and inflammation in animal models and in humans.  Its signaling activity is terminated through degrdn. by N-acylethanolamine acid amidase (NAAA), a cysteine hydrolase expressed at high levels in immune cells.  Pharmacol. inhibitors of NAAA activity exert profound analgesic and antiinflammatory effects in rodent models, pointing to this protein as a potential target for therapeutic drug discovery.  To facilitate these efforts and to better understand the mol. mechanism of action of NAAA, we detd. crystal structures of this enzyme in various activation states and in complex with several ligands, including both a covalent and a reversible inhibitor.  Self-proteolysis exposes the otherwise buried active site of NAAA to allow catalysis.  Formation of a stable substrate- or inhibitor-binding site appears to be conformationally coupled to the interaction of a pair of hydrophobic helixes in the enzyme with lipid membranes, resulting in the creation of a linear hydrophobic cavity near the active site that accommodates the liganda's acyl chain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe4SyudaY7MrVg90H21EOLACvtfcHk0lgiziLsz1AYtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVyhsLvP&md5=9debd68d3239a82bd60849c9cf98e8ae</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1811759115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1811759115%26sid%3Dliteratum%253Aachs%26aulast%3DGorelik%26aufirst%3DA.%26aulast%3DGebai%26aufirst%3DA.%26aulast%3DIlles%26aufirst%3DK.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DNagar%26aufirst%3DB.%26atitle%3DMolecular%2520mechanism%2520of%2520activation%2520of%2520the%2520immunoregulatory%2520amidase%2520NAAA%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2018%26volume%3D115%26spage%3DE10032%26epage%3DE10040%26doi%3D10.1073%2Fpnas.1811759115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Al, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiffany, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomes de Mesquita, D.
S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moser, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tager, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schram, A. W.</span></span> <span> </span><span class="NLM_article-title">Properties of acid ceramidase from human spleen</span>. <i>Biochim. Biophys. Acta, Lipids Lipid Metab.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>1004</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">251</span>, <span class="refDoi"> DOI: 10.1016/0005-2760(89)90274-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1016%2F0005-2760%2889%2990274-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=2526656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A528%3ADyaL1MXlsV2htbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1004&publication_year=1989&pages=245-251&author=B.+J.+Alauthor=C.+W.+Tiffanyauthor=D.%0AS.+Gomes+de+Mesquitaauthor=H.+W.+Moserauthor=J.+M.+Tagerauthor=A.+W.+Schram&title=Properties+of+acid+ceramidase+from+human+spleen&doi=10.1016%2F0005-2760%2889%2990274-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Properties of acid ceramidase from human spleen</span></div><div class="casAuthors">Al, Bert J. M.; Tiffany, Carol W.; Gomes de Mesquita, Daniel S.; Moser, Hugo W.; Tager, Joseph M.; Schram, Andre W.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Lipids and Lipid Metabolism</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">1004</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">245-51</span>CODEN:
                <span class="NLM_cas:coden">BBLLA6</span>;
        ISSN:<span class="NLM_cas:issn">0005-2760</span>.
    </div><div class="casAbstract">Ceramidase activity in exts. of human spleen from control subjects and from patients with Gaucher disease was characterized.  In Triton X-100 exts. of control spleens, a broad optimum pH 3.5-5.0 was found; no ceramidase activity was detectable at neutral or alk. pH.  About 45-60% of acid ceramidase could be extd. from spleen without detergents, but for complete extn. Triton X-100 was required.  For the radiolabeled substrate oleoylsphingosine, a Km of 0.22 mM and a Vmax of 57 H nmol/h per mg protein was calcd. in spleen from a control subject.  Flat-bed isoelec. focussing in the presence of Triton X 100 revealed a pI of 6.0-7.0 for acid ceramidase; values were similar for sphingomyelinase and glucerebrosidase.  HPLC-gel filtration indicated that in the presence of Triton X 100, acid ceramidase has an Mr of ∼100 kDa.  In the absence of detergents, the enzyme forms high-mol.-wt. aggregates.  Similar aggregation behavior was obsd. for sphingomyelinase, whereas the elution of β-hexosaminidase was not affected by detergents.  The elution profile of glucocerebrosidase was only slightly altered by Triton X 100.  There was no difference in the properties of acid ceramidase in spleen from control subjects and from patients with type I Gaucher disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHT137-2vCKLVg90H21EOLACvtfcHk0lhqY_k8INo1rA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXlsV2htbw%253D&md5=dff6290c6bd9e65ffd881132f145be7b</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2F0005-2760%2889%2990274-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0005-2760%252889%252990274-9%26sid%3Dliteratum%253Aachs%26aulast%3DAl%26aufirst%3DB.%2BJ.%26aulast%3DTiffany%26aufirst%3DC.%2BW.%26aulast%3DGomes%2Bde%2BMesquita%26aufirst%3DD.%2BS.%26aulast%3DMoser%26aufirst%3DH.%2BW.%26aulast%3DTager%26aufirst%3DJ.%2BM.%26aulast%3DSchram%26aufirst%3DA.%2BW.%26atitle%3DProperties%2520of%2520acid%2520ceramidase%2520from%2520human%2520spleen%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Lipids%2520Lipid%2520Metab.%26date%3D1989%26volume%3D1004%26spage%3D245%26epage%3D251%26doi%3D10.1016%2F0005-2760%2889%2990274-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckham, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrison, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yount, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartlett, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keane, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armeson, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keane, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drake, R. R.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bielawska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norris, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span> <span> </span><span class="NLM_article-title">Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">4344</span>– <span class="NLM_lpage">4358</span>, <span class="refDoi"> DOI: 10.1172/JCI64791</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1172%2FJCI64791" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2013&pages=4344-4358&author=J.+C.+Chengauthor=A.+Baiauthor=T.+H.+Beckhamauthor=S.+T.+Marrisonauthor=C.+L.+Yountauthor=K.+Youngauthor=P.+Luauthor=A.+M.+Bartlettauthor=B.+X.+Wuauthor=B.+J.+Keaneauthor=K.+E.+Armesonauthor=D.+T.+Marshallauthor=T.+E.+Keaneauthor=M.+T.+Smithauthor=E.+E.+Jonesauthor=R.+R.+Drakeauthor=A.+Bielawskaauthor=J.+S.+Norrisauthor=X.+Liu&title=Radiation-induced+acid+ceramidase+confers+prostate+cancer+resistance+and+tumor+relapse&doi=10.1172%2FJCI64791"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1172%2FJCI64791&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI64791%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DJ.%2BC.%26aulast%3DBai%26aufirst%3DA.%26aulast%3DBeckham%26aufirst%3DT.%2BH.%26aulast%3DMarrison%26aufirst%3DS.%2BT.%26aulast%3DYount%26aufirst%3DC.%2BL.%26aulast%3DYoung%26aufirst%3DK.%26aulast%3DLu%26aufirst%3DP.%26aulast%3DBartlett%26aufirst%3DA.%2BM.%26aulast%3DWu%26aufirst%3DB.%2BX.%26aulast%3DKeane%26aufirst%3DB.%2BJ.%26aulast%3DArmeson%26aufirst%3DK.%2BE.%26aulast%3DMarshall%26aufirst%3DD.%2BT.%26aulast%3DKeane%26aufirst%3DT.%2BE.%26aulast%3DSmith%26aufirst%3DM.%2BT.%26aulast%3DJones%26aufirst%3DE.%2BE.%26aulast%3DDrake%26aufirst%3DR.%2BR.%26aulast%3DBielawska%26aufirst%3DA.%26aulast%3DNorris%26aufirst%3DJ.%2BS.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DRadiation-induced%2520acid%2520ceramidase%2520confers%2520prostate%2520cancer%2520resistance%2520and%2520tumor%2520relapse%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2013%26volume%3D123%26spage%3D4344%26epage%3D4358%26doi%3D10.1172%2FJCI64791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doan, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montoure, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Gizawiy, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurpad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rand, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connelly, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chitambar, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmainda, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirza, S. P.</span></span> <span> </span><span class="NLM_article-title">Acid ceramidase is a novel drug target for pediatric brain tumors</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">24753</span>– <span class="NLM_lpage">24761</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.15800</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.18632%2Foncotarget.15800" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=24753-24761&author=N.+B.+Doanauthor=H.+S.+Nguyenauthor=A.+Montoureauthor=M.+M.+Al-Gizawiyauthor=W.+M.+Muellerauthor=S.+Kurpadauthor=S.+D.+Randauthor=J.+M.+Connellyauthor=C.+R.+Chitambarauthor=K.+M.+Schmaindaauthor=S.+P.+Mirza&title=Acid+ceramidase+is+a+novel+drug+target+for+pediatric+brain+tumors&doi=10.18632%2Foncotarget.15800"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.15800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.15800%26sid%3Dliteratum%253Aachs%26aulast%3DDoan%26aufirst%3DN.%2BB.%26aulast%3DNguyen%26aufirst%3DH.%2BS.%26aulast%3DMontoure%26aufirst%3DA.%26aulast%3DAl-Gizawiy%26aufirst%3DM.%2BM.%26aulast%3DMueller%26aufirst%3DW.%2BM.%26aulast%3DKurpad%26aufirst%3DS.%26aulast%3DRand%26aufirst%3DS.%2BD.%26aulast%3DConnelly%26aufirst%3DJ.%2BM.%26aulast%3DChitambar%26aufirst%3DC.%2BR.%26aulast%3DSchmainda%26aufirst%3DK.%2BM.%26aulast%3DMirza%26aufirst%3DS.%2BP.%26atitle%3DAcid%2520ceramidase%2520is%2520a%2520novel%2520drug%2520target%2520for%2520pediatric%2520brain%2520tumors%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D24753%26epage%3D24761%26doi%3D10.18632%2Foncotarget.15800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elojeimy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahdy, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeidan, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bielawska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bielawski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Zawahry, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannun, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holman, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubinchik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szulc, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keane, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavassoli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norris, J. S.</span></span> <span> </span><span class="NLM_article-title">Acid ceramidase inhibition: a novel target for cancer therapy</span>. <i>Front. Biosci., Landmark Ed.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2293</span>– <span class="NLM_lpage">2298</span>, <span class="refDoi"> DOI: 10.2741/2843</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.2741%2F2843" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=17981711" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=2293-2298&author=X.+Liuauthor=S.+Elojeimyauthor=L.+S.+Turnerauthor=A.+E.+Mahdyauthor=Y.+H.+Zeidanauthor=A.+Bielawskaauthor=J.+Bielawskiauthor=J.+Y.+Dongauthor=A.+M.+El-Zawahryauthor=G.+W.+Guoauthor=Y.+A.+Hannunauthor=D.+H.+Holmanauthor=S.+Rubinchikauthor=Z.+Szulcauthor=T.+E.+Keaneauthor=M.+Tavassoliauthor=J.+S.+Norris&title=Acid+ceramidase+inhibition%3A+a+novel+target+for+cancer+therapy&doi=10.2741%2F2843"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.2741%2F2843&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F2843%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DElojeimy%26aufirst%3DS.%26aulast%3DTurner%26aufirst%3DL.%2BS.%26aulast%3DMahdy%26aufirst%3DA.%2BE.%26aulast%3DZeidan%26aufirst%3DY.%2BH.%26aulast%3DBielawska%26aufirst%3DA.%26aulast%3DBielawski%26aufirst%3DJ.%26aulast%3DDong%26aufirst%3DJ.%2BY.%26aulast%3DEl-Zawahry%26aufirst%3DA.%2BM.%26aulast%3DGuo%26aufirst%3DG.%2BW.%26aulast%3DHannun%26aufirst%3DY.%2BA.%26aulast%3DHolman%26aufirst%3DD.%2BH.%26aulast%3DRubinchik%26aufirst%3DS.%26aulast%3DSzulc%26aufirst%3DZ.%26aulast%3DKeane%26aufirst%3DT.%2BE.%26aulast%3DTavassoli%26aufirst%3DM.%26aulast%3DNorris%26aufirst%3DJ.%2BS.%26atitle%3DAcid%2520ceramidase%2520inhibition%253A%2520a%2520novel%2520target%2520for%2520cancer%2520therapy%26jtitle%3DFront.%2520Biosci.%252C%2520Landmark%2520Ed.%26date%3D2008%26volume%3D13%26spage%3D2293%26epage%3D2298%26doi%3D10.2741%2F2843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mahdy, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elojeimy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meacham, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gault, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPherson, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckham, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bielawska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bielawski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannun, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keane, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taha, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammouda, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norris, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span> <span> </span><span class="NLM_article-title">Acid ceramidase upregulation in prostate cancer cells confers resistance to radiation: AC inhibition, a potential radiosensitizer</span>. <i>Mol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">430</span>– <span class="NLM_lpage">438</span>, <span class="refDoi"> DOI: 10.1038/mt.2008.281</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1038%2Fmt.2008.281" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=19107118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFart7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=430-438&author=A.+E.+Mahdyauthor=J.+C.+Chengauthor=J.+Liauthor=S.+Elojeimyauthor=W.+D.+Meachamauthor=L.+S.+Turnerauthor=A.+Baiauthor=C.+R.+Gaultauthor=A.+S.+McPhersonauthor=N.+Garciaauthor=T.+H.+Beckhamauthor=A.+Saadauthor=A.+Bielawskaauthor=J.+Bielawskiauthor=Y.+A.+Hannunauthor=T.+E.+Keaneauthor=M.+I.+Tahaauthor=H.+M.+Hammoudaauthor=J.+S.+Norrisauthor=X.+Liu&title=Acid+ceramidase+upregulation+in+prostate+cancer+cells+confers+resistance+to+radiation%3A+AC+inhibition%2C+a+potential+radiosensitizer&doi=10.1038%2Fmt.2008.281"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Acid Ceramidase Upregulation in Prostate Cancer Cells Confers Resistance to Radiation: AC Inhibition, a Potential Radiosensitizer</span></div><div class="casAuthors">Mahdy, Ayman E. M.; Cheng, Joseph C.; Li, Jun; Elojeimy, Saeed; Meacham, William D.; Turner, Lorianne S.; Bai, Aiping; Gault, Christopher R.; McPherson, Alex S.; Garcia, Nicole; Beckham, Thomas H.; Saad, Antonio; Bielawska, Alicja; Bielawski, Jacek; Hannun, Yusuf A.; Keane, Thomas E.; Taha, Mohhammed I.; Hammouda, Hisham M.; Norris, James S.; Liu, Xiang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Therapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">430-438</span>CODEN:
                <span class="NLM_cas:coden">MTOHCK</span>;
        ISSN:<span class="NLM_cas:issn">1525-0016</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Radiation resistance in a subset of prostate tumors remains a challenge to prostate cancer radiotherapy.  The current study on the effects of radiation on prostate cancer cells reveals that radiation programs an unpredicted resistance mechanism by upregulating acid ceramidase (AC).  Irradiated cells demonstrated limited changes of ceramide levels while elevating levels of sphingosine and sphingosine-1-phosphate.  By genetically downregulating AC with small interfering RNA (siRNA), we obsd. radiosensitization of cells using clonogenic and cytotoxicity assays.  Conversely, AC overexpression further decreased sensitivity to radiation.  We also obsd. that radiation-induced AC upregulation was sufficient to create cross-resistance to chemotherapy as demonstrated by decreased sensitivity to Taxol and C6 ceramide compared to controls.  Lower levels of caspase 3/7 activity were detected in cells pretreated with radiation, also indicating increased resistance.  Finally, utilization of the small mol. AC inhibitor, LCL385, sensitized PPC-1 cells to radiation and significantly decreased tumor xenograft growth.  These data suggest a new mechanism of cancer cell resistance to radiation, through upregulation of AC i.e., in part, mediated by application of the therapy itself.  An improved understanding of radiotherapy and the application of combination therapy achieved in this study offer new opportunities for the modulation of radiation effects in the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcfZKQJLJrLbVg90H21EOLACvtfcHk0lglBmWtcQX8wA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFart7fF&md5=96aa1d9b77ef926f93655a78e610e20a</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fmt.2008.281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmt.2008.281%26sid%3Dliteratum%253Aachs%26aulast%3DMahdy%26aufirst%3DA.%2BE.%26aulast%3DCheng%26aufirst%3DJ.%2BC.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DElojeimy%26aufirst%3DS.%26aulast%3DMeacham%26aufirst%3DW.%2BD.%26aulast%3DTurner%26aufirst%3DL.%2BS.%26aulast%3DBai%26aufirst%3DA.%26aulast%3DGault%26aufirst%3DC.%2BR.%26aulast%3DMcPherson%26aufirst%3DA.%2BS.%26aulast%3DGarcia%26aufirst%3DN.%26aulast%3DBeckham%26aufirst%3DT.%2BH.%26aulast%3DSaad%26aufirst%3DA.%26aulast%3DBielawska%26aufirst%3DA.%26aulast%3DBielawski%26aufirst%3DJ.%26aulast%3DHannun%26aufirst%3DY.%2BA.%26aulast%3DKeane%26aufirst%3DT.%2BE.%26aulast%3DTaha%26aufirst%3DM.%2BI.%26aulast%3DHammouda%26aufirst%3DH.%2BM.%26aulast%3DNorris%26aufirst%3DJ.%2BS.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DAcid%2520ceramidase%2520upregulation%2520in%2520prostate%2520cancer%2520cells%2520confers%2520resistance%2520to%2520radiation%253A%2520AC%2520inhibition%252C%2520a%2520potential%2520radiosensitizer%26jtitle%3DMol.%2520Ther.%26date%3D2009%26volume%3D17%26spage%3D430%26epage%3D438%26doi%3D10.1038%2Fmt.2008.281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Otwinowski, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minor, W.</span></span> <span> </span><span class="NLM_article-title">Processing of x-ray diffraction data collected in oscillation mode</span>. <i>Methods Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">307</span>– <span class="NLM_lpage">326</span>, <span class="refDoi"> DOI: 10.1016/S0076-6879(97)76066-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1016%2FS0076-6879%2897%2976066-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=27754618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=1997&pages=307-326&author=Z.+Otwinowskiauthor=W.+Minor&title=Processing+of+x-ray+diffraction+data+collected+in+oscillation+mode&doi=10.1016%2FS0076-6879%2897%2976066-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Processing of x-ray diffraction data collected in oscillation mode</span></div><div class="casAuthors">Otwinowski, Zbyszek; Minor, Wladek</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">Macromolecular Crystallography, Part A</span>),
    <span class="NLM_cas:pages">307-326</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Macromol. crystallog. is an iterative process.  Rarely do the first crystals provide all the necessary data to solve the biol. problem being studied.  Each step benefits from experience learned in previous steps.  To monitor the progress, the HKL package provides 2 tools: (1) statistics, both weighted (χ2) and unweighted (R-merge), are provided, and the Bayesian reasoning and multicomponent error model facilitates obtaining the proper error ests. and (2) visualization of the process plays a double role by helping the operator to confirm that the process of data redn., including the resulting statistics, is correct, and allowing one to evaluate problems for which there are no good statistical criteria.  Visualization also provides confidence that the point of diminishing returns in data collection and redn. has been reached.  At that point, the effort should be directed to solving the structure.  The methods presented here have been applied to solve a large variety of problems, from inorg. mols. with 5 Å unit cell to rotavirus of 700 Å diam. crystd. in 700 × 1000 × 1400 Å cell.  Overall quality of the method was tested by many researchers by successful application of the programs to MAD structure detns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA3fvBOHqhhrVg90H21EOLACvtfcHk0lglBmWtcQX8wA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D&md5=c9536971d4e32cc35352c40fb9368131</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2897%2976066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252897%252976066-X%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26aulast%3DMinor%26aufirst%3DW.%26atitle%3DProcessing%2520of%2520x-ray%2520diffraction%2520data%2520collected%2520in%2520oscillation%2520mode%26jtitle%3DMethods%2520Enzymol.%26date%3D1997%26volume%3D276%26spage%3D307%26epage%3D326%26doi%3D10.1016%2FS0076-6879%2897%2976066-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storoni, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span> <span> </span><span class="NLM_article-title">Phaser crystallographic software</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">658</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0lglBmWtcQX8wA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodson, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keegan, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krissinel, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNicholas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannu, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potterton, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, K. S.</span></span> <span> </span><span class="NLM_article-title">Overview of the CCP4 suite and current developments</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">242</span>, <span class="refDoi"> DOI: 10.1107/S0907444910045749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1107%2FS0907444910045749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=21460441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=235-242&author=M.+D.+Winnauthor=C.+C.+Ballardauthor=K.+D.+Cowtanauthor=E.+J.+Dodsonauthor=P.+Emsleyauthor=P.+R.+Evansauthor=R.+M.+Keeganauthor=E.+B.+Krissinelauthor=A.+G.+Leslieauthor=A.+McCoyauthor=S.+J.+McNicholasauthor=G.+N.+Murshudovauthor=N.+S.+Pannuauthor=E.+A.+Pottertonauthor=H.+R.+Powellauthor=R.+J.+Readauthor=A.+Vaginauthor=K.+S.+Wilson&title=Overview+of+the+CCP4+suite+and+current+developments&doi=10.1107%2FS0907444910045749"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the CCP4 suite and current developments</span></div><div class="casAuthors">Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.; Dodson, Eleanor J.; Emsley, Paul; Evans, Phil R.; Keegan, Ronan M.; Krissinel, Eugene B.; Leslie, Andrew G. W.; McCoy, Airlie; McNicholas, Stuart J.; Murshudov, Garib N.; Pannu, Navraj S.; Potterton, Elizabeth A.; Powell, Harold R.; Read, Randy J.; Vagin, Alexei; Wilson, Keith S.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  The CCP4 (Collaborative Computational Project, No. 4) software suite is a collection of programs and assocd. data and software libraries which can be used for macromol. structure detn. by X-ray crystallog.  The suite is designed to be flexible, allowing users a no. of methods of achieving their aims.  The programs are from a wide variety of sources but are connected by a common infrastructure provided by std. file formats, data objects and graphical interfaces.  Structure soln. by macromol. crystallog. is becoming increasingly automated and the CCP4 suite includes several automation pipelines.  After giving a brief description of the evolution of CCP4 over the last 30 years, an overview of the current suite is given.  While detailed descriptions are given in the accompanying articles, here it is shown how the individual programs contribute to a complete software package.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_wWMMIol6UrVg90H21EOLACvtfcHk0lhrq9wLAEZltA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D&md5=c407e4d47bef46864be336d60147c17d</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1107%2FS0907444910045749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910045749%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DBallard%26aufirst%3DC.%2BC.%26aulast%3DCowtan%26aufirst%3DK.%2BD.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DKeegan%26aufirst%3DR.%2BM.%26aulast%3DKrissinel%26aufirst%3DE.%2BB.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%26aulast%3DMcCoy%26aufirst%3DA.%26aulast%3DMcNicholas%26aufirst%3DS.%2BJ.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DPotterton%26aufirst%3DE.%2BA.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26atitle%3DOverview%2520of%2520the%2520CCP4%2520suite%2520and%2520current%2520developments%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D235%26epage%3D242%26doi%3D10.1107%2FS0907444910045749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afonine, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunkoczi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echols, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Headd, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapral, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oeffner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwart, P. H.</span></span> <span> </span><span class="NLM_article-title">PHENIX: a comprehensive python-based system for macromolecular structure solution</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1107/S0907444909052925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunkocziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.+W.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grosse-Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=PHENIX%3A+a+comprehensive+python-based+system+for+macromolecular+structure+solution&doi=10.1107%2FS0907444909052925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0lhrq9wLAEZltA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunkoczi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.%2BW.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DPHENIX%253A%2520a%2520comprehensive%2520python-based%2520system%2520for%2520macromolecular%2520structure%2520solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D213%26epage%3D221%26doi%3D10.1107%2FS0907444909052925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5U7Z" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5U7Z','PDB','5U7Z'); return false;">PDB: 5U7Z</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MHM" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MHM','PDB','6MHM'); return false;">PDB: 6MHM</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i11"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01723">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_25206"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b01723">10.1021/acs.jmedchem.8b01723</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Chemical structures of carmofur and its mechanism of inhibition (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01723/suppl_file/jm8b01723_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01723/suppl_file/jm8b01723_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01723/suppl_file/jm8b01723_si_001.pdf">jm8b01723_si_001.pdf (132.32 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01723/suppl_file/jm8b01723_si_002.csv">jm8b01723_si_002.csv (0.11 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Structures and reflection data of AC-carmofur complexes reported here have been deposited to the Protein Data Bank under the accession code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MHM">6MHM</a>. Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01723&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01723%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-2%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01723" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a6e15a91d3d2a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
